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Tuberculosis is among the most prevalent infectious diseases on the planet. 
The causative pathogens from the Mycobacterium tuberculosis complex 
successfully counter host immunity and survive environmental stressors such 
as hypoxia and starvation to enter an antibiotic-tolerant persistent state. 
These “dormant” bacteria establish a latent disease that can relapse decades 
after the primary infection. Thus, elucidating the molecular mechanisms 
underlying persistence is critical to developing therapeutic interventions. To 
this end, systems-level analyses were performed to define the molecular 
responses to nutrient deprivation and hypoxia. For nutrient deprivation, 
transcriptional profiling was combined with flow cytometric measurements of 
microbe physiology and multiplexed metabolic phenotypic screens to deduce 
that starved mycobacteria enter a state of lipid metabolism-induced ketosis 
that results in formation of reactive oxygen species by upregulating 
cytochrome P450s. Further biochemical investigations established that 
targeted killing of persister populations could be accomplished using Fenton 
reactions that damage these enzymes. For hypoxic stress, data-driven 
analyses of the ribonucleome and proteome of hypoxic mycobacteria 
revealed chemical reprogramming of modified ribonucleosides in transfer 
RNAs, which caused selective translation of codon-biased mRNAs essential 
to the stress response. Disruption of this system by codon reengineering 
caused dormancy responses to be mistimed and this is detrimental to hypoxia 
survival. Together, these discoveries offer insights into the mechanisms 
underlying mycobacterial persistence, dormancy and drug tolerance, which 
provide new targets for drug development, platforms for drug screening, and 
biomarkers of disease state. 
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1.  Background and Significance 
1.1. Motivation and goal 
This thesis is motivated by the convergence of three factors: the continued 
tuberculosis (TB) pandemic, the emergence of significant antibiotic resistance 
in its causative organism, Mycobacterium tuberculosis (Mtb), and an evolving 
paradigm of translational control of cell response. Members of the Dedon 
research group at MIT recently described a new mechanism by which 
eukaryotic cells respond to stress, involving enzymatic reprogramming of 
chemically modified ribonucleotides in transfer ribonucleic acids (tRNAs) to 
control gene expression under stress. Given the conservation of tRNA 
modifications and translational machinery in all living organisms, I rationalized 
that this translational control mechanism would be operant in prokaryotes, 
including mycobacteria. Thus, the overarching goal of my research has been 
to understand how pathogens of the Mtb complex regulate their gene 
expression in response to nutrient deprivation and hypoxia – physiological 
stresses associated with the host’s immune response and disease 
pathogenesis. This understanding would not only further our knowledge in 
microbiology in general and mycobacteriology specifically, but more 
importantly, it would open unexplored avenues in TB drug development and 
biomarker discovery. 
1.2. Scope 
The scope of the problem of tuberculosis (TB) is highlighted by both its long 
history and its prevalence. The historical context is set with the following 
milestones: 6000 years ago, mycobacteria evolved as human pathogens [1]; 
Hippocrates first described the disease 2400 years ago [2, 3]; Robert Koch 
identified the causative agent 133 years ago [4]; Albert Calmette and Camille 
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Guérin introduced attenuated Mycobacterium bovis, Bacille de Calmette et 
Guérin (BCG), as a vaccine against TB 94 years ago [5]; and 48 years ago,  
rifampicin was introduced to modern treatment regiments [6]. In spite of this 
long history of study, TB remains, save for human immunodeficiency virus 
infections and acquired immune deficiency syndrome (HIV/AIDS), as the 
greatest killer worldwide due to a single infectious agent [7], with an estimated 
one-third of humanity infected.  The lack of progress in developing new 
antibiotics and vaccines for TB is apparent from the fact that today’s TB drug 
regimen takes too long (6-24 months) to be effective and requires too many 
medications [8, 9]. Furthermore, current first- and second-line drugs are 
highly toxic [10-12], expensive and incompatible with common anti-retroviral 
(ARV) therapies used to treat HIV co-infections [13]. The most worrying 
problem, which motivates this thesis, is the recent advent of multi-drug 
resistant (MDR), extensively drug resistant (XDR) and even totally drug 
resistant (TDR) TB [7, 14]. Together, these developments highlight the urgent 
need for new therapeutics, active against current drug-resistant strains, with 
reduced side effects and increased potency. With these traits, new TB 
medications would shorten treatment times, improve patient adherence, and 
lessen the likelihood of bacterial strains developing drug resistance [15, 16]. 
Yet, disregarding serendipity, the discovery and development of TB drugs 
with novel mechanisms of action require a fundamental understanding of how 
pathogens of the Mtb complex evade the host innate and adaptive immunity, 
enter a persistent state in nutrient-limited, hypoxic granulomatous lesions, 
develop antibiotic resistance or tolerance (both genetic and phenotypic), and 
re-emerge years after the primary infection to the detriment of the host [17].   
This thesis is aimed at gaining molecular insights in the fundamental 
mechanisms of mycobacterial-host interactions, which requires a critical 
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evaluation of reported experimental observations and occasionally a 
challenge to long-standing dogma. The scope of my research project is based 
on recent novel observations on the roles of metabolism and reactive oxygen 
species (ROS) in bacterial persistence [18, 19], and on the translational 
control of cell survival [20, 21]. My goals were to first to redefine these cellular 
and molecular systems in the context of mycobacterial survival of 
physiological stresses; second, to expand the original observations by 
quantifying how each component varies as a function of stress exposure; and 
third, to utilize this quantitative formulation of observed biological phenomena 
to build new models for mycobacterial-host interactions. 
Throughout this process, quantitative biology allows us an “extra sense”, as 
appreciated by Charles Darwin himself [22], to decide whether a given 
biological claim actually makes sense. This is illustrated in Chapter 2, in 
which we disproved earlier over-estimates on total RNA quantities 
mycobacteria and the length of mycobacterial 5S ribosomal RNA (rRNA) by 
providing its exact sequence and quantities within BCG. This recursive 
approach between hypothesis- and data-driven research enables us to gain a 
systems-level appreciation of mycobacterial stress responses, which is an 
appreciation sorely needed for the design and development of biomarkers of 
infection, diagnostic tools and new antibiotics. 
In the following introductory chapter, we will travel down the scales of 
quantitative biology by first examining how TB epidemiology reflects Mtb 
pathophysiology, then narrowing the focus on Mtb cellular stress responses 
and how Mtb metabolism determines persistence. Next, we address gene 
expression by introducing an innovative new model of the translation control 
of stress response proteins in Saccharomyces cerevisiae and discussing its 
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implication for non-replicating mycobacteria. Finally, we conclude by providing 
an outline of the specific aims of each section of this thesis. 
1.3. Tuberculosis: etiology, epidemiology and pathophysiology 
TB is an “heirloom disease”: one caused by mycobacteria that infected early 
humans and evolved with the species as people have spread around the 
world [23]. As the causative agent of TB, Mtb emerged relatively recently in 
evolutionary terms [1]. Although commonly defined as a latent, slowly 
debilitating disease, TB occasionally assumes an acute, rapidly progressive 
course. Initial tuberculous mycobacterial infection usually goes unnoticed and 
is a condition known as latent TB infection (LTBI). About 10% of 
immunocompetent adults with LTBI will eventually progress to active disease, 
and half of them will do so in the first two years following infection [8, 24]. The 
risk of progression to active disease is increased in immuno-compromised 
persons, such as in diabetics and patients co-infected with HIV, and children 
under 5 years of age [25-27]. The disease also affects practically all 
vertebrate species, which can serve as reservoirs for zoonotic infections.  For 
instance, M. bovis infection of cattle is not only an economic threat on the 
scale of bovine spongiform encephalitis or hand, foot and mouth disease to 
the dairy industry, but it is still a significant zoonosis in non-industrialized 
countries of the world [28]. 
1.3.1. Disease burden of Mtb infections  
Globally in 2013, 9 million people fell ill with TB, 11 million suffered from 
active TB, and 1.5 million died from the disease. Although gradual, the global 
incidence, prevalence and mortality declined 1.5%,  1.8% and 1.9%, 
respectively, on average yearly from 1990 - 2013 (Fig 1.1) [7]. Economically, 
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TB causes losses of US$12 billion in productivity annually [16], but this 
estimate does not consider the costs of vaccination, surveillance, prevention 
and eradication programs nor does it consider the losses caused by livestock 
TB [29]. These numbers, however, fail to capture the inequality with which the 
burden is shared. Most of the estimated number of cases of TB in 2013 
occurred in Asia (56%) and the African Region (29%), with India and China 
alone accounting for 24% and 11% of global cases, respectively. The lowest 
epidemiological burden occurred predominantly in high-income countries 
including most countries in Western Europe, North America and Japan [7]. 
Singapore, interestingly, possesses the highest incidences rates for a 
developed country at ~40 new cases per 100,000 persons from 2000-2013 
[30], though this is mostly attributed to the large, foreign-born, migrant 
workforce from developing nations [30, 31]. Indeed, TB and poverty are 
closely linked. Malnutrition, overcrowding, poor air circulation and sanitation-
 
Figure 1.1. Estimated rates of TB incidence, prevalence and mortality 
(1990-2015). Left: Global incidence rate including HIV-positive TB (green) 
and estimated incidence rate of HIV-positive TB (red). Centre and right: TB 
prevalence and mortality rates 1990–2013 and forecast TB prevalence and 
mortality rates 2014–2015. The horizontal dashed lines represent the Stop 
TB Partnership targets of a 50% reduction in prevalence and mortality 
rates by 2015 compared with 1990. Shaded areas represent uncertainty 
bands. Mortality excludes TB deaths among HIV-positive people. Taken 
from [7], rights of noncommercial reprint for academic purposes obtained 
from http://www.who.int/licensing/reprints/en/. 
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factors associated with poverty all increase both the probability of becoming 
infected and the probability of developing clinical disease. Together, poverty 
and the tubercle bacillus create a vicious cycle: poor people go hungry and 
live in close, unhygienic quarters where TB flourishes; TB decreases people's 
capacity to work, and adds treatment expenses, exacerbating their poverty. 
Meanwhile, the poor receive inadequate health care, preventing even the 
diagnosis of their TB. Treatment, if received at all, is often erratic or simply 
incorrect. The poor are also less likely to seek and receive care from medical 
practitioners when ill, and are two- to three-times more likely than other 
income groups to self-medicate [16]. Self-medication encourages the 
emergence of drug-resistant TB strains [32], which might lead one to expect 
higher rates of drug resistant (DR) TB in developing countries. This 
assumption, however, is not fully supported by epidemiological evidence, 
which suggests that other factors are involved in the emergence and spread 
of DR TB. 
1.3.2. Multidrug resistant tuberculosis is associated with disease 
relapse 
The current standard ‘directly observed treatment, short-course’  (DOTS) 
treatment for pulmonary TB consists of isoniazid (INH), rifampin (RIF), 
pyrazinamide (PZA), and ethambutol (EMB) for 2 months, then INH and RIF 
alone for a further 4-7 months depending on dosage [33]. Clinically, MDR-TB 
is defined as TB that is resistant to at least isoniazid (INH) and rifampin (RIF) 
[34]; strains further resistant to any member of the quinolone family and at 
least one of the second-line anti-TB injectable drugs (kanamycin, 
capreomycin, or amikacin) are classified as XDR-TB [7]. Obviously, TDR-TB 
strains are resistant to all tested first- and second-line drugs [14]. Globally, 
levels of MDR-TB among new TB cases had remained steady at 3.5% (95% 
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confidence interval, CI: 2.2–4.7%) for the last decade, while levels among 
previously treated cases, however, had been steadily increasing and reached 
21% (95%CI: 14–28%) in 2013 [7]. This makes TB relapse, either re-
infections or reactivation of latent infections, as the single largest risk factor 
for MDR-TB worldwide [35, 36]. Breaking this down regionally, we note that 
the African Region composed of mostly developing countries and possessing 
high incidences of TB, does not have higher rates of MDR-TB among either 
new or re-treated TB cases (Table 1.1). The surprising outlier is the European 
Region, in which 14% of new cases and 44% of previously treated cases had 
MDR-TB. This number is skewed by contributions from ex-Soviet bloc 
countries (e.g., Russian Federation- new: 19%, retreated: 49%; Belarus- new: 
35%, retreated: 55%; Estonia- new: 17%, retreated: 48%; Kazakhstan- new: 
25%, retreated: 55%) [7]. Since per capita gross domestic product (GDP) in 
2013 is US$22,267 in the Eurasian Economic Union and US$2,320 in Africa, 
economics is not the sole determinant of MDR-TB1 [37].  
Table 1.1 Estimated proportions of TB cases that have MDR-TB in WHO 

















Africa 2.4 0.2–5.0 13 0.02–27 
Americas 2.2 1.3–3.0 13 4.9–22 
Eastern 
Mediterranean 
3.6 2.3–5.0 22 12–32 
Europe 14 9.7–19 44 36–52 
Southeast 
Asia 
2.2 1.8–2.7 16 12–20 
Western 
Pacific 
4.4 2.6–6.3 22 18–26 
Global 3.5 2.2–4.7 21 14–28 
Source: World Health Organization Global TB Programme Information 
Resource Centre. www.who.int/tb/data. Retrieved 9th January 2015. 
                                                          
1
  Further discussion on the role of national healthcare policies on limiting the development 
of DR TB is not within the purview of this review. 
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1.3.3. Development of antibiotic resistance in TB relapse reflects 
disease pathology 
So why is TB relapse indicative of the development of MDR-TB? Our first 
clues come from the pathology of the disease itself. Inhalation of infected 
droplets expelled from the lungs is the usual route of TB infection, although 
ingestion, particularly via contaminated milk or water, also occurs [38]. 
Intrauterine, coital and intravenous routes of infection are less common [39, 
40]. Inhaled bacilli are phagocytosed by alveolar macrophages that may 
either clear the infection or allow the mycobacteria to proliferate. In the latter 
instance, a primary focus may form, mediated by cytokines, notably tumour 
necrosis factor alpha (TNF-α), interferon gamma (IFN-γ) and interleukin 4 and 
12 (IL-4/12) [41, 42], associated with a delayed hypersensitivity reaction that 
consists of dead and degenerate macrophages surrounded by epithelioid 
cells, granulocytes, lymphocytes, and later, multinucleated giant cells. The 
purulent to caseous, necrotic center may calcify, and the lesion may become 
surrounded by granulation tissue and a fibrous capsule to form the classic 
tubercle or granuloma. The primary focus, plus similar lesions formed in the 
regional lymph node, is known as the “primary complex.” In alimentary forms 
of disease, the primary focus may be found in the pharynx or mesenteric 
lymph nodes or, less commonly, in the tonsils or intestines [43]. The cellular 
composition of and presence of acid-fast bacilli in tuberculous lesions differs 
between granulomatous lesions even within the same host [44, 45]. 
Established Mtb infections usually persist for the entire lifespan of the host 
and cannot be cleared without therapeutic intervention. Although a significant 
proportion of lesions remains unhealed in hosts, most infections (>90%) are 
latent [43]. However, in about 10% of individuals, the bacteria reactivates and 
rapidly multiplies and spreads to develop active TB [24]. Dissemination 
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through vascular and lymphatic channels may be generalized and rapidly 
fatal, as in acute miliary TB. Nodular lesions may form in many organs, 
including the pleura, peritoneum, liver, kidney, spleen, skeleton, mammary 
glands, reproductive tract, and central nervous system [46]. These potential 
life-threatening forms of reactivated disease accounts for 47–87% of active 
TB disease in low-prevalence regions, such as in the United States [47-49].  
Throughout the course of the infection, Mtb is exposed to a range of 
microenvironments that induce compensatory metabolic pathways and 
physiological states. Prominent among these is the non-replicating persistent 
(NRP) or “dormant” state. Within the lung, regional differences exist in 
ventilation and perfusion, and in the degree of blood oxygenation. In a 
seminal study using resected lung tissue, lesions classified as ‘open’ (oxygen 
rich) were found to contain bacilli that grew readily on nutrient agar and a 
majority (~80%) produced cultures that were resistant to the drugs 
streptomycin (STM), 4-aminosalicylic acid (PAS) or INH, with which the 
patients had been treated. However, bacilli isolated from ‘closed’ (oxygen 
poor) lesions showed delayed growth (up to 4 months from 4-8 weeks) and 
were mostly drug sensitive upon resuscitation (83%) [50-52]. In agreement, 
recent studies in macaques demonstrate that granulomas whether non-
necrotising, fibrocalcific or caseous, possessed varying bacterial numbers, 
even within the same individual. In these monkeys, the ability of the host 
immunity to sterilize infecting bacilli remains unchanged in both active and 
latent manifestations of the disease; however, killing efficiency is diminished 
in caseous granulomas and TB pneumonia resulting in residue bacterial 
growths in these regions [53]. Together, these results suggests that there are 
two aspects to drug resistance in Mtb, one acquired through genetics, 
dependent on the selection of mutant strains with increased fitness when 
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exposed to antibiotics and to the host immunity – as observed in the readily 
cultured bacilli found in ‘open’ lung lesions, and the second innate, 
determined by transient adaptations to the varied microenvironments of 
different granulomas – as observed in the dormant mycobacteria found in 
‘closed’ lung lesions. 
1.3.4. Acquired antibiotic resistance 
Antibiotic resistance can emerge by spontaneous mutations in chromosomal 
genes or gained through the acquisition of genes by conjugation, transduction 
or transformation. Unlike other microorganisms, acquired drug resistance 
does not occur by horizontal gene transfer, since Mtb lacks plasmids and 
efficient genomic DNA transfer mechanisms – outside of mycobacterial 
phages – have not been described. Thus, acquired drug resistance most 
likely arises from spontaneous mutations in specific target genes rendering 
the bacteria resistant to a given drug [54].  
These mutations could either occur within protein coding sequences, which 
would affect protein function or activity, or within promoter regions, which 
would affect gene expression. Recent studies on the mutation rates of Mtb 
clinical isolates in humans and non-human primates suggest that rates of 
spontaneous mutations are higher than expected; and though modulated by 
host environments these rates do not differ between active and latent 
infections [55-57]. Under selection pressure from antibiotics, transient mutator 
strains could readily gain the necessary mutations required to develop MDR-
TB. Some of the most effective mutations (at least from the perspective of 
Mtb) are single-nucleotide polymorphism (SNPs). For instance, INH 
resistance in clinical MDR-TB strains is most frequently attributed to non-
synonymous point mutations in katG catalase protein coding sequences, 
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which results in S315T mutants [58-60]. Another common function SNP 
involves 15CT substitution in the promoter region for NADH-dependent 
enoyl-ACP reductase (inhA) [61-64]. INH is a prodrug and must be activated 
by KatG, which involves coupling INH with NADH to form isonicotinic acyl-
NADH complexes. These complexes bind tightly to InhA, thereby blocking the 
natural enoyl-AcpM substrate and its fatty acid synthase activity. Hence, 
mycolic acid synthesis – an essential process for cell wall formation – is 
inhibited by INH through its activation by KatG [64]. S315T mutations 
decrease catalase-peroxidase activity of KatG, resulting in a deficiency in the 
formation of INH-NAD adducts [65], while15CT mutations in inhA promoters 
cause InhA over-expression which helps the mutant overcome INH-NAD 
inhibition [64]. When exposed to non-sterlizing doses of INH, these mutants 
survive and proliferate, which spreads INH-resistant Mtb [63]. Resistance to 
RIF, PZA, STM, EMB and other second line drugs can arise through similar 
mechanisms (Table 1.2).  
1.3.5. Innate antibiotic tolerance or phenotypic drug resistance 
Not all cases of drug resistance in clinical isolates can be explained by the 
presence of stable gene mutations. The mutations in genes associated with 
INH and RIF mutants, for instance, are found in ~30-86% of INH-resistant and 
~5-69% of RIF-resistant in Mtb clinical isolates [66, 83]. This suggests that 
other mechanisms of drug resistance exist. Intrinsic drug resistance in Mtb 
has been attributed to a combination of a highly impermeable mycolic acid 
containing cell wall and active drug efflux mechanisms [84-87]. ATP-binding 
cassettes (ABC), for example, make up ~2.5% of the Mtb genome [88]; 
several of which contribute to tolerance to β-lactams [89], novobiocins, 
pyrazolones, biarylpiperazines, bisanilinopyrimidines, pyrroles and pyridones 
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Table 1.2. Genes associated with acquired drug resistance 
Druga Geneb Function of gene product 
INH 
katG Catalase/peroxidase 
inhA promoter Enoyl-ACP reductase 
ahpC Alkyl hydroperoxide reductase 
RIF rpoB RNA polymerase β-subunit 
PZA pncA PZase 
STM 
rpsL Ribosomal protein S12 
rrs 16S rRNA 
gidB RNA 7-methylguanosine 
methyltransferase 
EMB embB Arabinosyl transferase 
Fluoroquinolones gyrAB DNA gyrase 
KAN,AMK rrs 16S rRNA 
eis promoter GCN5-related N-acetyltransferase 
AMK,CAP,VIO tlyA rRNA methyltransferase 
ETH inhA promoter Enoyl-ACP reductase 
PAS thyA Thymidylate synthase A 
PA-824 ddn Deazaflavin-dependent 
nitroreductase 
TM207 atpE ATP synthase 
 
a AMK, amikacin, CAP, capreomycin; EMB, ethambutol; ETH, ethionamide; 
INH, isoniazid; KAN, kanamycin; PA-824, pretomanid; PAS, p-amino salicylic 
acid; RIF, rifampin; STM, streptomycin; TM207; bedaquiline; VIO, viomycin. 
b Collated from literature searches [58, 63, 66-82] and the TB drug resistance 
database https://tbdreamdb.ki.se/Info/.   
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[90]. Table 1.3 lists the known drug efflux pumps in Mtb. Together they form a 
formidable pharmacokinetic barrier preventing drug uptake and facilitating 
drug efflux. 
Since caseous granulomas and inflammatory lung tissues in TB pneumonia 
are hypoxic, it should come as no surprise that in vitro studies show that 
under hypoxia Mtb becomes refractory to antibiotic killing [111, 112]. High O2 
tension exists in the upper lung, whereas the ventral lung experiences low O2 
tension. Consistent with anatomy and function, the partial O2 pressure (pO2) 
of atmospheric O2 (150–160 mmHg) drops from ~150 to ~60 mm Hg from the 
trachea to the bronchioles [113, 114]. Across the alveoli, the diffusion 
distance is ∼100–200 μm, resulting in a rapid diffusion to the blood vessels 
[114, 115]. Using redox-active dyes that are reduced at pO2 lower than 10 
mm Hg, studies in guinea pigs and non-human primates have shown that the 
granulomas are indeed hypoxic ( ~1. 9 mm Hg) [45, 116]. Thus, hypoxic 
exposures within inflammatory and granulatomous tissues is closely 
associated with an indifference to antibiotic killing. 
The hypoxic stress response of Mtb is well defined. Part of this response 
involves a dynamic shift in cellular metabolism. A consensus from studies of 
gene expression of Mtb in infected primary human macrophages, mouse 
bone marrow derived macrophages, rodents models and in vitro culture 
systems leads to a model involving an upregulation of genes involved in the 
glyoxylate cycle, gluconeogenesis and fatty acid metabolism, including 
isocitrate lyases (icl, aceA1), citrate synthase (gltA), PEP carboxykinase 
(pckA), pyruvate phosphate dikinase (ppdK), fructose-bisphosphate aldolase 
(fba), acyl CoA dehydrogenases (fadE) and enoyl CoA hydratase (echA), as 
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Table 1.3. Known drug efflux pumps in Mtb. 
Genesa Drug extrudedb Transporter familyc 
Rv0194 STM ABC 
IniABC  
(Rv0341-Rv0343) 
INH, EMB Membrane transporter 
MmpL5-MmpS5  
(Rv0676c-Rv0677c) 
Azoles, TET RND 
EmrB (Rv0783) RIF MFS 
Rv0849 β-Lactams MFS 
PstB (Rv0933) INH, RIF, EMB, CIP ABC 
Rv1218c β-Lactams ABC 
Rv1258c 
INH, RIF, EMB, OFL,  
β-lactams 
MFS 
P55 (Rv1410c) STM,INH, RIF MFS 
Rv1634 Fluoroquinolones MFS 
Rv1747 INH ABC 
BacA (Rv1819c) Bleomycin ABC 
Rv1877 TET, KAN, erythromycin MFS 
Rv2333c TET, spectinomycin MFS 
Rv2459 INH, EMB MFS 
Rv2686c-Rv2888c CIP ABC 
DrrABC  
(Rv2936-Rv2938) 
TET, STM, EMB, RIF ABC 
EfpA (Rv2846c) INH, ETH MFS 
MmpL7 (Rv2942) INH RND 
Mmr (Rv3065) Erythromycin, β-lactams SMR 
 
a Collated from literature searches [89-101] and genomic annotation 
comparisons from http://tuberculist.epfl.ch/; http://www.tbdb.org/ and 
http://www.genome.jp/kegg/.  
b CIP, ciprofloxacin; EMB, ethambutol; ETH, ethionamide; INH, isoniazid; 
KAN, kanamycin; OFL, ofloxacin; RIF, rifampin; STM, streptomycin; TET, 
tetracycline. 
c ABC, ATP-binding cassette; MFS, major facilitator superfamily; SMR, small 
multidrug resistance family; RND, resistance/nodulation/cell division family. 
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well as the genes for uptake of glycerol-3-phosphate (ugp and glpD) and 
cholesterol (mce4 operon). There is also down-regulation of key cytochrome 
complexes in the electron transport chain (ETC) [117-121]. The net effect: a 
shift towards lipotropy and a five-fold reduction in steady-state ATP levels in 
dormant Mtb compared to their replicating counterparts [107, 122]. A unique 
feature of this lipolytic shift is the conservation of carbon through the cycling 
of acetyl-CoA, from even-chain fatty acid β-oxidation, to glyoxylate and 
succinate by the glyoxylate shunt [123, 124]. The former is condensed with a 
molecule of acetyl CoA to form oxaloacetate that can be further converted to 
phosphoenolpyruvate, which allows further reductive carboxylation to take 
place [125]. The latter is coupled to ATP synthesis and membrane potential 
maintenance, respectively, through the interaction of succinate 
dehydrogenase (SDH) with the ETC and by it accumulation within hypoxic 
cells [124]. Isocitrate lyase, in turn, is required for Mtb persistence in mouse 
models [126, 127], highlighting its importance in dormant mycobacteria. 
Though the precise mechanism is unclear, these studies suggest that altered 
lipid utilization is closely associated with the antibiotic tolerance of dormant 
mycobacteria. Further characterization of the close links between lipid 
catabolism and antibiotic resistance is presented in Chapter 5 of this thesis, 
wherein we highlight the consequences of this catabolic shift and its effects 
on phenotypic drug resistance in mycobacterial persisters. 
1.3.6. Regulation of stress responses in Mtb 
Mtb contains a plethora of regulatory systems controlling growth, physiology 
and metabolism during stress. These include serine/threonine protein kinases 
(STPKs – 11 identified) that are coupled to sensors of environmental signals 
and mediate host-pathogen interactions, cell division and developmental 
changes [128, 129]; WhiB proteins (7 identified) that bind to iron-sulfur 
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clusters and DNA, thus coupling transcription to intracellular redox potential 
[130, 131]; guanosine pentaphosphate alarmone signaling (RelMtb)and toxin-
antitoxin systems (~80 pairs identified) best known their role in bacterial 
stringent responses [132, 133] (further discussed in Chapter 5); sigma factors 
(13 identified) regulating gene expression under stress [134-136]; and two-
component systems (11 identified) that use phosphorelay to “sense” the 
environment and induce the expression of gene regulons necessary for 
survival within host cells [137-141].  
The coordination of stress responses is a complex process, involving multiple 
dynamic interactions between regulatory systems, though the full extent of 
these interactions, their triggers and effectors are still unknown. For hypoxic 
stress, it is generally accepted that the DosRS/T two-component system 
plays a prominent role mediating adaptations to O2-limited environments by 
influencing the reversible shifts between aerobic and anaerobic respiration 
[117, 120, 142-146]. Recent work on Ser/Thr Protein Kinase B (PknB), 
however, details its DosR-independent activity in resuming growth after 
hypoxic exposures [147]. Nonetheless, the dormancy survival (Dos) regulon, 
a set of 48 genes controlled by DosRS/T [117, 144, 148, 149], remains the 
best characterized regulatory network in mycobacteria.  
First identified in a screen for genes differentially expressed (DevSR) in the 
virulent lab adapted strain of Mtb (H37Rv) compared to the avirulent H37Ra 
strain [150], these proteins were found to be important in dormancy survival 
(Dos) and alternatively named DosR and DosS [151, 152]. In this system, 
DosS and DosT are heme-containing, redox- and hypoxia-sensing histidine 
kinases that activate DosR, a transcription factor, which induces transcription 
of Dos regulon genes and small non-coding RNAs (ncRNA), as well as 
activating STPK [153-156]. In addition to hypoxia, nitric oxide (NO) produced 
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by activated macrophages [120], and carbon monoxide (CO) from pro-
inflammatory responses in lung lesions [157, 158], have also been 
demonstrated to activate the Dos regulon. Extended exposure to hypoxia 
further induces a larger enduring hypoxia response leading to dormancy 
[145]. During hypoxia, one of the most highly upregulated genes in the 
regulon is hspX which encodes an alpha-crystallin (Acr) heat shock chaperon 
protein that is strongly associated with growth arrest in vitro [144, 159, 160] 
(Fig. 1.2). The significance of this regulon for survival within hosts has been 
demonstrated in rabbit and guinea pig models of TB – both displaying a 
human-like histopathology and hypoxic lesions – and in humans wherein Dos 
regulon proteins are found to be expressed in latent infections [161-164].  
1.4. Models for the study of Mtb dormancy and persistence in vitro 
Much of our knowledge about dormant Mtb comes from the analysis of 
differentially expressed transcripts upon stress exposures [165-168]. Variation 
in transcript levels, however, only shows 30-40% correlation with protein 
abundance, and thus, fails to fully explain complex biological phenomena 
such as Mtb dormancy and persistence [169-171]. Since variation in 
underlying transcript levels cannot account for the majority of variation 
observed in the corresponding protein levels our knowledge of the control of 
mycobacterial stress responses is incomplete without a thorough 
understanding of post-transcriptional process that regulate gene expression. 
For instance, it is assumed, based on transcript levels, that DosR plays a 
prominent role in the switch towards, but not the maintenance of, non- 
replicating persistence [145]. However, in Chapter 6 we demonstrate that 
while dosR transcript levels fall after the establishment of the NRP state, 
DosR protein levels remain elevated until resuscitation (by re-aeration). This 
discovery and the others detailed in the latter sections of this thesis were
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facilitated through the use of deterministic models that mimic physiological 
stresses in vitro. 
1.4.1. The Wayne model for hypoxia-induced dormancy 
An ideal model for Mtb dormancy should be tractable and biologically 
relevant. The Wayne model and its variants seek to imitate the hypoxic 
conditions faced by Mtb in closed, necrotic lesions by inducing gradual 
depletion of oxygen within a sealed, stirred culture tube of specific dimensions 
[172]. The model starts with aerobic cultures in balanced growth. Over time, 
oxygen is consumed and, when dissolved oxygen falls below 1% in culture, 
 
Figure 1.2. Regulation of hypoxia-induced 
nonreplicating persistence by DosR. Under hypoxic 
conditions, DosS and DosT are sensor histidine kinases 
that activate DosR. Induction of DosR upregulates the 
dos regulon (which dosR and dosS are members of), 
leading to changes in cellular metabolism, protein 
homeostasis and nucleotide repair. A subsequent 
enduring hypoxic response is induced, enabling the cell to 
enter nonreplicating persistence. 
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the bacilli enters the microaerophilic non-replicating phase (NRP1). This 
phase is defined by a slow increase in turbidity without a corresponding 
increase in cell numbers (determined by colony forming units, CFU) or cellular 
DNA. The bacilli remain viable, steadily producing ATP while regenerating 
NAD through the activity of glycine dehydrogenase [173, 174]. As time 
progresses, dissolved oxygen drops below 0.06%, and now, the bacilli enters 
a second non-replicating phase phase (NRP2). Under these anaerobic 
conditions, steady-state ATP production glycine dehydrogenase activity 
decreases while culture turbidity and viability remain unchanged. Evidence for 
the clinical and therapeutic relevance of these Wayne bacilli comes from their 
selective susceptibility to metronidazole, a drug that damages bacterial DNA 
only under anaerobiosis [175-177]. Aerobically growing bacilli are not affected 
by the drug [172, 178]. Studies in rabbits – a TB animal model presenting 
hypoxic lesions – showed that metronidazole significantly reduces the number 
of bacilli in the lung [45]. These results are consistent with metronidazole 
studies in macques and human patients, with the latter showing increased 
efficacy when used against INH- and RIF-resistant Mtb [179, 180]. This is the 
basis for the development of nitroimidazoles – a new class of TB antibiotics of 
which nitrodihydroimidazooxazole (Delamanid, OPC-67683; Otsuka 
Pharmaceutical Co., Ltd.) and nitroimidazoloxazine (Pretomanid, PA-824; TB 
Alliance) are currently in phase III and II trials, respectively [181].  
1.4.2. Nutrient deprivation models for Mtb persistence 
Hypoxia induces a reversal in the susceptibility of Mtb to INH and 
metronidazole as the bacilli switch between replicating and non-replicating 
states. This is similar to type I Escherichia coli persisters formed in response 
to external triggers such as starvation (rather than “type II”, which are 
produced by spontaneous switching without environmental triggers and 
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stressors) [182]. First proposed by Imlay and later verified through single-cell 
observations [183-185], this theory suggests that bacterial populations are 
heterogeneous (containing both persisters and non-persisters), with 
physiological stresses in the environment pushing a greater part of the 
population to become dormant persisters [186]. These dormant bacteria are 
thought to be the basis for phenotypic antibiotic tolerance [18].  
A shift towards lipid catabolism is detected in Mtb recovered from granulomas 
[187-189]. This suggests that the availability of lipids for nutrition could be an 
environmental cue for phenotype switching. Lipids required for survival early 
during infections are likely obtained from foamy macrophages found within 
granulomas [190, 191]. Direct observation of the interior of Mtb-containing 
granulomatous lesions showed that bacilli could be found in close proximity to 
cholesterol and triacylglycerol rich intracellular lipid droplets within foam cells 
[187]. Further studies also showed that phagocytosed bacteria preferentially 
utilize host lipids as carbon sources [151, 190, 192, 193]. But what happens 
when this nutrient source runs out? 
Indeed, there is evidence to suggest that non-replicating mycobacteria 
recovered in resected lung lesions are type I persisters induced by nutrient 
starvation. Mtb isolated from lung lesions were found to display altered 
morphology and staining properties that are remarkably similar to those 
observed in mycobacteria left to survive in distilled water [194, 195]. When 
starved in phosphate-saline buffers, Mtb stopped growing, gained tolerance to 
several antibiotics, and retained their virulence [112, 189, 196]. Restricted 
mycobacterial growth was also observed under phosphate-limiting conditions 
and the persisters are phenotypically resistance to INH [197]. Nutrient 
starvation also induces large shifts in transcriptional activities that share many 
common features with the transcriptional reprogramming observed in Wayne 
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bacilli [192]. In Chapter 5, we revisited the pioneering work of Loebel [198, 
199], developed a nutrient starvation model to characterize starved 
mycobacteria at the molecular (transcriptomic and metabolic) and cellular 
(single-cell and population) levels, and found that mycobacterial persisters 
possess a selective but reversible vulnerability to hydrogen peroxide (H2O2) – 
a phenomenon that is reminiscent of the hypoxia-induced susceptibility to 
metronidazole in dormant Mtb. 
1.5. Control of gene expression in response to stress 
Adaptation of gene expression through the regulation of transcription and 
translation are key mechanisms in microbial responses to fluctuating 
environmental conditions. For pathogens of the Mtb complex, stresses in the 
microenvironment induced by host immune responses cause the activation of 
a variety of regulatory mechanisms corresponding to their inducers – 
oxidative, nitrosative and acid pH stresses and macro- and micro-nutrient 
depletion [19, 120, 199-202]. In parallel, this evokes cellular survival and 
evasion responses to cell-mediated immunity and resistance to reactive 
oxygen species (ROS), reactive nitrogen species (RNS) and therapeutic 
agents [117, 196]. Though mRNA copy number is often used as a proxy for 
gene expression [203], transcription, translation and degradation processes 
(for both RNA and protein) can be extensively coupled and may frequently 
regulate each other through feedback loops [204]. This is highlighted in 
several time-course studies of bacterial stress responses wherein large 
differences between protein and mRNA abundance changes were detected 
[205, 206]. Clearly, our understanding of perturbed systems is still incomplete. 
Alternate transcriptional start sites, alternative splicing, RNA editing, RNA 
interference, stop codon read-through, protein degradation and modulation of 
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enzyme function and activities are just some of the post-transcriptional and 
post-translational processes that impact gene expression and cellular 
homeostasis [207-211]. Yet, these processes only explain cell phenotypes in 
a piecemeal manner. Recently, however, a new paradigm for the translational 
control of cellular stress responses was developed. Based on the response of 
S. cerevisiae to cytotoxins, this paradigm unifies longstanding, but 
unexplained, observations in tRNA modifications and codon usage bias to 
redefine translational control as a function of tRNA reprogramming [20, 21].  
1.5.1. RNA modifications – a well characterized but poorly understood 
aspect of molecular biology 
All canonical ribonucleosides (adenosine, A; uridine, U; guanosine, G; and 
cytosine, C) can be modified enzymatically in vivo.  These modifications 
range from simple alkylation, isomerizations, sulfonation, oxidation, and 
deamination to complex linkages to glycosides and amino acids [212-215]. 
Though biosynthesis pathways and enzyme mechanisms for many of these 
modifications are unknown, several of these modifications are catalyzed by 
processes that involve multiple enzymes and reactions [215-217]. Currently, 
there are more than 120 known post-transcriptional structural modifications in 
all RNA species across all living organisms and, while most commonly found 
in transfer RNA (tRNA), a significant number of modifications are also 
observed in ribosomal RNA (rRNA) and even mRNA [218-220]. Not only are 
modified nucleosides contained in tRNA from all three phylogenetic domains -
- Archea, Bacteria and Eukarya [221] – eight of them (pseudouridine, Ψ; 
dihydropseudouridine, D; N4-acetylcytidine, ac4C, (cyclic)N6-
threonylcarbamoyladenosine, (c)t6A; 5-methyluridine, m5U; 1-
methylguanosine, m1G; 1-methyladenosine, m1A; and  2’-O-methylcytidine, 
Cm. Fig 1.3) are present in the same position and in the same subpopulation 
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of tRNAs in organisms from all domains [222-224]. Furthermore, recent 
theoretical and experimental studies have endeavored to derive the minimal 
set of genes that are necessary and sufficient to sustain a functioning cell, 
with the repeated finding that several tRNA modifying enzymes are essential 
for life [225-228]. Surprisingly, despite their conservation and profusion in 
biological systems, the precise function of these modifications has eluded 
understanding, a problem that is compounded by a paucity of knowledge 
about the identities of RNA modifications in important pathogens such as Mtb.  
 
Figure 1.3. Chemical structures of conserved tRNA modifications. 
Modifications derived from all 4 canonical ribonucleosides are shown. 
Pseudouridine, Ψ; dihydropseudouridine, D; N4-acetylcytidine, ac4C; 
(cyclic)N6-threonylcarbamoyladenosine, (c)t6A; 5-methyluridine, m5U; 1-
methylguanosine, m1G; 1-methyladenosine, m1A; and  2’-O-methylcytidine, 
Cm are common to all three kingdoms of life. 5-methoxycarbonyl-
methyluridine (mcm5U) and queuosine (Q) are wobble modifications thought 
to be conserved in eukaryotes and most prokaryotes respectively; their 
functions are discussed in text.  
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To date, there has been no complete definition of the spectrum of RNA 
modifications in any microorganism, with the possible exception of E. coli and 
S.cerevisiae (Table 1.4). 
1.5.2. Known functions of tRNA modifications 
Modified ribonucleosides are found in virtually all coding and non-coding RNA 
species [229-231], but they are most abundant in tRNA, the adaptor 
biomolecule serving as the physical link between genetic information coded in 
mRNA transcripts and amino acids. tRNAs are typically 75 to 90 nucleotides 
(nt) long and on average, each contain 8 modifications [232]. These 
modifications can occur at virtually any position, but are most consistently 
found at positions 34 – the wobble position – and position 37 (Fig. 1.4). Early 
observations show that these modifications can modulate base pairing and pi- 
stacking, thus, stabilizing secondary and tertiary RNA structures [234, 235]. 
Their presence also serves as a tRNA maturation marker [236, 237]. For 
instance, wybutosine (yW) only replaces m1G at position 37 of tRNAPhe in S. 
cerevisae after intron splicing taken place [238]. Hypomodified tRNA would 
represent misfolded tRNA or aberrant splicing events, allowing the cell to 
target them for degradation [239]. In vitro experiments with unmodified tRNAs 
caused translational pausing and increased translational errors suggesting 
that modifications also help maintain reading frames at the ribosomal A site 
and reduce the rates of translational frameshift mutations that might occur 
through tRNA slippage [240, 241]. Most importantly, tRNA modifications are 
essential for accurately decoding the genome, through both the expansion 
and restriction of genetic decoding by codon recognition [242, 243]. tRNA 
modifications a play a key role in the wobble hypothesis by expanding 
possible codon-anticodon pairing [242, 244]. These wobble base pairings 
allows organisms to use less and 61 codons to translate mRNAs. For  
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Table 1.4. Modified ribonucleosides in total tRNA* 
Ribonucleoside Symbol E. coli S. cerevisiae 
Pseudouridiine Ψ   
dihydrouridine D   
5-methylcytidine m
5
C   
2’-O-methylcytidine Cm   
3-methylcytidine m
3
C   
5-methyluridine m
5
U   
2-thiocytidine s
2
C   
4-thiouridine s
4
U   
inosine I   
1-methyladenosine m
2
A   
N6-methyladenosine m
6
A   
1-methyladenosine m
1
A   
2’-O-methyladenosine Am   
1-methylinosine m
1
I   
N4-acetylcytidine ac
4
C   
5-methylaminomethyluridine mnm
5
U   
7-methylguanosine m
7
G   
1-methylguanosine m
1
G   
2’-O-methylguanosine Gm   
N2-methylguanosine m
2
G   
5-carbamoylmethyluridine ncm
5





U   
N2,N2-dimethylguanosine m
2
2G   
5-methoxycarbonylmethyluridine mcm
5
U   
uridine 5-oxyacetic acid cmo
5





U   
uridine 5-oxyacetic acid methyl ester mcmo
5
U   
N6-isopentenyladenosine i
6
A   
3-(3-amino-3-carboxypropyl)uridine acp
3
U   
lysidine k
2





A   
cyclic N6-threonylcarbamoyladenosine ct
6
A   
queuosine Q   
N6-threonylcarbamoyladenosine t
6
A   







A   
wybutosine yW   
Total 27 24 
* Shaded (grey) and unshaded cells represent presence or absence of the 
modified ribonucleoside respectively. Based on tRNA modification studies of 
Suzuki and coworkers [217, 233]. And cross validated with tRNA sequences 
catalogued on Modomics (http://modomics.genesilico.pl/). 
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example, wobble 5-oxyacetyl-uridine (cmo5U) allows for the decoding of G-
ending codons [245, 246]. This property, as we demonstrate Chapter 6, 
allows for the selective translation of hypoxia-induced transcripts in 
mycobacteria entering dormancy. 
1.5.3. Translation control of stress responses by tRNA modifications 
tRNA modifications are not static. There is solid evidence to indicate that their 
abundance changes dynamically in response to stress. For example, the 
levels of pseudouridines in tRNA are induced by nutrient deprivation while 2-
thiouridine (s2U) and 2-thiouridine (s4U) content decreases upon cyanogen 
bromide and near-UV exposures respectively [247-249]. The virulence of 
fungi pathogens has been shown to be linked to 7-methylguanosine (m7G46), 
a modification found on position 46 in the hypervariable loop of tRNA in 
eurkaryotes and prokaryotes (Fig. 1.4). Mutants lacking this crucial 
modification grow as well as their wild-type counterparts in culture, but fail to 
invade their natural plants host. Loss of virulence was due to a lack of 
adaptive stress responses to oxidative and osmotic stresses [250]. Later, it 
was determined that m7G46 modifications support the introduction of wobble 
position modifications [251]. 
Wobble modifications, in particular, play an important role in cellular 
responses to stress. For example, queuosine (Q) (Fig. 1.3), a cyclopentadiol 
derivative of 7-cyano-7-deazaguanosine (pre-Q0) synthesized in bacteria by 4 
enzymes QueC-F, is post-transcriptionally exchanged with wobble guanine by 
tRNA-guanine transglycosylase (TGTase) [252-254]. Wobble Q has been 
implicated in a number of physiological processes such as cell proliferation 
[255, 256], oxidative metabolism [257], tyrosine biosynthesis [258], and 
bacterial virulence [259, 260]. While non-essential (Q-deficient HeLa cell  
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 Figure 1.4. Distribution of modified nucleosides in tRNA. Representation 
of a tRNA showing the positions at which modifications in archea, bacteria 
and eukaryotes may be found. A variety of modifications had been identified 
at virtually all positions in tRNA. Positions 34 and 37 are most frequently 
hypermodified. Figure adapted from references [222, 224]. 
grows well under aerobic and hypoxic conditions), proliferation of HeLa cells 
improved under aerobic conditions but declined under hypoxia in the 
presence of queuine; suggesting a role for Q in the cellular response to 
hypoxia [256, 261]. The biological activity of Q-base is likely due to its 
influence on the coding capacity of tRNA [241]. tRNAHis with guanidine at the 
wobble base (G34) clearly prefers the histidine codon CAC to the CAU, 
whereas tRNAHis (Q34) has little preference for the codon CAC [262]. 
Furthermore, queuosine-modified tRNAs have been shown to suppress stop 
codons as tRNATyr(G34) allows stop codon readthrough, whereas 
tRNATyr(Q34) prevents it [263]. 
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How does the decoding property of a modified ribonucleoside regulate cellular 
responses to stress? An emerging model, in which modification-dependent 
tRNA decoding activities are keyed to codon use in genetic programs, thereby 
allowing for the switching between genetic programs when cells are exposed 
to environmental stresses, provides insights into the translational control of 
stress responses. In S. cerevisiae, deletion of tRNA anticodon 
methyltransferase Trm9 increase sensitivity to DNA damage induced by 
alkylating stress. Trm9 is necessary for formation of wobble 5-
methylcarbonylmethyluridine (mcm5U34, Fig. 1.3), which is necessary to 
decode AGA and GAA codons. When treated with the alkylating cytotoxin 
methylmethansulfonate (MMS), levels of mcm5U34 increase and, 
interestingly, the stress-induced transcripts that were required to rescue the 
cell had a large over-abundance of the codons AGA and GAA – the very 
same codons preferentially read by mcm5U34 containing tRNAs [264]. 
Subsequent experiments performed at the systems-level show that, while 
every stress has its own characteristic tRNA modification signature, the 
general model remains unchanged [264]. Codon bias – the overabundance of 
specific codons and the deficiency of others – is innate in all organisms and is 
‘keyed’ to the levels of modifications in a tRNA pool [265].  
Though it is clear that limits to the amount of protein produced from mRNAs 
are determined by levels of the copy numbers cognate tRNAs [266, 267], this 
model predicts that tRNA levels could be regulated to match codon use by 
specific mRNAs as part of a genetic program. In this model, the tRNA pool is 
reprogrammed during stress, either through increased activity of tRNA 
modifying enzymes or through changes in the number of copies of a tRNA 
[20, 21, 237]. This altered tRNA pool results in the selective translation of 
mRNA transcripts enriched in a specific codon that are selectively decoded by 
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the reprogrammed tRNA [242]. This model also provides a biological role for 
codon usage bias, long shown to be non-random and evolutionarily driven by 
selection pressures [268], in the cellular responses to stress (Fig. 1.5). 
 
Figure 1.5. General model for the translational control of stress 
responses by tRNA modifications. Following stress, cells reprogram their 
tRNA pools enriching for tRNA species with specific wobble modifications. 
These wobble modified tRNAs bind to particular codons more efficiently than 
others driving the selective translation of transcripts enriched these codons. 
Here, for illustration, hydrogen peroxide (H2O2) exposures induces Trm4 
activity in yeast which modifies tRNALeu(CAA) to tRNALeu(m5CAA). tRNALeu(m5CAA) 
preferentially decodes transcripts overusing LeuUUG codons. As a corollary, 
mRNA transcripts lacking these selected codons are translated less 
efficiently. The result is a rapid, coordinated and just-in-time stress response 
allowing cells to survive otherwise cytotoxic stresses. Adapted from [21, 269]. 
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Subsequent experiments performed at the systems-level, show that toxicants 
with distinct molecular mechanisms induce has its own characteristic tRNA 
modification signature, unique in a manner that enables the bias translation of 
specific survival proteins [265, 269]. The general model was further 
corroborated by numerous experiments showing that loss of specific tRNA 
modifying enzymes sensitizes yeast to the associated stress esposures [270, 
271]. While these systems have hitherto been described in eukaryotes, the 
ubiquitous nature of its components led us to hypothesis that they are present 
in all organisms. In particular, these molecular mechanisms may play an 
important role in the events associated with TB pathogenesis; modulating key 
processes such as Mtb dormancy. 
1.6. Thesis overview and research aims 
My doctoral thesis research is split into two parts. The first is an exploratory 
characterization of the stress responses of pathogenic mycobacteria. The 
second is to test the hypothesis that the spectrum of tRNA modifications in 
mycobacteria changes as a function of cellular environment, and that these 
pathogens utilize them to control their translation to survive physiological 
stresses associated with disease pathogenesis. I pursued this research in 
three integrated stages, each with its own specific aims; starting with the 
development of a sensitive analytical platform to quantify stress responses at 
the population, cellular and molecular levels; applying it to M. bovis BCG as a 
tractable surrogate for Mtb, and then translating the these findings into 
molecular mechanisms which could be applied in the development of 
disease-state biomarkers, antibiotic targets and drug screening platforms. 
Aim 1: Develop a platform to characterize and quantify tRNA secondary 
modifications 
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Objectives:  Develop and validate bioanalytical tools for identification and 
quantification of the cellular stress response with a focus on RNA and their 
spectrum of modified ribonucleosides.   
Experimental strategy: Overall this involves developing methods for the 
unbiased and efficient isolation of total RNA (Chapter 2), purification of each 
non-coding RNA species by high performance liquid chromatography (HPLC) 
(Chapter 3), identification, structural characterization and quantification of 
every modified ribonucleoside in the enzymatic digests from purified tRNA by 
liquid chromatography coupled tandem mass spectrometry (LC-MS/MS) 
(Chapter 4). 
Aim 2: Characterize mycobacterial stress responses 
Objectives:  Establish and define in vitro models for mycobacterial dormancy 
and persistence. 
Experimental strategy: We revisited the batch culture models of Loebel and 
Wayne [172, 198]. In the former, we established a nutrient starvation model 
that reproducibly generated antibiotic tolerant persisters in a well-defined 
culture media and used flow cytometry, phenotypic microarrays, RNA-seq 
and targeted biochemical measurements of cellular metabolism to 
characterize the persistent state of mycobacteria (Chapter 5). In the latter, we 
scaled-up the original hypoxic batch culture protocol 20 folds and used the 
bioanalytical platform developed in aim 1 to determine the full specturm of 
tRNA modifications in BCG. tRNA reprogramming during the transistion into 
and out of a hypoxia-induced dormancy was tracked by the quantification of 
tRNA modifications and copy numbers while dynamic changes in the 
proteome was determined using isobaric tags for relative and absolute 
quantitation (iTRAQ) proteomics (Chapter 6). 
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Aim 3: Integrate findings at the systems level to identify vulnerabilities 
that can be exploited as antibiotic targets 
Experimental strategy: New metabolic pathways and molecular mechanisms 
of translational control were identified through multivariate data analysis. 
Precise predictions on population phenotypes under stress were made and 
validated using whole-cell chemical susceptibility screens or codon re-
engineering approaches. Specific models of mycobacterial adaptation to 
nutrient starvation (Chapter 5) and hypoxic (Chapter 6) were made and 
general biological principles applied to design drug discovery platforms 
(Chapter 7). 
Together, the studies present in this thesis advance our understanding of 
mycobacterial dormancy and persistence: cellular states that contribute to 
clinical presentations of latent and relapse TB. We discovered metabolic 
pathways, tRNA modifications and translation control mechanisms that give 
us further insights into bacterial physiology and disease pathogenesis.  These 
findings increase our scientific resources against TB – one of humanity’s 
oldest and greatest foes. 
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2.  Mycobacterial RNA isolation optimized for non-
coding RNA: High fidelity isolation of 5S rRNA from 
Mycobacterium bovis BCG reveals novel post-
transcriptional processing and a complete spectrum of 
modified ribonucleosides1 
2.1. Abstract 
A major challenge in the study of mycobacterial RNA biology is the lack of a 
comprehensive RNA isolation method that overcomes the unusual cell wall to 
faithfully yield the full spectrum of non-coding RNA (ncRNA) species. Here, 
we describe a simple and robust procedure optimized for the isolation of total 
ncRNA, including 5S, 16S and 23S ribosomal RNA (rRNA) and tRNA, from 
mycobacteria, using Mycobacterium bovis BCG to illustrate the method. 
Based on a combination of mechanical disruption and liquid and solid-phase 
technologies, the method produces all major species of ncRNA in high yield 
and with high integrity, enabling direct chemical and sequence analysis of the 
ncRNA species. The reproducibility of the method with BCG was evident in 
bioanalyzer electrophoretic analysis of isolated RNA, which revealed 
quantitatively significant differences in the ncRNA profiles of exponentially 
growing and non-replicating hypoxic bacilli. The method also overcame an 
historical inconsistency in 5S rRNA isolation, with direct sequencing revealing 
a novel post-transcriptional processing of 5S rRNA to its functional form and 
with chemical analysis revealing seven post-transcriptional ribonucleoside 
modifications in the 5S rRNA. This optimized RNA isolation procedure thus 
                                                          
1
 Featured in Nucleic Acids Res. 2014 Dec 24. pii: gku1317. Reproduced with 
permission from Oxford University Press. 
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Infection with Mycobacterium tuberculosis (Mtb) represents one of the most 
widespread microbial diseases, with nearly one-third of the world's population 
showing signs of exposure, more than 20 million people actively infected, and 
almost 80% of the population of some countries testing positive in tuberculin 
tests [1, 2]. This rate of infection is due to both a paucity of diagnostic tools [3-
6] and ineffective chemotherapy in the face of emerging drug-resistance [7, 
8], both of which reflect poor understanding of mycobacterial biology and 
host-pathogen interactions [9, 10]. One feature of mycobacterial biology that 
has hampered investigations is a thick, waxy cell wall consisting of a network 
of peptidoglycans, arabinogalactans, mycolic acids, and polysaccharides [11, 
12], which makes mycobacteria resistant to lysis by most commercial 
chaotropic or cell lysis reagents and poses challenges to the rigorous 
purification of cellular biomolecules. We are concerned here with the isolation 
of non-coding RNA (ncRNA). The importance of rigorous ncRNA purification 
is illustrated by recent advances in RNA sequencing and bioinformatics that 
have led to the discovery of disease-relevant ncRNA species in mycobacteria 
[13, 14], while critical features of modified ribonucleosides in transfer RNA 
(tRNA) and ribosomal RNA (rRNA) are known to play a role in adaptive 
responses to stress [15-18]. In all cases, the systems-level analysis of ncRNA 
requires unbiased isolation of RNA with sequence integrity and relative 
quantity intact. Numerous methods for mycobacterial RNA isolation have 
been developed that include liquid or solid-phase extraction following cell lysis 
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by either sonication, enzymatic hydrolysis, chemical treatment, French 
pressure cell rupture, or bead-beating [19-22]. However, there has been no 
rigorous optimization of mycobacterial RNA isolation techniques to ensure 
purification of the full spectrum of ncRNA species with quantitative and 
qualitative fidelity. Furthermore, in addition to recognized size- and sequence-
dependent biases in the isolation of specific non-coding RNA species [23], 
these methods require large quantities of cells or have time-consuming steps 
that can lead to degradation or enzymatic modification of the RNA [24]. To 
address these problems, we developed an optimized method for efficient 
isolation of all types of ncRNA from mycobacteria with high biological fidelity. 
Using Mycobacterium bovis Bacille Calmette-Guérin (BCG) as the model 
mycobacterial species, the method represents a combination of bead-beating 
with phenol-chloroform and solid-phase extraction steps optimized for both 
yield and quality of tRNA, 5S, 16S and 23S rRNA, as well as mRNA for seven 
genes. Application of the method to BCG revealed hypoxia-induced 
alterations of the relative quantities of 16S and 23S rRNA, a novel post-
transcriptional processing of 5S rRNA, and the first complete analysis of the 
full set of modified ribonucleosides in mycobacterial 5S rRNA.  
 
2.3. Material and methods 
2.3.1. Bacterial cultures  
For exponentially growing mycobacteria, Mycobacterium bovis Bacille 
Calmette-Guérin (str. Pasteur 1173P2; BCG) was grown at 37 oC in a shaking 
incubator in Middlebrook 7H9 broth (Difco, BD Diagnostics, Sparks, MD) to an 
OD600 of 0.6 – 0.8. BCG cells in a hypoxia-induced non-replicative state were 
obtained using the Wayne model adapted from Low et al. [25]. Briefly, a 
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culture of exponentially growing BCG in Dubos broth (Difco) was diluted to an 
OD600 of 0.05 and placed in a tightly-sealed (latex-lined cap) 1 L glass flask 
(Duran, Mainz, Germany) with stirring at 170 rpm and air headspace volume 
of 450 mL. With a plateau in cell growth at 7 d (as determined by OD600), 
induction of a non-replicative state was confirmed by the absence of change 
in OD600 for the next 14 d, at which point the cells were harvested 
(Supplementary Figure 2.1).  
 
2.3.2. Development of the RNA isolation method  
The optimized RNA isolation protocol was developed around a simple 
framework consisting of lysis by bead-beating in a denaturing extraction 
solvent, with subsequent RNA retrieval from the solvent. Using this 
framework, we systematically tested a variety of conditions and parameters, 
including extraction reagent, bead beating conditions, and RNA retrieval 
method, to define an optimal protocol to extract all types of ncRNA from BCG. 
Two nucleic acid extraction reagents were considered: TRIzol (Invitrogen, 
Carlsbad, CA) and phenol:chloroform:isoamyl alcohol (Qiagen, Hilden, 
Germany). While harshly denaturing, these reagents are insufficient to lyse 
mycobacterial cells. To assist in lysing cells, mechanical disruption by bead 
beating on a reciprocal shaker was chosen, with optimization of bead size, 
extraction solvent volumes, and duration. For retrieval of RNA from the 
extraction solvent following mechanical disruption, we compared simple 
isopropanol precipitation of RNA to solid-phase isolation of RNA using the 
Purelink miRNA Isolation Kit (Invitrogen, Carlsbad, CA). A summary of all 
conditions tested and their respective nucleic acid yields before DNase I 
treatment as assessed by UV spectroscopy is detailed in Supplementary 
Table 2.1; the analyses were performed in three biological replicates. 
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Supplementary Figure 2.2 illustrates the final optimized ncRNA isolation 
method, which was applied to BCG cultures growing exponentially or in a 
hypoxia-induced non-replicative state. Cells are harvested from culture 
medium by centrifugation at 4,000 x g for 5 min at 4 oC. Pellets containing 109 
cells were washed in phosphate-buffered saline (PBS) containing 0.5% 
Tween 80 to remove media debri that could interfere with RNA isolation and 
resuspended in 1 mL of ice-cold phenol:chloroform:isoamyl alcohol (volume 
ratio 25:24:1; saturated with 10 mM Tris, 1 mM EDTA, pH 8) and 400 µL of 2 
M sodium acetate (pH 5.2). The suspension was combined with 100 µL of 0.1 
mm zirconia-silica beads (Biospec, Bartesville, OK) in a 2 mL screw-capped 
tube and vigorously shaken on a Qiagen Tissuelyser II (Qiagen, Hilden, 
Germany) with chambers pre-chilled to -20 °C to account for heating to 
ambient temperature by the end of the 30 min run at a frequency of 30 Hz. 
After centrifugation (12,000 x g, 15 min, 4 oC), the aqueous phase (~400 µL) 
was transferred into a new tube to which 215 µL of 100% ethanol was added 
with mixing and the solution loaded onto a Purelink miRNA Isolation Kit 
(Invitrogen, Carlsbad, CA) column (column #1) to retain large RNA species. 
Following centrifugation of the column (12,000 x g, 1 min), the flow-through 
containing small RNAs was collected, placed on ice, combined with 700 µL of 
100% ethanol, and loaded onto a second Purelink miRNA Isolation column 
(column #2) to retain the small RNA species. The column was again 
centrifuged (12,000 x g, 1 min) and the flow-through discarded. Both columns 
(#1 and #2) were washed twice with washing buffer provided with the kit. 
RNase-free water (50 µL) was added to the columns, which were incubated 
at ambient temperature for 2 min followed by centrifugation (12,000 x g, 1 
min). The eluates from columns #1 and #2 contained mainly large and small 
RNA, respectively, and these were combined to recreate a total RNA 
preparation. Aliquots of each RNA sample were adjusted to a concentration of 
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1 ng/μL and thee integrity and relative quantities of the RNA species in the 
sample were assessed using an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). Column eluates were stored at -80 oC. 
 
2.3.3. HPLC purification of individual ncRNA species  
Individual RNA species were purified by size-exclusion (SEC) high-
performance liquid chromatography (HPLC), as described in a recent 
publication [26]. Following addition of 30 units of DNAse I (Qiagen, Hilden, 
Germany) to each sample, the total RNA preparation in 20 L was injected 
onto an Agilent Bio SEC3 column (300 Å, 7.8 x 100 mm; Agilent, Foster City, 
CA) attached to an Agilent 1200 HPLC system to resolve tRNA and 5S rRNA 
species. For 16S and 23S rRNA, an Agilent Bio SEC5 column (1000 Å, 7.8 x 
100 mm) was used. Both columns were eluted with an isocratic gradient with 
100 mM ammonium acetate (pH 7.5) at 0.5 mL/min and 60 oC with RNA 
elution monitored by UV absorbance. Peak resolution (R) was calculated 
using the following equation where tRA and tRB are the retention times for 
peaks A and B, respectively, and WA and WB are the peak base widths for 
peaks A and B, respectively: 
     
       
      
  
Fractions containing individual RNA species were analyzed on an Agilent 
2100 Bioanalyzer. The 5S rRNA fraction was concentrated and desalted 
using a 2,000 Da molecular weight cut-off spin filter (Sartorius-Stedium, 
Goettingen, Germany). Purified 5S rRNA was quantified by integrating the UV 
absorbance for the 5S rRNA peak in HPLC profiles and interpolating 
concentration from linear standard curves prepared with purified 28S rRNA 
(CCRF-SB cells), as shown in Supplementary Figure 2.3.  
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2.3.4. Sequencing of BCG 5S rRNA  
To confirm the identity of the purified 5S rRNA, the 3’ end of 25 pmol of the 
RNA was ligated to 50 pmol of a pre-adenylated DNA adaptor (IDT, Coralville, 
IA) using 1.5 μg of RNA ligase 2 (truncated K227Q, NEB, Beverly, MA) with 
incubation at 22 °C for 16 h. The ligated product was purified by SEC3 HPLC 
and then reverse transcribed with 200 U of Superscript III RT (Invitrogen, 
Carlsbad, CA). The resulting cDNA was ligated to 50 pmol of another pre-
adenylated 3’ adaptor (IDT, Coralville, IA) using 10 U of T4 RNA ligase 1 
(NEB, Beverly, MA) with incubation at 4 °C for 16 h. Following SEC3 HPLC 
purification, the ligated cDNA was PCR amplified, TA cloned (Genewiz, South 
Plainfield, NJ), and sequenced to confirm its identity (Genewiz, South 
Plainfield, NJ). Sequence analysis was performed with Nucleotide BLAST 
(NCBI) against the annotated full genome sequence of the same BCG strain 
(NC_008769.1). The cDNA sequence from mature 5S rRNA is available on 
GeneBank (Accession number KC203333). 
 
2.3.5. Analysis of mRNA by quantitative real-time polymerase chain 
reaction (qPCR)  
To compare the mRNA yield from the optimized RNA isolation approach to 
that of the conventional TRIzol method, RNA was isolated from exponentially 
growing BCG cultures using TRIzol or the optimized RNA isolation method 
and DNA was removed using the TURBO DNA-free Kit (Ambion, Life 
Technologies, Carlsbad, CA). RNA (50 ng/μL) was reverse transcribed using 
the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) according to the 
manufacturer’s instructions. The reverse transcription program was run as 
follows: 25 oC for 5 min, 42 oC for 30 min and 85 oC for 5 min, followed by a 
cooling step at 4 oC. Two-step real-time qPCR was then performed using the 
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SsoAdvanced universal SYBR Green supermix (Bio-Rad, Hercules, CA). 
Primer sequences and melting temperatures can be found in Supplementary 
Table 2.3. The qPCR program was run as follows: 95 oC for 30 s followed by 
40 cycles of denaturation at 95 oC for 15 s and annealing/extension at 60 oC 
for 30 s. A melting curve analysis consisting of 0.5 oC increments from 65 to 
95 oC was performed for all reactions to ascertain the specificity of the 
primers. 
 
2.3.6. Identification and characterization of modified ribonucleosides in 
BCG 5S rRNA  
The full spectrum of modified ribonucleosides in the purified 5S rRNA was 
characterized by analysis of ribonucleoside hydrolysates of the RNA by 
chromatography-coupled quadrupole time-of-flight and triple quadrupole mass 
spectrometry, using methods described previously [15, 26, 27]. Briefly, 
purified BCG 5S rRNA was enzymatically hydrolyzed in the presence of 
antioxidants and deaminase inhibitors and the ribonucleosides resolved by 
HPLC using a Hypersil GOLD aQ Analytical HPLC Column (100 × 2.1 mm, 
1.9 μm particle size) (Thermo Scientific, Wilmington, DE) coupled to either an 
Agilent 6460 triple quadrupole mass spectrometer or an Agilent 6520 
quadrupole time-of-flight mass spectrometer (LC-MS/MS) with ESI ionization 
operated in positive ion mode. The identity of individual ribonucleosides was 
confirmed by comparison with synthetic standards for HPLC retention time, 
exact molecular weight, and collision-induced dissociation (CID) 
fragmentation patterns. In cases where a standard was not available, a 
putative structure was inferred from exact molecular weight and collision-
induced dissociation (CID) fragmentation patterns.  
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2.3.7. Statistical analysis 
Statistical analysis for comparison of qPCR CT values for the RNA isolation 
methods and quantities of RNA species in exponentially growing and hypoxic, 
non-replicative (Wayne day 21) cultures was performed using Student’s t-test 
with significance set at p ≤ 0.05. 
 
2.4. Results 
Given the challenges of working with mycobacteria, we sought to develop a 
method for purification of ncRNA that optimized the cell lysis, RNA extraction 
and RNA purification steps to yield the full spectrum of intact ncRNA species 
in quantities that reflect their abundances in vivo. The workflow shown in 
Supplementary Figure 2.2 represents the culmination of a series of 
optimization studies in which different procedures were assessed for the yield 
of RNA, the relative quantities of the various ncRNA species and the quality 
of the RNA in terms of degradation. Subsequent analysis of the isolated 
ncRNA species from BCG revealed several novel features of RNA biology in 
mycobacteria. 
 
2.4.1. Optimization of RNA isolation parameters  
With all of the optimization data shown in Supplementary Table 2.1, 
optimization of the ncRNA isolation method was initiated with a comparison of 
two standard extraction reagents, TRIzol and the 25:25:1 mixture of phenol, 
chloroform, and isoamyl alcohol. An extraction reagent was added to the cells 
prior to bead beating to quench adventitious enzymatic reactions during cell 
lysis, including nucleases and RNA modification enzymes. Given the 
evidence for biased isolation of miRNA with TRIzol [23], we compared the 
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yields of the major ncRNA species in BCG with TRIzol and 
phenol:chloroform:isoamyl alcohol. A 77% increase in nucleic acid recovery 
was obtained with phenol:chloroform:isoamyl alcohol compared to TRIzol 
(Supplementary Table 2.1). Since phenol:chloroform:isoamyl alcohol 
saturated with 10 mM Tris, pH 8.0, also extracts DNA, it is possible that part 
of the observed increase in nucleic acid mass results from DNA 
contamination. However, the yield of longer RNA species, in particular 16S 
and 23S rRNA, was significantly reduced using traditional acid phenol or 
TRIzol-based RNA extraction methods (Supplementary Figure 2.4). Hence, 
it was preferable to use the phenol:chloroform:isoamyl alcohol approach to 
obtain all cellular RNA species in high yield and in proportions that truly reflect 
their abundances in vivo, with contaminating DNA subsequently removed by 
DNAse I digestion or HPLC purification, without sacrificing longer RNA 
species (Supplementary Figure 2.5). 
 
Next, we optimized for cell lysis, comparing the RNA yield obtained using 0.5 
mm and 1.0 mm glass beads and 0.1 mm zirconia-silica beads. While 0.5 mm 
glass beads offered a 61% increase in nucleic acid yield against 1.0 mm 
glass beads, we observed an additional 37% increase in RNA yield with 0.1 
mm zirconia-silica beads (Supplementary Table 2.1). Using 0.1 mm zirconia-
silica beads, we optimized for the duration of bead beating. A duration of 10 
min was sufficient for lysis of mycobacterial cells using the TissueLyzer II, 
while a duration of 30 min was required for the TissueLyzer LT. Use of a 
French press was ruled out due to the time required for the lysis process (>15 
min) in the absence of denaturants, which allows enzymatic reactions to 
affect the spectrum of tRNA and rRNA modifications or cause RNA 
degradation.  
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Finally, to recover RNA from the extraction solvents, we chose the Purelink 
miRNA Isolation Kit system over isopropanol-based RNA precipitation. While 
the Purelink columns were optimized for use with TRIzol, we modified the 
manufacturer’s protocol to use phenol:chloroform:isoamyl alcohol instead, 
which allowed for the maximal recovery of both large and small RNA. Using 
35% ethanol, larger RNA species were recovered on column #1 while smaller 
RNA species were recovered on column #2 using 70% ethanol. 
 
2.4.2. Qualitative assessment of the optimized ncRNA isolation method 
 To assess the performance of the optimized RNA isolation method and the 
quality of the isolated ncRNA, the method was applied to BCG cells growing 
exponentially and to cells arrested in a hypoxia-induced non-replicative state 
that mimics the granuloma of pulmonary mycobacterial infections. The quality 
and relative quantities of the various ncRNA species in total RNA extracted 
from BCG were assessed using a Bioanalyzer with either the Agilent Pico 
Chip for large RNA (16S, 23S) and the Agilent Small RNA Chip for small RNA 
species (<200 nt; miRNA-sized, tRNA, 5S rRNA). As shown in Figure 2.1, the 
peaks corresponding to individual ncRNA species were sharp and 
distinguishable. From the exponentially growing cultures, the eluate from 
column #1 contained 23S rRNA, 16S rRNA, 5S rRNA and tRNA (Figures 
2.1A, B), whereas column #2 eluate contained predominantly tRNA (Figures 
2.1C, D). As a numeric index of the quality of the isolated RNA, the RNA 
integrity number (RIN) determined from the Bioanalyzer profile ranges from 
10 for theoretically intact RNA to 1 for completely degraded RNA [28]. For 
exponentially growing BCG, the RIN for RNA eluted from column #1 in four 
independent extractions was 9.0 ± 0.5, while the RIN for the combined 
eluates from columns #1 and #2 from five independent extractions was 8.5 ±  




Figure 2.1. Representative Bioanalyzer electropherograms for BCG 
RNA recovered from Purelink miRNA Isolation columns #1 and #2. 
Electropherograms from column #1 RNA resolved on (A) a Pico Chip 
and (B) a Small RNA Chip, and from column #2 RNA resolved on (C) a 
Pico Chip and (D) a Small RNA Chip. Electropherograms for the 
combined RNA from columns #1 and #2 resolved on (E) a Pico Chip and 
(F) Small RNA Chip. RNA isolated from BCG subjected to hypoxic stress 
(combined columns #1 and #2) was resolved on (G) a Pico Chip and (H) 
a Small RNA Chip. The electropherogram profiles presented here are 
representative of three independent experiments. Note that the small 
RNA chip on the Agilent Bioanalyzer 2100 system is not optimized to 
read large RNA species (>150 nucleotides). Thus the amount of RNA in 
the ‘large RNA’ peak cannot be accurately quantified. 
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0.3. Interestingly, Bioanalyzer RNA profiles of the hypoxic cultures displayed 
lower relative intensities of the 16S and 23S rRNA peaks compared to those 
from exponentially growing cultures (Figure 2.1G), with comparable 
quantities of tRNA under both conditions (Figure 2.1H). The RIN for the 
combined eluates from columns #1 and #2 from four independent RNA 
extractions of hypoxic bacilli was 5.9 ± 0.2, which suggested a degree of 
degradation of both 23S and 16S rRNA peaks (Figure 2.1G). 
To assess the performance of the Purelink miRNA Isolation columns, the 
proportions of ncRNA species in column eluates were calculated by manual 
integration of electropherogram peaks with Bioanalyzer 2100 Expert software. 
A comparison of the TRIzol and phenol:chloroform:isoamyl alcohol methods 
is summarized in Supplementary Table 2.2. Using this approach, large 
ncRNAs (16S and 23S, identified by size) were almost entirely recovered 
from column #1 along with a significant portion of the small ncRNAs (<200 
nt), while small ncRNAs represented >95% of the RNA eluted from column 
#2. The small ncRNAs, whose identities were assigned based on size, 
consisted of three major species: miRNA-like species, tRNA and 5S rRNA. 
This retention of small ncRNAs on column #1 points to potential bias in the 
small ncRNAs recovered from column #2 as “small RNA”. However, by 
combining the eluates from both columns, the yield of all ncRNA species was 
maximized (Figures 2.1E, F), with small RNA, and mainly tRNA, as the 
dominant species of ncRNA in BCG (Supplementary Table 2.2A). For 
TRIzol however, small RNA was the predominant species of ncRNA, with 
tRNA consisting of more than 80% of the small RNA species 
(Supplementary Table 2.2B).  
Considering both the RIN and the recovery of all ncRNAs from the columns 
using the phenol:chloroform:isoamyl alcohol approach, the results with 
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exponentially growing BCG RNA suggest that the degradation apparent in 
hypoxic, non-replicative BCG is not the result of the RNA isolation procedure 
and instead reflects physiological processing of the RNA. These differences 
were next assessed more quantitatively. 
 
2.4.3. Application of the mycobacterial RNA isolation method in 
isolating mRNA  
While optimized for the isolation of ncRNA, we investigated the possibility of 
utilizing our approach for mRNA isolation. Here, we performed qPCR against 
seven gene transcripts on samples derived from RNA isolation with our 
approach and samples derived from the conventional TRIzol RNA isolation 
approach. Analysis revealed that there were no significant differences in CT 
values against five gene transcripts as illustrated in Table 2.1. The remaining 
two transcripts showed that our RNA isolation method yielded a lower CT 
value (i.e. higher concentration of mRNA) compared to the TRIzol approach.   
 
2.4.4. Application of the mycobacterial RNA isolation method: 
Quantitative comparison of ncRNA species in non-replicative and 
exponentially growing BCG  
Given the differences in the relative quantities of 23S and 16S rRNAs 
between exponential and non-replicative cultures noted in the Bioanalyzer 
electropherograms (Figures 2.1E, G), we undertook a more rigorous 
quantitative analysis by HPLC resolution of total RNA extracts from BCG 
during large-scale purification of ncRNA species. As shown in Figures 2.2A 
and 2B, we were able to achieve baseline resolution (R = 3.9 ± 0.02) of 16S 
and 23S rRNAs using an Agilent size-exclusion HPLC column (SEC5 1000 
Å), while tRNA and 5S rRNA were well resolved (R = 4.1 ± 0.04) using a solid 
phase with a smaller pore size (SEC3 300Å). The absolute quantities of 
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Table 2.1. CT values obtained from qPCR analysis of samples derived from TRIzol and the optimized RNA isolation approach
 . 
An unpaired Student’s t-test was performed for the samples derived from the two approaches. Data represent mean ± SD for three biological 
replicates. 
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Figure 2.2. Size-exclusion HPLC chromatograms for individual RNA 
species. BCG total RNA was resolved on an Agilent Bio Size Exclusion 
Column SEC5, 1000Å (A), or on an Agilent Bio Size Exclusion Column SEC3, 
300Å (B). Panels A and B are representative of six independent HPLC runs. 
(C) Cellular quantities of 5S, 16S and 23S rRNA and tRNA species based on 
HPLC UV absorbance interpolated from a standard curve based on purified 
human 28S rRNa. An asterisk indicates a significant difference in the quantity 
of RNA from exponentially growing cells compared to hypoxic cells on day 21 
(unpaired T-test, p ≤ 0.05). Data represent mean ± SD for three biological 
replicates. 
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individual ncRNA species were calculated by interpolating the UV absorbance 
peak areas for HPLC-resolved ncRNA species with a standard curve 
prepared from purified 28S rRNA. These quantities were then combined with 
cell counts from colony forming assays for cultures used in the RNA isolation 
to calculate the quantity of each rRNA species on a per cell basis. As shown 
in Figure 2.2C, the quantities of 16S and 23S rRNA from exponentially 
growing BCG were significantly higher than in hypoxia-induced non-
replicative BCG (p ≤ 0.05), yet there was no difference in the quantities of 5S 
rRNA and tRNA for the two growth conditions. These data for cellular 
quantities of ncRNA are consistent with theoretical estimates of mycobacterial 
molecular composition [29]. 
2.4.5. Sequence of BCG 5S rRNA  
Using the optimized RNA isolation method with BCG, we were able to 
reproducibly detect an RNA species with a size consistent with 5S rRNA. 
Though relatively abundant when compared to other bacterial small RNAs, 
the observation of 5S rRNA is notable in light of the fact that this species has 
never been isolated for direct sequencing. In other studies of mycobacterial 
ncRNA, small RNA were identified by genomic analysis, by microarray 
detection of non-coding transcripts, by shotgun cloning of small RNAs, or by 
co-purification with RNA-binding proteins [30-34]. Here, pure 5S rRNA-
containing fractions were collected from the HPLC resolution and the 5S 
rRNA subjected to sequencing to confirm its identity and to define the 
sequence of its mature, functional form. Analysis revealed a sequence of 109 
nt that, in a Blast search, yielded an expect value (E) of 4 x e-49 and a 
maximal identity of 100% for several Mycobacterium species, including BCG, 
M. tuberculosis, M. canettii, and M. africanum. Comparison of the annotated 
BCG 5S rRNA sequence (M. bovis BCG str. Pasteur 1173P2, Gene ID: 
Page | 64  
 
4698678) and the cDNA sequence of our purified 5S rRNA revealed several 
differences in the 3’- and 5’-ends, as shown in Figure 2.3B. The purified 5S 
rRNA lacked 6 nt: positions 1 to 5 and position 115 in the annotated 5S rRNA 
sequence. These results suggest discrete processing of 5S rRNA from its 
genomic transcript as a 9S precursor to the functional sequence by a 
mycobacterial enzyme such as RNase E/G (MycRne), as illustrated in Figure 
2.3C. 
 
2.4.6. The spectrum of modified ribonucleosides in BCG 5S rRNA  
To take advantage of the ability to isolate 5S rRNA using the optimized 
method, we further explored 5S rRNA maturation by analysing post-
transcriptional modifications. Here, we used a highly sensitive 
chromatography-coupled mass spectrometric platform to identify modified 
ribonucleosides in RNA [15, 26, 27]. As shown in Table 2.2, application of this 
platform to BCG 5S rRNA revealed seven modified ribonucleosides: N1-
methyladenosine (m1A), N6,N6-dimethyladenosine (m6,6A), N7-
methylguanosine (m7G), N1-methylguaonsine (m1G), 2’-O-methylguanosine 
(Gm) and inosine (I), each with distinct mass-to-charge transition ratios and 
retention times as shown in Supplementary Figure 2.6. The structures of six 
of the modified ribonucleosides were confirmed with synthetic standards, 
while the structure of the seventh is tentatively assigned as N4-methyl-2’-O-
methylcytidine (m4Cm) based on collision-induced dissociation fragmentation 
patterns. 
2.5. Discussion 
While there are established approaches for isolating specific types of RNA 
from mycobacteria [19-22], there are no methods that have been optimized to 
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yield the complete set of commonly recognized ncRNA species (tRNA and 
5S, 16S, and 23S rRNA). The value of preserving the fidelity of a cellular RNA 
population by isolating the full complement of ncRNA is illustrated in recent 
discoveries of many new ncRNA species in M. tuberculosis based on 
genomic analyses [13, 14] and with the application of quantitative RNA-seq 
methods to both coding and ncRNA in mycobacteria [35]. Furthermore, the 
systems-level analysis modified ribonucleosides in mycobacterial ncRNA also 
requires isolation of the full spectrum of ncRNA species [15-17]. To address 
these challenges, we used M. bovis BCG to develop an optimized method for 
mycobacterial RNA isolation that combines accessible reagents and 
approaches with commercial kits to achieve rapid isolation of the full spectrum 
of ncRNA in high yield with minimal artefacts. The method yielded high quality 
ncRNA and led to the discovery of novel post-transcriptional processing of 5S 
rRNA in BCG. 
A step-by-step analysis of the RNA isolation method provides insights into the 
importance of preserving both the quantitative and qualitative fidelity of the 
isolated RNA. Perhaps the most challenging step in mycobacterial RNA 
isolation involves cell lysis, owing to the unique biochemistry of mycobacterial 
cell walls, which renders them refractory to typical chaotropic or mild 
detergent-based cell lysis solutions used with other bacteria and eukaryotic 
cells. Several methods to overcome this problem have been developed, 
including enzymatic spheroplasting followed by sonication [19], detergent-
based lysis [20], mechanical disruption by bead-beating [21], and mechanical 
shearing with a French pressure cell [22]. However, in the absence of 
denaturants, all of these methods provide an opportunity for adventitious 
enzymatic reactions to occur during the lysis step, including nuclease 
degradation and alteration of modified ribonucleosides in the RNA. Our  
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Figure 2.3. Purification and sequencing of BCG 5S rRNA and a 
proposed model for 5S rRNA processing. (A) A Bioanalyzer 
electropherogram for HPLC-purified 5S rRNA shows high purity. (B) 
Comparison of sequenced 5S rRNA against its annotated gene 
sequence. A total of six nucleotides are absent from the sequenced 5S 
rRNA (highlighted in red). (C) Possible fates of the putative 9S RNA, a 
precursor of functional 5S rRNA. Zeller et al. demonstrated in vitro 
processing of 9S rRNA to a 116 nt 5S rRNA by MycRNE/RNase E/G 
[36], while our analysis reveals different or further in vivo processing to 
yield a 109 nt functional 5S rRNA molecule. 
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Table 2.2. List of modified bases detected in BCG 5S rRNA.  
 
 Identity of modifications determined by comparisions of accurate mass measurements on QTOF and retention times of chemical standards on the LC-QTOF 
and LC-QqQ. *Based on accurate mass of precursor ion on QTOF and neutral loss of 2'O methyl ribose on QqQ; no standards available.
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approach of bead-beating in the presence of a strong denaturant such as 
phenol:chloroform:isoamyl alcohol minimizes artefacts by reducing the time 
required for lysis and by quenching all physiological and biochemical 
processes. 
It is also important to consider the choice of denaturing extraction solvents as 
a determinant the fidelity of the RNA population. The introduction of the 
‘single-step’ method of RNA isolation using acid guanidinium thiocynate-
phenol-chloroform (i.e., TRIzol) provided versatility and ease in retrieving 
RNA from a wide variety of sources [37]. However, Kim et al. recently 
described poor recovery of small RNA with low GC content when utilizing the 
isopropanol precipitation step in the TRIzol approach, challenging the 
assumption that total RNA preparations recover all RNA species with equal 
efficiency [23]. We also observed that TRIzol yields a smaller proportion of 
16S and 23S rRNA from mycobacteria compared to the phenol, chloroform, 
isoamyl alcohol mixture (Supplementary Figures 2.2B and 2.4). The 
alternative use of cetyltrimethylammonium bromide with phenol and bead-
beating for RNA extraction from mycobacteria by Cheung et al. [38] proved to 
be problematic [20]. For retrieval of RNA from the extraction solvents, an 
isopropanol precipitation step is frequently used, though this results in biases 
against small RNAs. Given these issues of extraction and recovery, we found 
that the combination of phenol:chloroform:isoamyl alcohol extraction with 
bead-beating followed by solid-phase extraction columns for RNA retrieval 
provided optimal RNA yields in terms of quantity and quality. As the use of 
phenol:chloroform:isoamyl alcohol at an alkaline pH increases the co-
purification of genomic DNA, a DNA removal step, such as addition of DNase 
I or HPLC purification, should be employed for downstream applications 
involving PCR amplification or chemical analysis of RNA. The solid phase 
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extraction technology is based on nucleic acid binding to silica-based 
polymers with RNA retention dependent on the concentration of salt and 
ethanol in the aqueous phase [39]. Lower percentages of ethanol (e.g. 35%) 
allow retention of larger RNA while higher percentages of ethanol (e.g., 70%) 
retain small RNA. While there is significant loss of small RNAs, most notably 
tRNA, on the column supposedly retaining large RNAs (column #1 in the 
current method), quantitative recovery of all RNA species is achieved by 
combining the eluates from both columns.  
 
This optimized approach of using denaturing extraction solvents during bead-
beating to lyse mycobacteria, followed by solid-phase recovery of RNA allows 
for rapid, efficient isolation of the complete set of ncRNA species with minimal 
degradation artefacts. The efficiency of the method is evident in the yield of 
DNA-free RNA, which amounted to a reproducible 2.6 µg of RNA from 109 
bacilli (i.e., 2.6 fg per cell). This amount of cellular RNA is consistent with 
recent studies on the molecular composition of mycobacteria that gave a 
theoretical total content of RNA in a single BCG bacillus at 2.2-10 fg with 
dependence on the growth rate [29]. Given our isolation results and the 
agreement with theoretical RNA amounts, previous claims of 20 fg RNA per 
cell for mycobacteria are likely over-estimates possibly resulting from DNA or 
other contamination [20, 38]. For the highest degree of purity needed for 
chemical analysis of RNA, for example, individual RNA species can purified 
by one-, two- or even three-dimensional chromatography combining size-
exclusion with reversed-phase matrices [26]. This step provides an 
opportunity to remove contaminating DNA and DNase I. In our experiments, 
we show essentially complete digestion of DNA by DNase I in order to 
minimize DNA contamination in purification steps (Supplementary Figure 
2.5). 
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The immediate application of this method to the M. tuberculosis surrogate, M. 
bovis BCG, which is also the tuberculosis vaccine strain, led to three 
important observations: pathophysiological shifts in the relative quantities of 
ncRNA species, and novel post-transcriptional processing of the elusive 5S 
rRNA in terms of sequence trimming and an expanded set of modified 
ribonucleosides. Among a variety of environmental changes that occur in the 
hallmark pathology of M. tuberculosis infection, oxygen depletion in vitro and 
granulomas have been shown to induce a non-replicative persistent state that 
mimics the dormant state of tuberculosis bacilli [40]; this phenotype is shared 
by BCG and the faster growing M. smegmatis [41]. Consistent with the 
observation of a hypoxia-induced decrease in nucleic acid synthesis [42] and 
loss of both 50S and 30S ribosomal subunits [41], we observed significant 
decreases in the relative quantities of 16S and 23S at the fully developed 
non-replicative state at 21 days of hypoxia (Figure 2.2C). Surprisingly, the 
levels of small RNAs did not change significantly in the hypoxic state, either in 
terms of Bioanalyzer RNA profiles or HPLC quantification. Furthermore, the 
decrease in the relative quantity of 16S rRNA raises questions about the 
feasibility of using bacterial 16S rRNA a housekeeping gene in bacterial gene 
expression studies, particularly those examining stress conditions. While 
possible, it unlikely that the thicker cell wall of the hypoxic, non-replicative 
state could lead to less cell wall disruption during the cell lysis step and cause 
differential release of small and large ncRNA species. 
 
The optimized RNA isolation method also yielded insights into the maturation 
and processing of 5S rRNA in mycobacteria. In 1978, using temperature-
sensitive rne E. coli mutants, several small RNA molecules were discovered, 
including 9S RNA that contained the 5S rRNA sequence [43]. Further studies 
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demonstrated that processing of 9S RNA by RNase E and/or RNase G yields 
what was thought to be a mature 5S rRNA [43, 44]. An RNase E/G 
homologue was identified from M. tuberculosis and was characterized as a 5’-
endoribonuclease able to cleave putative 9S RNA in vitro as well as in vivo 
[36]. This RNase E/G homologue, termed MycRne, was shown to cleave 9S 
RNA in proximity to, but upstream of, the annotated genomic 5S rRNA 
sequence, with the difference attributed to the association of ribosomal 
proteins. Using the RNA isolation method with HPLC purification, we were 
able to obtain a homogeneous population of 5S rRNA molecules for 
sequence analysis and chemical analysis of modified ribonucleosides. 
Sequencing of purified 5S rRNA uncovered two sites of truncation with 
respect to the BCG 5S rRNA gene, as shown in Figure 2.3B. Our findings 
strongly support the idea of a cleavage downstream from, but in proximity to, 
the start of the annotated genomic sequence, as well as a cleavage one 
nucleotide upstream from the end sequence to yield a functional 5S rRNA. To 
determine the cleavage site of 9S RNA, the previously mentioned group 
incubated PCR-amplified putative 9S sequences with a truncated form of 
MycRne protein that was overexpressed in E. coli. Additionally, their group 
utilized primer extension of total RNA to determine the position of the 5’ end 
of 5S rRNA. As the sequences differed by one or two nucleotides, they 
attributed the differences to the presence of ribosomal proteins [36]. The 
uniformity of the observed 5S rRNA sequence in our studies rigorously 
establishes the functional form of this RNA. 
 
In addition to sequence alterations, ncRNAs undergo maturation in form of 
post-transcriptional insertion of dozens of different modified ribonucleosides, 
especially tRNA. To date, however, there have been very few observations of 
modified ribonucleosides in 5S rRNA in either eukaryotes or prokaryotes. 
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Modified ribonucleosides in 5S rRNA have been described in archea and to a 
smaller extent, eukaryotes [45, 46]. Although Yan et al. claim to have 
detected Am, Cm, m3C, m6A in mouse liver 5S rRNA, and while Cm, ac4C, 
ac4Cm have been detected in Sulfolobus solfataricus, Pyrodictium occultum, 
and Haloferax volcanii 5S rRNA [46, 47], the Albany Modification Database 
lists only four modifications in 5S rRNA: Cm, ac4C, ac4Cm, and Y [48]. Our 
analysis of BCG 5S rRNA thus adds seven more modified ribonucleosides to 
the 5S rRNA roster: m1A, m6
6A, m7G, m1G, Gm, I and a putative m4Cm (Table 
2.2). Given the importance of rRNA modifications in 16S and 23S rRNA in 
ribosome assembly and translational fidelity, as well as in mechanisms of 
resistance to aminoglycoside, macrolide and linezolid antibiotics [49-52], it is 
reasonable to assume that 5S rRNA modifications have potential effects with 
respect to bacterial growth and survival.  
 
Given that the use of phenol:chloroform:isoamyl alcohol at an alkaline pH 
partitions nucleic acids in the organic phase (including mRNA), we sought  to 
determine if our method was suitable for mRNA isolation or gene expression 
studies. We thus probed for the presence of seven mRNA transcripts on 
samples derived from our RNA isolation approach and samples derived from 
the conventional TRIzol RNA isolation approach. Analysis showed that the 
optimized phenol:chloroform:isoamyl alcohol approach resulted in a similar 
yield of mRNA when compared to TRIzol-based RNA isolation, while the RIN 
data attests to the quality of the total RNA preparation. We therefore believe 
that total RNA derived from our approach can be used for gene expression 
studies. 
 
The results presented here demonstrate the utility of a mycobacterial RNA 
isolation method that maximally preserves the quantitative and qualitative 
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fidelity of ncRNA species. While optimized for ncRNA, the method also 
provides high fidelity isolation of mRNA from mycobacteria.  
 
2.6. Supplementary material 




Supplementary Figure 2.1. Growth of M. bovis BCG under hypoxia. 
Cultures of BCG were sealed on day = 0 and the OD600 determined regularly 
for 21 days. The plateau in growth represents the hypoxia-induced non-
replicative state. 
 
   





Supplementary Figure 2.2. Workflow for the isolation of total ncRNA 
from BCG. Bacilli are lysed by reciprocal shaking with 0.1 mm silica beads in 
phenol/chloroform/isoamyl alcohol and the RNA retrieved using a solid-phase 
extraction system (Purelink miRNA Isolation Kit). RNA from both columns is 
eluted and combined to yield total RNA. The ncRNA species are 
subsequently isolated by size-exclusion HPLC.
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Supplementary Figure 2.3. Standard curve (R2 = 0.999) for RNA quantification as determined by HPLC analysis of 28S rRNA 
standards of varying concentrations. 
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Supplementary Figure 2.4. Comparison of RNA extractions with phenol:chloroform:isoamyl 
alcohol 25:24:1 (P:C:IAA), saturated with 10 mM Tris, pH 8.0, 1 mM EDTA (Black) and TRIzol 
(grey). When used on BCG, significant less 16S and 23S rRNA are extracted with TRIzol when 
compared to phenol:chloroform:isoamyl alcohol. 
 
 
Supplementary Figure 2.5. Size-exclusion HPLC analysis showing the removal of DNA from 



































DNase I Treatment 













Supplementary Figure 2.6. Composite extracted ion chromatograms of modified 
ribonucleosides in hydrolyzed BCG 5S rRNA. 
 
2.6.2. Supplementary tables 
(next page) 
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Supplementary Table 2.1. Conditions used for the optimization of mycobacterial RNA extractions. 
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Supplementary Table 2.2. RNA integrity numbers (RIN) and proportions 
of non-coding RNA as determined using the Agilent RNA 6000 Pico Kit 
and Agilent Small RNA kit as determined by the Agilent Bioanalyzer 
2100 system. (A) the phenol;chloroform:isoamyl alcohol approach and (B) 
the conventional TRIzol approach.
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Supplementary Table 2.3. qPCR Primers for M. bovis BCG str. Pasteur 1173P2.
 
* Primer sequence obtained from Cappelli et al. [53] 
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3.  A multi-dimensional platform for the purification of 
non-coding RNA species1 
3.1. Abstract 
A renewed interest in non-coding RNA (ncRNA) has led to the discovery of 
novel RNA species and post-transcriptional ribonucleoside modifications, and 
an emerging appreciation for the role of ncRNA in RNA epigenetics. While 
much can be learned by amplification-based analysis of ncRNA sequence 
and quantity, there is a significant need for direct analysis of RNA, which has 
led to numerous methods for purification of specific ncRNA molecules. 
However, no single method allows purification of the full range of cellular 
ncRNA species. To this end, we developed a multi-dimensional 
chromatographic platform to resolve, isolate, and quantify all canonical 
ncRNAs in a single sample of cells or tissue, as well as novel ncRNA species. 
The applicability of the platform is demonstrated in analyses of ncRNA from 
bacteria, human cells and plasmodium-infected reticulocytes, as well as a 
viral RNA genome. Among the many potential applications of this platform are 
a systems level analysis of the dozens of modified ribonucleosides in ncRNA, 
characterization of novel long ncRNA species, enhanced detection of rare 
transcript variants, and analysis of viral genomes. 
3.2. Introduction 
The renewed interest in RNA modifications and the discovery of many new 
non-coding RNA species (ncRNA)[1-5] has increased the demand for 
methods to purify RNA species. However, while eukaryotic mRNA is readily 
purified by exploiting a polyA tail, studies of ncRNA structure and 
                                                          
1
 Featured in Nucleic Acids Res. 2013 Sep;41(17):e168. Reproduced with permission 
from Oxford University Press. 
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biochemistry, post-transcriptional processing (capping, end-processing), 
ribonucleoside modification, and biological function have been limited by the 
inability to obtain RNA in pure form [6-11]. This is especially important given 
the emerging interest in studying RNA biology on a systems level, with 
coordinated analysis of modified ribonucleosides present in virtually all forms 
of RNA [4, 5, 12, 13]. Existing RNA purification methods are limited by 
specificity, size range, or yield. While affinity purification approaches are 
specific to a unique sequence, more general size-based gel electrophoretic 
approaches are hampered by a narrow size range, gel contaminants from 
RNA elution, and high losses during purification [14-16]. Liquid 
chromatography (LC) approaches employing all types of stationary phase 
have solved some of these problems, with a wider size range but lower 
resolving power than gel electrophoresis [17-22]. Improvements in capacity 
and specificity have been achieved by specialized combinations of 
chromatography with affinity purification [23, 24] and electrophoresis [25]. 
Though useful for isolating specific RNA classes or RNA species, these 
methods do not permit size-fractionation of total RNA or isolation of all 
classes of ncRNA from single sample for a systems-level analysis of modified 
ribonucleosides, for example.  
To address this unmet need in RNA biology, we report a comprehensive, 
multi-dimensional, high performance liquid chromatography (HPLC) platform 
that can be used to purify all major classes of ncRNA from a single sample of 
total RNA. The method takes advantage of the strengths of two types of 
HPLC, thus increasing the peak capacity and the resolution of ncRNA across 
a wide size range. Such an approach is well developed in proteomics and has 
proven valuable in fractionating complex biological mixtures [26, 27]. To 
resolve ncRNA, we combined two ranges of size-exclusion chromatography 
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(SEC) with ion-pair reverse-phase chromatography (IP RPC) to achieve a 
complete separation of RNA species ranging from 20 to >10,000 nucleotides 
(nt), including viral RNA genomes, large and small subunit rRNAs, tRNA and 
miRNA. The approach is demonstrated for both individual HPLC steps (1-
dimensional, 1-D) and for 2-dimensional (2-D) HPLC resolution of total RNA 
from human, plasmodium parasite and bacterial cells, as well as a dengue 
viral RNA genome. 
3.3 Material and methods 
3.3.1. Chemicals and reagents 
RPMI 1640, fetal bovine serum and Penicillin Streptomycin (Pen-Strep) for 
cell cultures were purchased from Gibco, Invitrogen (Carlsbad, CA). 
RiboGreen and PicoGreen kits for RNA and DNA quantitation respectively 
were purchased from Molecular Probes, Invitrogen (Eugene, OR). Chemicals 
unless otherwise specified were purchased from Sigma Chemical Co. (St. 
Louis, MO). 
3.3.2. Bacterial and mammalian cell culture 
E. coli strain DH5α, was grown for 3 h in Luria-Bertani (LB) medium (Becton, 
Dickinson and Company, Franklin Lakes, NJ) at 37°C with shaking (250 rpm) 
until an optical density (600 nm; OD600) of 0.6 was reached at mid-
exponential growth phase. M. bovis BCG strain Pasteur 1173P2 bacilli 
(ATCC) were grown in 7H9 culture media (4.9 g of 7H9 powder, 10 mL of 
50% glycerol, 2.5 mL of 20% TWEEN 80, 900 mL of water and 100 mL of 
ADS solution) at 37 oC in an 850 cm2 polystyrene roller bottle (Corning, NY, 
USA) at 10 rpm to an OD600 = 0.6, at which point the concentration of cells 
was ~5x107/mL. Mononuclear, B lymphoblastoid CCRF-SB and TK6 cells 
(ATCC) were grown in suspension cultures in RPMI complete medium (90% 
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RPMI 1640 medium, 10% fetal bovine serum with added Pen-Strep) to a 
density of 107 cells/mL. 
3.3.3. In vitro transcription of dengue viral RNA from plasmid DNA 
template 
Genome-length 10.7 kb viral RNA (vRNA) of DENV-1 was in vitro transcribed 
from full-length cDNA plasmid linearized by SacII [28]. The vector is then 
electroporated into BHK-21 cells and transfected cells resuspended in 20 mL 
of DMEM medium[29]. The transfected cultures were subsequently subjected 
to viral production and specific infectivity assays as communicated previously 
[28]. RNA was isolated with Trizol reagent (Invitrogen) as directed by the 
manufacturer and re-purified on an Agilent Bio SEC-5 2000Å (i.d. 7.8 mm; 
length 300 mm) column (Agilent Technologies, Foster City, CA) with an 
isocratic elusion as described below. 
3.3.4. Rodent infection with Plasmodium berghei and isolation of 
schizont-infected murine reticulocytes 
Male BALB/c mice and male WISTAR rats of 6–8 weeks old were obtained 
from Sembawang Laboratory Animal Center, National University of 
Singapore, and subsequently bred under specific pathogen free (SPF) 
conditions at Nanyang Technological University Animal Holding Unit. Infection 
and handling of laboratory animals with the blood-stage Plasmodium berghei 
ANKA strain were performed using the methods described elsewhere [30]. 
Blood was collected from infected rats at a parasitemia of 1-3% by cardiac 
puncture with heparin (Sigma). Blood was then filtered by leukocyte filter 
(Plasmodipur filter, Euro-Diagnostica) and cultured until the schizont stage in 
complete RPMI 1640 containing 20% FBS with gentle shaking at 37 °C. 
Schizont-infected cells were separated from uninfected cells by 50%–60% 
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Nycodenz (Sigma-Aldrich) gradient centrifugation. Schizonts were purified by 
lysing rat erythrocytes with 0.15% saponin and washed three times with cold 
PBS before flash freezing in liquid nitrogen. 
3.3.5. Ethics statement 
The study was carried out in strict accordance with the recommendations of 
the NACLAR (National Advisory Committee for Laboratory Animal Research) 
guidelines under the Animal and Birds (Care and Use of Animals for Scientific 
Purposes) Rules of Singapore. The protocol was approved by the Institutional 
Animal Care and Use Committee (IACUC) of the Nanyang Technological 
University of Singapore (Approval number: ARFSBS/ NIE A002). All efforts 
were made to minimize the suffering. 
3.3.6. Total RNA extraction 
Prior to lysis cells were washed with ice-cold PBS again. BCG pellets were 
lysed by French high-pressure homogenization (Thermo Scientific). Ice-cold 
phenol:chloroform:isoamyl alcohol (25:24:1) was added directly to the lysate 
and total RNA obtained with PureLink miRNA Isolation Kit (Invitrogen), as 
described by the manufacturer. For E. coli, the lysis was performed with 100 
μL of lysozyme (1 mg/mL) for 20 min at ambient temperature. E. coli total 
RNA was extracted with Trizol reagent (Invitrogen), precipitated with ice-cold 
isopropyl alcohol and washed with 75% ethanol.  CCRF-SB, TK6 and P. 
berghei infected reticulocytes were directly lysed in Trizol reagent and 
eukaryotic total RNA extracted in an identical fashion. RNA pellets were air 
dried and re-dissolved in RNAse-free water. DNase I (Qiagen, Valencia, CA) 
treatment was performed for 15 min at 37 °C. The quality and quantity of RNA 
was determined using Agilent Bioanalyzer RNA 6000 Nano chips (Agilent 
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Technologies, Santa Clara, CA). Only samples with a RNA Integrity Number 
(RIN) of 8.0 or greater were used for further experiments. 
3.3.7. Size-exclusion chromatography of total RNA 
One-dimensional SEC was performed with either a Bio SEC-3 300Å (i.d. 
7.8mm; length 300mm) or a Bio SEC-5 1000Å (i.d. 7.8mm; length 300mm) 
column (Agilent Technologies, Foster City, CA), with 100 mM ammonium 
acetate (pH 7.0) as the mobile phase. Isocratic separations were performed 
at 1 mL/min for 20 min under partially denaturing conditions at 60 °C on the 
Agilent 1200 HPLC system. 2-D SEC was performed with Bio SEC-3 300Å 
and either Bio SEC-5 1000Å or Bio SEC-5 2000Å (id 7.8 mm, length 300 mm) 
columns. A second Agilent 1260 Infinity system is connected with the valve 
configuration described in Supplementary Figure 3.2 and isocratic 
separations were performed with 100 mM ammonium acetate at 0.5 ml/min 
rates for 40 min at 60 °C. Chromatograms were recorded at every 10 nm from 
200 to 300 nm. Peaks were collected with an Agilent 1260 Infinity auto-
sampler by time segments. For separations of BCG total RNA, a Bio SEC-5 
1000Å column was connected to the column 1 position while a Bio SEC-3 
300Å column was connected to the column 2 position. From 0-0.1 min column 
1 is connected to the detector, from 0.1- 18.5 min, column 2 is connected and 
this is switched back to column 1 at 18.5 min. For separations of TK6 total 
RNA, a Bio SEC-5 2000Å column was connected to the column 1 position 
while a Bio SEC-3 300Å column was connected to the column 2 position. 
From 0-0.1 min, column1 is connected to the detector, and from 0.1-20 min, 
column 2 is connected and switched back to column 1 at 20 min. For 
separations of total RNA from P. berghei-infected rat reticulocytes, a Bio 
SEC-3 300Å column was connected to the column 1 position while a Bio 
SEC-5 1000Å column was connected to the column 2 position; the column 
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switching scheme is identical as that used for TK6 total RNA. For the analysis 
of TK6 total RNA, 100 mM triethylammonium acetate (TEAA) (pH 7.0) instead 
of 100 mM ammonium acetate was used as the mobile phase. In addition, a 
Bio SEC-5 2000 Å column was used. All other conditions were kept constant. 
3.3.8. Ion-pair reversed-phase chromatography of total RNA 
CCRF-SB and TK6 total RNA was analyzed by IP RPC on the Agilent 1200 
system using a Source 5RPC 4.6/150 column (GE Healthcare Life Sciences, 
Piscataway, NJ). HPLC was performed using a two eluent buffer system in 
which buffer A consists of an aqueous solution of 100 mM TEAA, pH 7.0 with 
2% acetonitrile and buffer B consists of 100% acetonitrile under partially 
denaturing conditions at 60 °C with chromatograms recorded and as 
described above. IP RPC were performed with the following gradient 
conditions: flow rate 1 mL/min, 5-5.5% B over 6 min, to 13% B over 45 min, to 
16.5% B over 9 min, to 100% B over 10 min, held at 100% B for 10 min, 
brought back to 5% B over 10 min. 
3.3.9. Analysis of isolated RNA species 
2D-SEC-purified DENV-110.7 kb vRNA, 28S, and 18S rRNA from CCRF-SB 
and TK6, 23S and 16S rRNA from E. coli and BCG, and P. berghei 28S, 18S 
and 800nt rRNA were concentrated and desalted with an Amicon Ultracel 10k 
MWCO spin column (Millipore, Bedford, MA), while 5.8S, 5S, tRNA and 
miRNA from the aforementioned total RNA preparations were concentrated 
and desalted with a Vivacon-500 2k MWCO spin column (Sartorius, 
Goettingen, Germany). The efficiency of the isolation process, quality and 
quantity of each RNA species after HPLC purification and desalting was 
assessed using the Agilent Bioanalyzer (Agilent). RNA 6000 Pico chips were 
used to evaluate 28S, 18S, 23S, 16S rRNA and P. berghei 800 nt rRNA while 
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5S, 5.8S rRNA, tRNA and miRNA were evaluated on Small RNA chips. The 
presence of contaminating DNA was determined using a PicoGreen dye-
based quantitation assay using calf-thymus DNA (Sigma) as a calibration 
standard. 
The theoretical maximum composition of each RNA species from their 
respective total RNA preparations was estimated by the product of the 
percentage area under the curve for each chromatographic peak with the 
quantity of total RNA injected into the chromatographic system. We then 
established the yields of each RNA species that was recovered from the RNA 
isolation process by calculating the ratios between the quantities of purified 
RNA against its corresponding theoretical maximum yield. 
3.3.10. RiboGreen assay for species-specific fluorometric responses  
Purified RNA samples were diluted to stock solutions of 20 μg/mL RNA in TE 
buffer, (10 mM Tris, 1 mM EDTA, pH 7.8) and their concentrations were 
confirmed with a Nanodrop Spectrophotometer (Thermo Scientific, 
Wilmington, DE). A 96-well based RiboGreen RNA quantitation assay was 
performed as indicated by the manufacturer instructions with the stocks of 
each purified RNA species used in place of the RNA standard provided. 
Scans for RiboGreen fluorescence were also performed from 450 to 650 nm 
at 10 nm intervals. Fluorometric measurements were conducted on a BioTek 
Synergy 2 Multi-Mode Microplate Reader (Winooski, VT) with 485/20 nm and 
528/20 nm bandpass filters for excitation and emission, respectively. All 
readings were taken at 25 °C. 
3.3.11. Detection and relative quantification of ribonucleosides from 
BCG tRNA by chromatography-coupled mass spectrometry 
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Purified BCG tRNA (5 g) from 3 independent exponentially growing cultures 
of BCG was hydrolyzed enzymatically as described previously [31]. 
Hydrolyzed RNA was resolved on a Thermo Hypersil aQ column (100 x 2.1 
mm, 1.9 m particle size) in a two buffer eluent system with buffer A 
consisting of water with 0.1% (v/v) formic acid and buffer B consisting of 
acetonitrile with 0.1% (v/v) formic acid. HPLC was performed at a flow rate of 
0.3 mL/min.  The gradient of acetonitrile in 0.1% formic acid was as follows: 
0-12 min, held at 0%; 12-15.3 min, 0%-1%; 15.3-18.7 min, 1%-6%; 18.7-20 
min, held at 6%; 20-24 min, 6%-100%; 24-30 min, held at 100%; 30-35 min, 
100%-0%; 35-40 min, 0%.  The HPLC column was maintained at 25 ºC and 
directly connected to an Agilent 6460 triple quadrupole mass spectrometer 
(LC-MS/MS) with ESI Jetstream ionization operated in positive ion mode. 
Multiple reaction monitoring (MRM) was performed to detect and quantify the 
ribonucleosides with the parameters of retention time, m/z of the transmitted 
parent ion, and m/z of the monitored product ion as noted in Supplementary 
Table 2. Fragmentor voltages of 89 V and collision energies of 18 V were 
used. The dwell time for each ribonucleoside was 100 ms and 18 ions were 
monitored from 0.5 to 28 min.  The voltages and source gas parameters were 
as follows: gas temperature, 350 ºC; gas flow, 5 L/min; nebulizer, 40 psi; 
sheath gas temperature, 325 ºC; sheath gas flow, 7 L/min and capillary 
voltage, 3500 V. 
3.3.12. MS2 Structural characterization of N6,N6-dimethyladenosine in 
BCG tRNA 
The ribonucleoside-like species eluting at 20.14 min and possessing an 
[M+H]+ ion with m/z of 296.1356 was subjected to structural characterization 
by collision-induced dissociation (CID) performed on the LC-QTOF system 
using the same column and chromatographic system as described above. 
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The mass spectrometer was operated in positive ion mode with the following 
voltages and source gas parameters: gas temperature, 325 ºC; drying gas, 7 
L/min; nebulizer, 15 psig; capillary voltage, 4000 V.  The m/z detection range 
for parent ions was 100 to 800 and that for product ions was 50 to 500.  The 
fragmentor voltage was set at 85 V and the collision energy was 25 V. 
3.3.13. Data graphing and statistical analysis 
Analysis of Covariance (ANCOVA) of RNA species-specific RiboGreen 
calibration curves was performed with Graphpad Prism 5.0. Multiple 
regressions were not performed. Instead, relative pair-wise comparisons were 
made between each purified RNA species and the total RNA from which it 
was isolated from. The 3-D and contour plots were made with Matlab R2012a 
(Mathworks, Natick, MA). Peaks in the raw chromatograms corresponding to 
miRNA, tRNA, 5S rRNA, sn/snoRNA, 5.8S rRNA, 18S rRNA and 28S rRNA 
were manually assigned based on their respective sizes as determined by 
Bioanalyzer 2100 LabChips. In the 3-D plot, the region on the X-Y basal plane 
that represents a particular RNA species was determined by the characteristic 
retention time of that species in both LC methods; the height of peaks in the 
Z-direction, each representing a particular RNA species, denotes the 
geometric average of the absorbance values of that specific RNA in both LC 
methods, which was calculated as the square root of the product of the two 
absorbance values. This assignment of Z-axis values takes into account the 
absorbance measurements by both LC methods and therefore accurately 
reflects the relative intensity or abundance of the different RNA species 
present within one cellular extract. For all areas on the X-Y basal plane other 
than those designated with a particular RNA species, the Z-axis values were 
set to be zero so as to remove the artifact peaks generated by juxtaposing 
data from two orthogonal LC methods. 
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3.4. Results 
The overall strategy for developing the RNA purification method involved 
defining the parameters for the individual chromatographic elements for 
purification of ncRNA and then combining the two size-exclusion steps into a 
2-D system. 
3.4.1. 1-D size exclusion chromatography of eukaryotic and prokaryotic 
total RNA 
Given the observation that virtually all classes of RNA, except mRNA, can be 
defined by their sequence lengths and molecular sizes, we coordinated two 
different size-range SEC columns to resolve total RNA. 1-D SEC of total 
cellular RNA has been used to separate small ncRNA (tRNA; 5S, 5.8S rRNA) 
from large ncRNA (16S, 18S, 23S, 26S rRNA), but large rRNA species were 
not resolved [21, 22, 32]. We empirically tested several commercial SEC 
columns and found that two second-generation columns (Agilent Bio SEC-5 
1000 Å pore size and Bio SEC-3 300 Å pore size) provided the best 
resolution after optimizing for temperature (60 °C; evaluated range: ambient-
70 °C), eluent ionic strength (10 mM ammonium acetate; evaluated range: 0-
100 mM) and flow rate (0.5 mL/min; evaluated range: 0.5-1 mL/min). 
Separations of total RNA from E. coli and human B lymphoblastic CCRF-SB 
cells on both columns are shown in Figure 3.1A-D. Baseline separation 
(resolution Rs > 1.5) of large rRNAs was achieved with the SEC-5 1000 Å 
column for both 23S and 16S rRNA from E. coli (Figure 3.1A) and for 28S 
and 18S rRNA from CCRF-SB (Figure 3.1B). While low molecular weight 
rRNAs (5.8S, 5S), tRNA and smaller ncRNA eluted together on this column 
(Figure 3.1A, B), the SEC-3 300 Å column achieved resolution of tRNA from 
5.8S/5S rRNA (Figure 3.1C, D).
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Figure 3.1. Separation of CCRF-SB and E. coli total RNA by SEC HPLC. 
(A) Typical profile of E. coli total RNA consisting of 23S, 16S rRNAs and co-
eluting 5S rRNA and tRNA obtained on a Bio SEC-5 1000Å column. (B) 
Typical profile of CCRF-SB total RNA consisting of 28S, 18S rRNAs and co-
eluting 5.8S, 5S rRNA and tRNA obtained on a Bio SEC-5 1000Å column. (C) 
Typical profile of E. coli total RNA consisting of 5S rRNA, tRNAs and co-
eluting 16S and 23S rRNAs obtained on a Bio SEC-3 300Å column. (D) 
Typical profile of CCRF-SB total RNA consisting of 5.8S, 5S rRNA, tRNAs 
and co-eluting 18S and 28S rRNAs obtained on a Bio SEC-3 300Å column. 
The chromatograms show the analysis of 10 µg of total RNA extracted using 
Trizol reagent (Material and Methods). (E) Separation of miRNA, tRNAs, 
5.8S, 5S rRNAs, putative snRNAs and snoRNAs, and co-eluting 18S and 28S 
rRNAs from human lymphoblastic cell line CCRF-SB total RNA by IP RP 
HPLC obtained on a SOURCE 5RPC ST 4.5/150 column. The identity and 
purity of the RNAs collected in each fraction was validated with Bioanalyzer 
RNA 6000 Pico and Small RNA LabChips (Supplementary Figures. 3.1 and 
3.3).
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For preparative SE-HPLC isolations of RNA at microgram quantities, a 
fraction collector (Agilent 1260 FC-AS) is placed in-line after the detector. 
Fractions are collected by time segments, and the purity and integrity of each 
fraction were analyzed on an Agilent 2100 Bioanalyzer with appropriate RNA 
microfluidic chips (Supplementary Figure 3.1). For each fraction, mRNA and 
other non-canonical ncRNA species were not detected above the 50 pg/l 
limit of detection of the RNA 6000 Pico (total RNA) and Small RNA chips. It 
should be noted that for these small, micro-fluidic separations, it is not always 
possible to fully discern degradation products or co-purified RNA species with 
similar electrophoretic properties. The small fronting or tailing peaks observed 
in several of the electropherograms (Supplementary Figures 3.1D, 3.1G, 
3.1H and 3.1L) may be attributed to these RNAs. Therefore, in these cases, 
we recommend a second purification using the same 1-D SEC system with 
strict time segment cut-offs to improve the purity of the targeted RNA species. 
Apart from miRNA and sRNAs, our isolation method allows recovery ≥80% for 
all other RNA species (Supplementary Figure 3.2A, 3.2B) on both SEC-3 
300 Å and SEC-5 1000 Å columns. In addition, we observed no change in the 
linearity of the absorption isotherm for each targeted RNA species for up to 
100 µg of injected total RNA (peak symmetries 1.0-1.4), with detector 
saturation at ~490 µg of total RNA injected. These parameters allow the user 
to optimize the injected load of RNA for purposes of recovery, purity or 
throughput. Equally important, we observed no volume overloading effects at 
sample volume injections up to 100 μl. 
3.4.2. 1-D ion-pair, reversed-phase chromatography for complete 
resolution of small RNA species 
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Ion-pair, reversed-phase chromatography (IP RPC) was employed as the 
third dimension of separation to resolve all small ncRNA species, including 5S 
and 5.8S rRNA [18, 33, 34]. Using a SOURCE 5RPC ST 4.5/150 column (5 
µm particle size; 4.6 x 150 mm) and triethylammonium acetate (TEAA) for 
charge neutralization, we achieved complete resolution of small ncRNA from 
CCRF-SB human lymphoblast cells (Figure 3.1E), including separation of 
miRNA-sized fragments from tRNA and 5S from 5.8S rRNA. The size-based 
identity of these RNA species was verified by Bioanalyzer (Supplementary 
Figure 3.3). We observed multiple RNA peaks between 31 and 48 min 
(Figure 3.1E), which proved to be ~60-80 nt in apparent length by 
Bioanalyzer analysis (Supplementary Figure 3.3E). Given reports of 
sequence dependency in IP RPC single-stranded RNA separations [35], we 
believe that these peaks represent groups of tRNA isoforms. In addition, from 
42 to 45 min (Figure 3.1E), another series of peaks with apparent lengths 
between 70-130 nt was observed (Supplementary Figure 3.3H), which 
match the size of several snoRNA and snRNA species [36]. A final 
noteworthy feature of these studies is that baseline separation of 18S and 
28S rRNA was achieved with SEC but not IP RPC (Figure 3.1A; 
Supplementary Figures 3.1G, 3.1H and 3.3B). Hence, the two 
complementary approaches provide complete resolution of all major ncRNA 
species. 
We validated this chromatographic system for preparative isolations with RNA 
loads up to 40 µg of total RNA. At this scale, we recovered ≥70-80% of the 
targeted RNA species (Supplementary Figure 3.2C) with no significant loss 
of peak quality and resolution. 
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3.4.3. 2-D SEC design and validation with total RNA from Mycobacterium 
bovis BCG 
The results with 1-D HPLC systems indicates that a 2-D separation utilizing 
both SEC-5 and SEC-3 columns would allow the complete resolution of most 
ncRNA under non-denaturing conditions, with the exception of 5S and 5.8S 
rRNA. To this end, we designed a valve-switching scheme that facilitates an 
online tandem SEC approach to the separation of total RNA (Supplementary 
Figure 3.4). In this non-orthologous 2D HPLC scheme, high molecular weight 
(MW) RNA (> 500 kDa; e.g., 28S, 23S, 18S, 16S rRNA) is resolved on the 
SEC-5 column, while low MW RNA (<40 kDa; e.g., 5.8S/5S rRNA, tRNA, 
miRNA) is resolved on the SEC-3 column. When total cellular RNA is injected 
onto the SEC-5 column, high MW species are resolved from each other and 
from the retained low MW RNAs, which elute as a group directly onto the 
SEC-3 column where they are fractionated. Conversely, high MW RNA 
species separated on the SEC-5 column bypass the SEC-3 column and elute 
directly. This arrangement is completely modular and the column positions 
can be swapped while achieving the same level of separation – with the low 
MW RNA eluting before the high MW species. We performed 2-D SEC on 
total RNA extracted from Mycobacterium bovis Bacille Calmette-Guérin 
(BCG) and separated its entire range of major ncRNA species within a single 
40 min run (Figure 3.2A). Reproducible baseline separations were achieved 
for tRNA and 5S rRNA (Rs = 4.4 ± 0.1), 5S rRNA and 16S rRNA (Rs = 22 ± 
0.2), and 16S rRNA and 18S rRNA (Rs = 3.9 ± 0.1) for total RNA extracted 
from three independent BCG cultures. Additionally, the chromatography did 
not affect the spectrum or quantity of modified ribonucleosides in tRNA 
(Figure 3.3B; Supplementary Table 3.1), relative to our published values 
[31].
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Figure 3.2. 2D-SEC of BCG total RNA preserves the native post-
transcriptional ribonucleoside modifications in purified tRNA. (A) 
Baseline separation of BCG total RNA to its component 23S (insert 1), 16S 
(insert 2), 5S rRNAs (insert 3) and tRNA (insert 4) obtained on a Bio SEC-5 
1000 Å (column 1) and Bio SEC-3 300 Å (column 2) two-column online HPLC 
system (ID 7.8mm, 300mm for each column) demonstrating the purity and 
quality of each RNA species based on sequence lengths on the Bioanalyzer 
RNA 6000 Pico and Small RNA LabChips. (B) Extracted ion chromatograms 
of naturally occurring modified ribonucleosides in hydrolyzed BCG tRNA 
identified by HPLC-coupled triple quadrupole mass spectrometry in multiple 
reaction monitoring mode. The peaks of m1A (2.87 min) and m7G (4.53 min) 
are marked with ‘//’ to indicate that they are in different scales from other 
peaks. Identities of the 18 post-transcriptional modifications detected are 
shown in Supplementary Table 2. Inset: MS/MS validation of N6,N6-
dimethyladenosine (m62A). Ribonucleoside with m/z of 296.1356 was targeted 
for CID fragmentation on a high mass accuracy quadrupole time-of-flight 
mass spectrometer yielding a daughter ion with m/z 164.0927.
3.4.4. Limitations of 2-D SEC  
To ascertain the biologically relevant exclusion limits of the 2-D SEC platform, 
we performed studies covering the size range of 22 to 10,700 nt. Calibration 
curves with synthetic RNA MW markers [37] would not provide information 
A 
B 
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about the exclusion and penetration limits for the columns for biological RNA 
species given the presence of RNA secondary structures that affect the 
molecular dimensions and thus chromatographic behavior of biological RNA 
molecules. Therefore, we used viral RNA and 22 nt miRNA-like molecules to 
define the exclusion limits of the 2-D system. We first spiked in vitro 
transcribed, full-length dengue viral RNA genome (DENV vRNA) measuring 
10.7 kb into total RNA extracted from CCRF-SB cells. Although a separation 
with a resolution of 3.7 was achieved for 28S rRNA and vRNA using an 
Agilent SEC5 column (Supplementary Figure 3.5A), comparison of this 
chromatogram with that of DENV vRNA alone reveals a large tailing from the 
vRNA peak that spreads into the 28S rRNA peak. This implies that pure 
fractions of vRNA but not 28S rRNA can be purified from this mixture using 
the current 2-D SEC setup. Similarly, to determine the biologically relevant 
penetration limit of the 2-D SEC platform, we analyzed the resolution of a 
mixture of random 22 nt synthetic oligos, to simulate miRNA, and purified 
tRNA from CCRF-SB cells on an Agilent SEC3 column (Supplementary 
Figure 3.5B). Although a partial separation could be achieved between these 
two small ncRNA species, given the low cellular abundance of miRNA relative 
to tRNA, isolation of pure fractions of miRNA, solely based on SEC, would not 
be possible under these 2-D SEC conditions. An additional IP RPC step could 
solve this problem (see Figure 3.1E). 
To demonstrate the resolving power of this multi-dimensional (2-D SEC, IP 
RPC) chromatographic approach to RNA purification, we reconstructed the 
RNA landscape of TK6 total RNA using the retention times of 2-D SEC and IP 
RPC chromatograms to define spatial localizations on the X-Y plane and peak 
area as the Z-axis (Figure 3.3A). As the relative intensities in the small RNA 
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region are two orders-of-magnitude smaller than those of large ribosomal 
RNA, we rescaled this region in Figure 3.3B.
 
Figure 3.3. Reconstruction of the RNA landscape of EBV transformed 
TK6 cells by 2D SEC and IP RPC. (A) The 3-D surface plot shows the 
analysis of 500 ng of total RNA extracted from TK6 cells using both 2-D SEC 
(Column 1: Bio SEC-3 300 Å; Column 2: Bio SEC-5 2000 Å) and IP RPC 
(SOURCE 5RPC ST 4.5/150). (B) Enhanced view of the smaller RNA species 
consisting of miRNA, tRNA, 5s and 5.8s rRNAs and putative snRNA and/or 
snoRNA. The identity and purity of the component RNA from orthographic 
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3.4.5. Application of 2-D SEC for isolation of Plasmodium berghei 
ncRNA from infected reticulocytes  
To assess the resolving power of the HPLC platform, we applied it to the 
particularly challenging problem of separating host RNA species from those of 
an infecting microbial pathogen, using the example of ncRNA from malaria 
parasites infecting mammalian red blood cells (RBC). Plasmodium berghei is 
a protozoan parasite that causes malaria in rodents and is used as an in vivo 
disease model for human malaria [38]. P. berghei preferably infects 
reticulocytes in which residual host RNA still exists. As a result, trace 
amounts of host RNA could contaminate preparations of P. berghei schizonts 
from lysed infected reticulocytes, as shown in Figure 3.4A. We injected total 
cellular RNA from purified P. berghei schizonts onto the 2-D SEC system and 
resolved the variety of small and large ncRNA species (Figure 3.4B), with 
Bioanalyzer analysis of the fractions collected for each peak confirming the 
predicted length of the isolated RNA species (Supplementary Figure 3.6). In 
particular, pure fractions of tRNA, 5.8S rRNA, and 5S rRNA were isolated, as 
well as putative snoRNA and snRNA species. We were able to completely 
resolve the unique ~800 nt partner of another ~3000 nt fragment that combine 
functionally to form the 28S rRNA of P. berghei (Figure 3.4A) [39, 40]. 
Baseline separation of the ~3000 nt 28S rRNA fragment and putative 18S 
rRNA was not achieved due to their close proximity in time (Figure 3.4B). In 
addition, no miRNA-length small RNA species were detected. 
3.4.6. Fluorometric quantification of purified RNA 
Of the many commonly used spectroscopic methods for quantifying RNA, 
fluorescent RNA-binding dyes have proven to be highly sensitive and specific 
when a simple correction is applied for DNA contamination [41] and they 
Page | 104  
 
Figure 3.4. Isolation of ncRNA from P. berghei-infected rodent 
reticulocytes. (A) Bioanalyzer analysis of total RNA extracted from whole 
blood from uninfected rats (black line) and total RNA extracted from P. 
berghei schizonts purified from infected rat erythrocytes following lysis of the 
RBC and washing of the schizonts, as described in Online Methods (gray 
lane). (B) 2D-SEC purification of P. berghei ncRNA. Total RNA from 
schizonts purified from lysed rodent reticulocytes was resolved on the 2-D 
HPLC system, with Bio SEC-3 300 Å resolution of 5.8S rRNA (1), 5s rRNA 
(2), putative snRNA/snoRNA (3) and tRNA (4), and Bio SEC-5 1000 Å 
resolution of the 28s 800nt rRNA fragment (6) from the co-eluting 18s rRNA 
and 28s 3000nt rRNA fragment (5). Individual RNA species were collected 
from the 2-D HPLC elution and the purity and identity of each fraction was 
evaluated by Bioanalyzer analysis as shown in Supplementary Figure 3.6.
A 
B 
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avoid the problems of protein and DNA contamination associated with 
absorbance at 260 nm. However, the variety of secondary structures in 
different RNA species could affect the efficiency of fluorescence emission 
upon dye binding and thus affect quantitative accuracy. To resolve this 
problem, we used the 2-D HPLC platform to purify specific ncRNA species 
and then determined fluorescence correction factors for each type of RNA. 
Purified fractions of 28S rRNA, 18S rRNA and tRNA from CCRF-SB, and 23S 
rRNA, 16S rRNA and tRNA from E. coli DH5α were concentrated, desalted, 
qualitatively assessed (Bioanalyzer 6000 Nano LabChip) and quantified by 
absorbance at 260 nm. Following addition of Ribogreen dye, fluorescence 
emissions were quantified in dilutions of each RNA standard over 
concentrations ranging from 20-1000 ng/mL. As shown in Figure 3.5, there 
are significant differences in the fluorescence emission profiles of each of the 
ncRNA species when compared to a standard using total cellular RNA. 
Particularly, the fluorescence signal for RiboGreen increases by 10% for 28S 
rRNA compared to CCRF-SB total RNA, while it decreases by up to 11% for 
bacterial tRNA compared to E. coli total RNA (Supplementary Tables 3.2A, 
3.2B). Application of these weighting factors thus allows the use of readily 
purified total RNA from target cells as a standard for accurate quantification of 
a specific ncRNA using fluorescence dye assays. 
3.5. Discussion 
To facilitate the study of the chemistry and biology of ncRNA, we developed a 
multi-dimensional HPLC platform that reproducibly and efficiently purifies the 
major species of ncRNA across the complete size range up to 10,000 nt. This 
universal platform allows resolution, purification and quantification of ncRNA 
species in a cell under non-denaturing conditions and with post-transcriptional 
ribonucleoside modifications intact. The method was validated by purifying 
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Figure 3.5. Fluorometric quantitation of purified RNA using RiboGreen with adjustments for species-specific responses. (A) 
Fluorescence enhancement of RiboGreen upon binding to E. coli total RNA () and HPLC purified E. coli 23S rRNA (), 16S rRNA () and 
tRNA (). (B) Fluorescence enhancement of RiboGreen upon binding to CCRF-SB total RNA () and HPLC purified CCRF-SB 28S rRNA (), 
18S rRNA () and tRNA (). (C) RNA concentration curves of E. coli total RNA () and HPLC purified E. coli 23S rRNA (), 16S rRNA () 
and tRNA (). (D) RNA concentration curves of CCRF-SB total RNA () and HPLC purified CCRF-SB 28S rRNA (), 18S rRNA () and tRNA 
(). The fluorescence of each RNA species with concentrations from 0 to 1000 ng/ml stained with RiboGreen was measured for fluorescence 
at 528/20nm.
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putative tRNA, small and large subunit rRNAs, and other small RNAs from E. 
coli, mycobacteria, human cells and plasmodium-infected rat reticulocytes, as 
well as in vitro transcribed, full-length viral RNA. As shown in Figure 3.3, the 
successful resolution of the major ncRNA species by the combined 2-D SEC 
and IP RPC provides a complete picture of the RNA landscape within a cell or 
tissue and allows both sequencing of purified ncRNA and chemical 
interrogation of the pool of ncRNA species, such as an analysis of the stress-
induced reprogramming of the spectrum of modified ribonucleosides in all 
ncRNA species in a cell [12, 13, 31]. 
This multi-dimensional chromatographic approach offers significant 
advantages over other methods for purifying ncRNA. Conventional 
preparative polyacrylamide gel electrophoresis is time-consuming (≥ 2 d), 
denaturing, and limited to RNA sizes less than 600 nt [42], with eluted RNA 
contaminated with acrylamide oligomers [15] and any dyes used to visualize 
the RNA. For purification of tRNA, denaturing (urea) polyacrylamide gels [43] 
have the advantage that larger amounts of RNA can be loaded into a single 
gel, with 1-3 mg of total RNA resolved on a 10% polyacrylamide gel (8 M 
urea) yielding 240 ± 60 ug of tRNA [13]. With tRNA representing ~14% of 
total RNA in yeast (based on areas under the curve for UV absorbance 
signals from HPLC chromatograms), this yield of tRNA represents ~70% of 
input tRNA. However, this does not account for losses in subsequent removal 
of polyacrylamide fragments by filtration and/or purification by SEC HPLC. 
Similarly, agarose gels can be used for resolution and purification of larger 
RNAs (> 600 nt) [44], with recovery by a variety of methods [45-48] that suffer 
from the same contamination problems. In contrast, RNA chromatography is 
faster, can be performed under non-denaturing conditions, utilizes simple 
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solvent mobile phases that do not contaminate the sample, and is more 
sensitive and easily automated for fraction collection [49]. 
The multi-dimensional chromatography platform developed here also has 
advantages over existing chromatographic methods that target individual 
ncRNA species [18, 22, 32, 50]. The newer Agilent SEC columns solve 
difficulties with the separation of large molecular weight rRNA observed in 
earlier work with RNA SEC [22, 32]. This limitation was only partially relieved 
in more recent efforts that utilize IP RPC for RNA separation [18, 50]. 
Conversely, purification of RNA species in the low molecular weight size 
ranges  (<100 nt) often requires an additional enrichment step either through 
the use of commercially available small RNA kits or with solid phase 
extraction processes due to their low natural abundance and inefficiencies in 
extracting them with the commonly used acidic phenol chloroform method 
[51, 52] without further enrichment on silica gel or glass fiber matrices [53]. 
Although commercial systems such as LabChip XT (Caliper) and Pippin Prep 
(Sage Science) have recently been developed for size-fractionation of DNA 
and analysis of quality of cDNA, an equivalent system for the analysis and 
separation of RNA that covers the entire range of biologically relevant lengths 
is not available. 
 We solved these technical problems using multi-dimensional HPLC. By 
coupling two different SEC columns together with a comprehensive offline IP 
RPC column, we were able to purify all major ncRNA species from miRNA to 
large 28s rRNA from a single batch of total RNA. The system was also 
capable of purifying viral genomic RNA intact from the host cell mixture of 
ncRNA. Interestingly, we were able to purify miRNA from CCRF-SB and TK6 
B lymphoblast cell lines but not from P. berghei-infected rat reticulocytes, 
which is consistent with recent work suggesting that plasmodium parasites do 
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not express miRNA [54]. These results demonstrate the utility of this HPLC 
platform for analysis and purification of the various ncRNA species within a 
cell. The sequences of the isolated RNA species can be collaborated their 
genomic sequences by either RNA-seq or northern blotting. It is also 
important to point out that, while 2-D chromatography provides the most 
efficient means to purify individual RNA species, the individual 1-D HPLC 
systems can be used separately to achieve the same results as the 2-D 
system in the event that the 2-D HPLC technology is not available.  
As with other chromatographic methods, the major limitation of this HPLC 
approach to RNA purification lies in the contamination of specific ncRNA 
fractions with similarly sized degradation products from larger RNA species. 
The problem presented by such contamination is illustrated with the analysis 
of modified ribonucleosides in RNA. For example, the nucleoside m62A has 
been identified in the 16S and 23S rRNA of archaea and bacteria and the 18S 
rRNA of eukarya, but never in tRNA. However, we identified m62A as an 
abundant modified ribonucleoside in tRNA from BCG [31] – detailed in 
Chapter 4, which raised the question of rRNA contamination of the tRNA 
fraction. m62A was not detected in HPLC-purified tRNA from yeast, rat liver 
and human cells, which partially ruled out contamination with rRNA fragments 
[31], and Bioanalyzer analysis further confirmed a lack of degradation of 
rRNA in all of the samples [31]. Along with such comparative analysis, 
contamination of small RNA fractions with fragments from larger RNA species 
can be assessed by RNA sequencing methods [55, 56] and can potentially be 
removed by repurification of RNA fractions by an orthogonal chromatographic 
system that provides another basis for separating the contaminating RNA 
species, such as SEC-purified tRNA analyzed on IP RPC. 
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Another critical parameter for many applications of purified ncRNA species 
involves accurate quantification of the isolated RNA. For example, analysis of 
stress-induced reprogramming of modified ribonucleosides in tRNA [12, 13, 
31] requires highly accurate quantification of input tRNA to control variance 
and allow meaningful comparisons of small changes. Our observation of 
variable emission spectra when RiboGreen is bound to different purified 
ncRNA species illustrates the impact of RNA composition on fluorescence-
based quantification methods. Interestingly, it has been reported that 
PicoGreen, a related dye used for DNA quantitation, yields divergent 
fluorescence emissions when bound to genomic DNA from different 
organisms (57). To obviate the host of structure- and sequence-based causes 
of this discrepancy (58-60), we took the pragmatic approach of empirically 
characterizing fluorescent emission for many types of ncRNA and presenting 
the data as correction factors (Supplementary Table 1) for the major ncRNAs 
in E. coli and human cells (CCRF-SB) when using total cellular RNA as the 
calibration standard.  
Among the most obvious applications for this RNA purification method are 
targeted RNA sequencing, characterization of modified ribonucleosides, 
purification of novel RNA species, and analysis of viral RNA genomes. 
Targeted purification of RNA is essential for structural and functional 
characterization of novel RNA species, such as the large number of 
regulatory long ncRNA . The functional forms of these ncRNA after post-
transcriptional processing events can then be correlated with their genomic 
sequences. The resulting enrichment for a specific transcript increases the 
sequencing power and efficiency for rare variants. Purification of individual 
ncRNA species is also critical for identifying and quantifying the dozens of 
chemically modified ribonucleosides incorporated post-transcriptionally into 
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both coding (5) and ncRNA (10) species as part of the mechanism of 
translational control of cell response (12,13). The analysis of viral RNA 
genomes would also be aided by the ability to purify the virus RNA free from 
host RNA species. For example, it was recently discovered that the 11 kb 
RNA genome of the dengue virus is subject to adenosine methylation, which 
warrants purification of the viral RNA for analysis of other modified 
ribonucleosides. Hence, this platform provides a general strategy for 
preparing RNA for large-scale sequencing and composition analysis, and for 
downstream functional elucidation projects. 
3.6. Supplementary material 
3.6.1 Supplementary figures 
(next page)




Supplementary Figure 3.1. Validation of RNA identity and purity of E. 
coli and CCRF-SB RNA species isolated using SEC by Bioanalyzer 
LabChip analysis. Top row: (A) Small RNA chip ladder standards (1, 4 nt; 2, 
20 nt; 3, 40 nt; 4, 60 nt; 5, 80 nt; 6, 100 nt; 7, 150 nt). (B) E. coli small RNA 
consisting of 5s rRNA and tRNA isolated using a Bio SEC-3 300 Å column. 
(C) E. coli 5s rRNA isolated using a Bio SEC-3 300 Å column. (D) E. coli 
tRNA isolated using a Bio SEC-5 1000 Å column. Second row: (E) RNA 6000 
Pico chip ladder standards (1, 25 nt; 2, 200 nt; 3, 500 nt; 4, 1000 nt; 5, 2000 
nt; 6, 4000 nt; 7, 6000 nt). (F) E. coli total RNA. (G) E. coli 16s rRNA isolated 
using a Bio SEC-5 1000 Å column. (H) E. coli 23s rRNA isolated using a Bio 
SEC-5 1000 Å column. Third row: (I) CCRF-SB small RNA consisting of 5.8s 
and 5s rRNAs isolated using a Bio SEC-5 1000 Å column. (J) CCRF-SB 5s 
rRNA isolated using a Bio SEC-3 300 Å column. (K) CCRF-SB 5.8s rRNA 
isolated using a Bio SEC-3 300 Å column. (L) CCRF-SB tRNA isolated using 
a Bio SEC-3 300 Å column. Bottom row: (M) CCRF-SB total RNA. (N) CCRF-
SB 18s rRNA isolated using a Bio SEC-5 1000 Å column. (O) CCRF-SB 28s 
rRNA isolated using a Bio SEC-5 1000 Å column.



















Supplementary Figure 3.2. Yields of ncRNA purified by SEC or IP-RPC. 
Fraction collection was automated by use of a fraction collector and RNA 
collected by custom time segments corresponding to the retention times and 
peak widths of each RNA species. Samples clean-up was then performed as 
stated in Material and Methods. (A) Recoveries (%) of sRNA (of lengths 
smaller than tRNA), tRNA, 5S rRNA and co-eluding 16S and 23S rRNA from 
E. coli total RNA (left) and miRNA and other sRNA, tRNA, 5S rRNA, 5.8S 
rRNA and co-eluding 18S and 28S rRNA from CCRF-SB total RNA (right) off 
the Bio-SEC3 300Å HPLC system. (B) Recoveries (%) of co-eluding 5S rRNA 
and tRNA, 16S rRNA and 23S rRNA from E. coli total RNA (left) and co-
eluding 5S, 5.8S rRNA and tRNA, 18S rRNA and 28S rRNA from CCRF-SB 
total RNA (right) off the Bio-SEC5 1000 Å HPLC system. 10-100 µg of total 
RNA are injected unto the SEC systems. (C) Recoveries (%) miRNA, tRNA, 
5S rRNA, 5.8S rRNA and co-eluding 18S and 28S rRNA from the Source 
RPC 4.6/150 HPLC system. 2-40 µg of total RNA are injected into the IP RPC 
system.
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Supplementary Figure 3.3. Validation of RNA identity and purity of 
CCRF-SB RNA species isolated using IP RPC on a Source 5RPC 4.6/150 
column by Bioanalyzer LabChip analysis. (A) RNA 6000 Pico chip ladder 
standards (From left to right: 25 nt; 200 nt; 500 nt; 1000 nt; 2000 nt; (B) Co-
eluding 18S and 28S rRNA analyzed on a RNA 6000 Pico chip. 4000 nt; 6000 
nt). (C) Small RNA chip ladder standards (From left to right: 4 nt; 20 nt; 40 nt; 
60 nt; 80 nt; 100 nt; 150 nt). (D) miRNA, (E) tRNA, (F) 5S rRNA, (G) 5.8S 
rRNA, (H) putative sn/sno RNA analyzed on a small RNA chip.
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Supplementary Figure 3.4. Valve configuration for 2-D SEC. Either Bio 
SEC-3 or Bio SEC-5 columns can be connected into the column 1 or 
column 2 positions. (A) Step 1: Columns are in tandem and detector is in-
line. If Bio SEC-5 is in the column 1 position, small RNAs are fractioned from 
large molecular weight rRNAs on the Bio SEC-5 and are eluted onto the Bio 
SEC-3 column (column 2) for separation. Alternatively, If Bio SEC-3 is in the 
column 1 position, large molecular weight rRNAs are eluted onto the Bio 
SEC-5 column (column 2) for separation. (B) Step 2: Column 2 is taken off-
line (switched to pump 2) while the detector is in-line with column 1. Hence, if 
Bio SEC-5 is in the column 1 position, large molecular weight rRNAs are 
quantified by absorbance and collected. Alternatively, if Bio SEC-3 is in the 
column 1 position, small RNAs are quantified and collected. With column 2 in-
line with pump 2, RNA separation can continue at the same or lower flow 
rates depending on the run time of column 1. (C) Step 3: Column 1 and 2 are 
connected in tandem and the detector is connected in-line with column 2. 
RNAs from column 2 (small RNA if Bio SEC-5 is in the column 1 position, and 
large molecular weight rRNAs if Bio SEC-3 is in the column 1 position) are 
quantified and collected





Supplementary Figure 3.5. Biologically relevant exclusion and 
permeation limit of SEC HPLC. (A) Exclusion limit of Bio SEC-5 1000 Å (ID 
7.8mm, 300mm) assessed with 10.7 kb in vitro transcribed full length DENV 
vRNA. Chromatograms of 50 ng of DENV 10.7 kb vRNA alone (red) and 50 
ng of 10.7 kb vRNA spiked into 50 ng of CCRF-SB total RNA (blue) 
performed with 100 mM ammonium acetate buffer (pH 7.0) at a flow rates of 
0.5 ml/min. (B) Permeation limit of Bio SEC-3 300 Å (ID 7.8mm, 300mm) 
assessed with synthetic 22 nt random oligonucleotides. Chromatograms of 
100 ng of 22 nt random oligonucleotides alone (red), 100 ng of CCRF-SB 
tRNA alone (blue) and 100 ng of 22 nt random oligonucleotides spiked into 
100 ng of CCRF-SB tRNA (brown) performed with 100 mM ammonium 
acetate buffer (pH 7.0) at a flow rate of 0.5 ml/min.
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Supplementary Figure 3.6. Bioanalyzer LabChip validation of RNA 
identity and purity of P. berghei RNA species isolated using 2-D SEC. 
(A) 5.8S rRNA (fraction 1). (B) 5S rRNA (fraction 2). (C) Small RNA (putative 
snoRNA and snRNA; fraction 3). (D) tRNA (fraction 4). (E) 28S rRNA 3000 nt 
fragment and 18S rRNA isolated from fraction 5 as labeled in Figure 3.4b. (F) 
28S rRNA 800 nt fragment isolated from fraction 6. Fractions 1-4 are 
analyzed on a Bioanalyzer Small RNA chip while Fraction 5 and 6 are 
analyzed on a Bioanalyzer RNA 6000 Pico chip. Sizing ladders are shown in 
Supplementary Figures 3.1A and 3.1E.
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Supplementary Figure 3.7. Orthogonal separations of TK6 total RNA by 2-D 
SEC and IP RPC. (A) 2-D SEC chromatogram of TK6 total RNA consisting of co-
eluting miRNA and tRNA, putative snRNA and snoRNA, 5S, 5.8S, 18S, 28S 
rRNAs separated obtained on a Bio SEC-3 300 Å (column 1) and Bio SEC-5 
2000 Å (column 2) arranged as an in-line two-column system. Both separations 
were performed in 100 mM TEAA (pH 7.0) buffer at a flow rate of 1 ml/min at 60 
°C. (B) IP RP HPLC of TK6 total RNA consisting of miRNA, tRNA, putative 
snRNA and snoRNA, 5S, 5.8S rRNAs, and co-eluting 18S and 28S rRNAs 
separated on a Source 5RPC 4.6/150 column, performed at a flow rate of 1 
ml/min at 60 °C. Buffer A: 100 mM TEAA, pH 7.0 with 2% acetonitrile. Buffer B: 
100% acetonitrile. Elution gradient as stated in Materials and Methods.
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3.6.2. Supplementary Tables 
 
1
 Multiple reaction monitoring (MRM) experiments were performed with a triple 
quadrupole mass spectrometer, as described in the Methods section. 
2
 RNA modifications noted in italics are tentative identifications based on 
collision-induced dissociation (CID) fragmentation on a quadrupole time-of-flight 
mass spectrometer. All other modified ribonucleosides were corroborated with 
synthetic standards.  
3











 95% confidence intervals are displayed in parenthesis. 
2
 Degrees of freedom for calculation of F are displayed in parenthesis. 
3
 Correction factors were calculated based on comparisons of slopes between 
each purified RNA species and E. coli total RNA and CCRF-SB total RNA 
(Figure 3.2C, 3.2D respectively). These represent the percentage change in 
fluorescence signals observed with the indicated purified RNA species relative to 
the total RNA the RNA species was isolated from. 
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4.  Quantitative analysis of modified ribonucleoside by 
HPLC-coupled mass spectrometry reveals N6, N6-
dimethyladenosine as a novel tRNA modification in 
Mycobacterium bovis Bacille Calmette-Guérin 1 
4.1. Abstract 
Post-transcriptional modification of RNA is an important determinant of RNA 
quality control, translational efficiency, RNA-protein interactions, and stress 
response. This is illustrated by the observation of toxicant-specific changes in 
the spectrum of tRNA modifications in a stress response mechanism involving 
selective translation of codon-biased mRNA for critical proteins. To facilitate 
systems-level studies of RNA modifications, we developed a liquid 
chromatography-coupled mass spectrometry (LC-MS) technique for the 
quantitative analysis of modified ribonucleosides in tRNA or other RNA 
species. The protocol includes tRNA purification by HPLC, enzymatic 
hydrolysis, reversed-phase HPLC resolution of the ribonucleosides, and 
identification and quantification of individual ribonucleosides by LC-MS using 
dynamic multiple reaction monitoring. This approach enabled the 
quantification of modified ribonucleosides in several micrograms of tRNA, or 
other RNA, in a 15-minute LC-MS run. We coupled this LC-MS platform with 
the RNA isolation and purification methods developed in Chapters 2 and 3. 
Our initial scan using this approach revealed 17 modified ribonucleoside BCG 
tRNA, of which 12 were definitively identified based on comparisons to 
synthetic standards and 5 were tentatively identified by exact mass 
comparisons to RNA modification databases.  Among these was one not 
                                                          
1
 Featured in Nat Protoc. 2014 Apr;9(4):828-41 and Molecules. 2011 Jun 
21;16(6):5168-81. Reproduced with permission from Nature Publishing Group and 
Multidisciplinary Digital Publishing Institute. 
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previously described in tRNA, which we characterized as N6, N6-
dimethyladenosine. 
4.2. Introduction 
While the four canonical nucleobases in DNA are adequate to encode the 
genome, the functional diversity of RNA is greatly enhanced by the presence 
of over 100 different targeted structural modifications of the nucleobase and 
ribose sugar in RNA across all organisms [1, 2].  Transfer RNA (tRNA) and 
ribosomal RNA (rRNA) are the most frequently modified forms of RNA, 
though other species such as messenger RNA (mRNA) and microRNAs are 
also known to possess specific ribonucleoside modifications, such as the N7-
methylguanosine cap on mRNA.   
Emerging evidence points to important roles for RNA modifications in 
translational control of cellular responses to stress and other stimuli [3-6]. For 
example, we recently observed that exposure of the yeast Saccharomyces 
cerevisiae to cytotoxic chemicals causes a reprogramming of the spectrum of 
two dozen RNA modifications in tRNA, with a unique ribonucleoside signature 
for each agent [7].  These observations point to the importance of fully 
understanding the structure and function of ribonucleoside analogs in both 
eukaryotic and prokaryotic organisms. 
The discovery of this emergent property of tRNA modifications has been 
enabled in part by application of liquid chromatography-coupled mass 
spectrometry (LC-MS) to quantify the complete set of tRNA modifications and 
how its composition varies in response to different stresses. Traditional 
approaches to quantifying individual modified ribonucleosides, such as two-
dimensional thin-layer chromatography [8, 9], are semi-quantitative at best 
and not suitable for studying all tRNA modifications at once, in addition to 
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being labor and time intensive and employing radioactive labeling. Mass 
spectrometry-based methods have recently emerged as powerful tools for 
identifying and quantifying RNA modifications.[10-19] For example, we 
recently developed a rigorously quantitative platform for LC-MS analysis of 
the system of modified ribonucleosides in the population of tRNA molecules in 
a cell or in individual, purified tRNA species (Figure 4.1), with the method 
applied to studies in bacteria, yeast and human cells [7, 20-23]. Application of 
this approach to the identification and quantification of 25 tRNA 
ribonucleoside modifications in Saccharomyces cerevisiae led to the 
discovery of a direct link between cell stress and translation of stress-
response proteins [7, 21]. As illustrated in Figure 4.1, there are 5 stages to 
this process. (1) exposure of cells to stress (see Chapters 5 and 6), (2) tRNA 
isolation, purification, quantification and its enzymatic hydrolysis to 
ribonucleosides; (3) reversed-phase HPLC resolution of hydrolysed 
ribonucleosides, (4) identification and quantification of ribonucleosides by 
tandem quadrupole mass spectrometry (QQQ); and (5) multivariate statistical 
analysis of patterns of change in the set of modified ribonucleosides caused 
by the stress or stimulus. 
Aiming to characterize the RNA modifications in the clinically important 
pathogens from the Mtb complex, we used Mycobacterium bovis Bacille 
Calmette-Guérin (BCG) as a surrogate for Mycobacterium tuberculosis (Mtb). 
Infection with Mtb represents one of the most widespread diseases in the 
world, with nearly one-third of the world's population showing signs of 
exposure, more than 20 million people actively infected, and almost 80% of 
the population of some developing countries testing positive in tuberculin 
tests [24, 25]. BCG is a mycobacterial species closely related to Mtb and is 
widely used as a vaccine [26]. Here, I present results from our initial 
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characterization of the modified ribonucleosides in BCG (the fully repertoire is 
presented in Chapter 6 and Appendix 1), with the discovery of N6, N6-
dimethyladenosine (m62A) as a novel tRNA modification. 
Figure 4.1. Workflow for the quantitative analysis of modified 
ribonucleosides in tRNA. Stages include (1) exposure of cells to stress, (2) 
tRNA isolation, purification, quantification and its hydrolysis to 
ribonucleosides; (3) reversed-phase HPLC resolution of hydrolysed 
ribonucleosides, (4) identification and quantification of ribonucleosides QQQ 
mass spectrometry; (5) multivariate statistical analysis (MVS).  
4.3. Material and methods 
4.3.1. Reagents and instrumentation 
OADC solution, 7H9 culture media powder, and 7H11 agar powder were 
purchased from Biomed Diagnostics (White City, OR).  Trizol reagent and 
PureLink miRNA Isolation Kit was purchased from Invitrogen (Carlsbad, CA).  
2′-O-Methyluridine (Um), pseudouridine (Y), N1-methyladenosine (m1A), 
N2,N2-dimethylguanosine (m22G), N
6,N6-dimethyladensoine (m62A), and 2′-O-
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methylguanosine (Gm) were purchased from Berry and Associates (Dexter, 
MI).  N6-threonylcarbamoyladenosine (t6A) was purchased from Biolog 
(Bremen, Germany). N6-isopentenyladenosine (i6A) was purchased from 
International Laboratory LLC (San Bruno, CA).  2′-O-Methyladenosine (Am), 
N4-acetylcytidine (ac4C), 5-methyluridine (m5U), inosine (I), 2-
methylguanosine (m2G), N7-methylguanosine (m7G), 2′-O-methylcytidine 
(Cm), 3-methylcytidine (m3C), 5-methylcytidine (m5C), alkaline phosphatase, 
RNase A, ammonium acetate, geneticine, bovine serum albumin, 
deferoxamine mesylate, butylated hydroxytoluene, glucose, sodium chloride, 
nuclease P1, formic acid, and 20% Tween80 solution were purchased from 
Sigma Chemical Co. (St. Louis, MO).  Glycerol was purchased from 
SinoChem Corp. (Beijing, China).  Phosphodiesterase I was purchased from 
USB (Cleveland, OH).  RNase A, RNase V1 and RNase T1 were purchased 
from Ambion Inc. (Austin, TX).  HPLC-grade water, acetonitrile, and 
chloroform were purchased from Mallinckrodt Baker (Phillipsburg, NJ).  M. 
bovis BCG was gifted by Sylvie Alonso (Department of Microbiology, National 
University of Singapore) and S. cerevisiae were purchased from American 
Type Culture Collections (Manassas, VA).  Rat liver tissue (discarded) was 
obtained from Laura J. Trudel (Department of Biological Engineering, 
Massachusetts Institute of Technology).  Filters with a 10 KDa MW cut-off 
were purchased from Pall Life Sciences (Port Washington, NY).   
Experiments were performed with Thermo FP120 Bead beater (Two Rivers, 
WI), Qiagen TissueRuptor (Valencia, CA), Agilent Bioanalyzer series 2100 
(Santa Clara, CA), Agilent LC/QQQ 6460 (Santa Clara, CA), Agilent LC/TOF 
G6210A (Santa Clara, CA) and Agilent LC/QTOF 6520 (Santa Clara, CA). 
4.3.2. Preparation of BCG culture media 
Page | 130  
 
The 7H9 media were prepared by mixing 4.9 g of 7H9 powder, 10 mL of 50% 
glycerol, 2.5 mL of 20% TWEEN 80, 900 mL of double-deionized water, and 
100 mL of ADS solution.  The ADS solution was prepared by mixing 50 g of 
BSA, 20 g of glucose, and 8.1 g of NaCl in 950 ml of double-deionized water.  
The 7H11 agar plates were prepared by mixing 4.2 g of 7H11 agar powder, 2 
mL of 50% glycerol, 180 ml of double-deionized water, and 20 mL of OADC 
solution.  The solution was then heated in a microwave oven until a clear 
solution was achieved and the solution was transferred to petri dishes.  The 
agar plates were cooled and solidified at ambient temperature. 
4.3.3. BCG cultures 
BCG cells were grown in 7H9 culture media (see Supporting Information) at 
37 oC in an incubator with 5 % CO2.  After the culture reached an optical 
density of OD600 ~0.6, at which point the concentration of cells was 
~3x107/mL, the cells were harvested by centrifugation at 12000xg for 10 min 
at 4 oC.  Cell pellets were snap-frozen in liquid nitrogen and stored at -80 oC.  
For glycerol stocks, the post-centrifugation cell pellet was resuspended in 1 
mL of 7H9 media with 25% glycerol.  The solution was then further diluted to 
a final concentration with OD600~1 and the stocks stored at -80 oC.  To 
determine the quantity of living cells in a glycerol stock or a culture, colony 
counting was performed with each cell sample with 100 μL of serial dilutions 
plated on 7H11 agar and incubated at 37 oC with 5% CO2. 
4.3.4. tRNA isolation 
tRNA was isolated from several organisms, including BCG (~108 cells), S. 
cerevisiae (5x107 cells), human B lymphoblastoid TK6 cells (3x107 cells), and 
rat liver (~150 mg).  Cells or tissues were suspended in 1.5 mL of Trizol 
reagent with 5 mg/mL coformycin, 50 µg/mL tetrahydrouridine, 0.1 mM 
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deferoxamine mesylate, and 0.5 mM butylated hydroxytoluene to prevent 
nucleoside modification artifacts [11, 12].  BCG was lysed as indicated in 
Chapter 2. S. cerevisiae cells were lysed by 3 cycles of bead beating in a 
Thermo FP120 Bead Beater set at 6.5 m/s for each 20 s cycle, with 1 min of 
cooling on ice between cycles.  The TK6 cells and rat liver tissue were lysed 
with a Qiagen TissueRuptor.  Following cell or tissue disruption, all lysates 
were warmed to ambient temperature for 5 min and extracted with 0.3 mL 
volume of chloroform, with subsequent incubation at ambient temperature for 
3 min.  The solutions were centrifuged at 12000xg for 15 min at 4 ºC and the 
aqueous phase was collected.  Absolute ethanol was added to the aqueous 
phase (35% v/v) and small RNA species were then isolated using the 
PureLink miRNA Isolation Kit according to manufacturer’s instructions.  The 
quality and concentration of the resulting small RNA mixture was assessed by 
Bioanalyzer analysis (Agilent Small RNA Kit), with tRNA comprising >95% of 
the small RNA species present in the mixture, with no detectable 5S rRNA 
(Figure 1).  tRNA from BCG was further purified from small RNA isolates by 
size-exclusion HPLC using an Agilent SEC3 300 Å, 7.8 x 300 mm column 
eluted with 10 mM ammonium acetate as described in Chapter 3.  The tRNA 
fraction was collected and desalted using an Ambion Millipore 5K MWCO 
column. 
4.3.5. Enzymatic hydrolysis of BCG tRNA 
Samples of purified tRNA (6 μg) were lyophilized and redissolved in 100 µL of 
10 ng/mL RNase A, 0.01 U/mL RNase T1, 0.001 U/mL RNase V1, 0.15 U/mL 
nuclease P1, 2.5 mM deferoxamine mesylate, 10 ng/mL coformycin, 50 
µg/mL tetrahydrouridine, 0.5 mM butylated hydroxytoluene, and 1xRNA 
Structure Buffer from Ambion.  The solution was incubated at 37 oC for 3 h, 
after which alkaline phosphatase was added to a final concentration of 0.1 
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U/mL.  The sample was incubated at 37 °C overnight, followed by removal of 
proteins by YM10 filtration.  The resulting filtrate was used directly for mass 
spectrometric analysis. 
4.3.6. Identification of ribonucleosides in small RNA from BCG 
Hydrolyzed RNA was resolved on a Thermo Hypersil aQ column (100 x 2.1 
mm, 1.9 m particle size) with an acetonitrile gradient (HPLC system A) in 
0.1% (v/v) formic acid in water as mobile phase at a flow rate of 0.3 mL/min.  
The gradient of acetonitrile in 0.1% formic acid was as follows: 0-15.3 min, 
0%; 15.3-18.7 min, 1%; 18.7-20 min, 6%; 20-24 min, 6%; 24-27.3 min, 100%; 
27.3-41 min, 0%.  The HPLC column was directly connected to a triple 
quadrupole mass spectrometer (Agilent LC/QQQ 6460) in positive ion, neutral 
loss mode for loss of m/z 132 and 146 in the range of m/z 200-700.  The 
voltages and source gas parameters were as follows: gas temperature, 300 
oC; gas flow, 6 L/min; nebulizer, 15 psi; and capillary voltage, 4000 V. The 
ions detected in neutral loss mode were selected for identification with the 
LC-MS/MS system in multiple reaction monitoring (MRM) mode using the 
same HPLC and mass spectrometer parameters.  Since the C-C glycosidic 
bond in pseudouridine (Ψ) does not readily fragment to produce neutral loss 
of a ribose residue, the presence of Ψ was verified by CID fragmentation of 
the ribose to yield the nucleobase with the ribose C1 methylene group 
attached (m/z 125) [27]. 
4.3.7. High mass-accuracy mass spectrometric analysis of candidate 
ribonucleosides 
The exact molecular weights of candidate ribonucleosides were determined 
by HPLC-coupled high mass-accuracy quadrupole time-of-flight mass 
spectrometry (Agilent LC/QTOF 6520).  Hydrolyzed RNA samples were 
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resolved on a Thermo Hypersil aQ column (150 x 2.1 mm, 3 m particle size) 
eluted with a mobile phase as noted earlier with the following solvent 
schedule for acetonitrile in 0.1% formic acid: 0-23 min, 0%; 23-28 min, 2%; 28 
-36 min, 7%; 36-47 min, 100%; 47-67 min, 0% (HPLC system, B).  The HPLC 
system was coupled to an Agilent QTOF 6520 Mass Spectrometer operated 
in positive ion mode and scanning for ions from m/z 100-1700 with the 
following parameters: gas temperature, 325 oC; drying gas, 5 L/min; 
nebulizer, 30 psi; and capillary voltage, 3500 V.  
4.3.8. Structural characterization of N6,N6-dimethyladenosine in BCG 
small RNA 
The ribonucleoside-like species eluting at 20.1 min and possessing an [M+H]+ 
ion with m/z of 296.1337 was subjected to structural characterization by 
collision-induced dissociation (CID) using both MS2 and pseudo-MS3 (i.e., in-
source fragmentation) performed on the LC-QTOF system using a Thermo 
Hypersil aQ column (100 x 1 mm, 3 m particle size) at a flow rate of 90 
μL/min using the same mobile phase described earlier, with a solvent 
schedule for the 0.1% formic acid in acetonitrile was as follows: 0-18 min, 0%; 
18-30 min, 7%; 30-44 min, 100%; and 44-60 min, 0% (HPLC system C).  The 
mass spectrometer was operated in positive ion mode with the following 
voltages and source gas parameters: gas temperature, 325 oC; drying gas, 8 
L/min; nebulizer, 30 psi; capillary voltage, 3500 V.  The m/z detection range 
for parent ions was 100 to 800 and that for product ions was 50 to 800.  For 
MS2 analysis, the fragmentor voltage was 85 V, the collision energy was 10 V 
and the target ion for the unknown was m/z 296.1, while the fragmentor 
voltage was increased to 250 V for MS3 analysis, which caused an in-source 
fragmentation of m/z 296.1 to give m/z 164.1 for further CID analysis.  The 
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m/z 164.1 ion was fragmented with collision energies of 0 V, 20 V, 30 V, and 
60V. 
4.3.9. Quantification of tRNA modifications 
Perhaps the most critical stage in this LC-MS platform for quantitative 
comparison of changes in modified ribonucleosides across samples is the 
quantification of RNA in each sample. Standard spectroscopic methods (i.e., 
A260) are entirely inadequate for this purpose, as they are heavily affected by 
contamination with even small amounts of protein, DNA, buffers and other 
chemicals. However, even highly precise and accurate RNA quantification 
methods, such as fluorescent dye binding,[28] will not provide accurate 
information about the RNA content of the sample if the method is applied too 
early in the sample processing and needs proper calibration standards (See 
Chapter 3). Notably, loss of RNA in subsequent HPLC purification and 
enzymatic digestion steps will cause artifacts in RNA quantification and wide 
variations in data from replicate. The optimal solution to these issues is to 
quantify the canonical ribonucleosides (i.e., cytidine, uridine, adenosine, and 
guanosine) in the fully processed sample at the time of LC-MS analysis, was 
achieved using an in-line UV absorbance detector, with an external calibration 
curve. To avoid problems caused by day-to-day variation in instrument 
performance, the precision of relative quantification of modifications across 
different analysis sessions may be enhanced by spiking into the fully 
processed analyte an internal standard, such as [15N]5-2-deoxyadenosine 
([15N]-dA) to a final concentration of 40 nM immediately prior to MS analysis. 
4 pmol of [15N]-dA was added to 4 μg of tRNA and the samples were 
subjected to enzymatic hydrolysis as described earlier.  Following volume 
adjustment to achieve final concentrations of ~40 nM [15N]-dA and ~40 ng/μl 
ribonucleosides, 10 μl of sample was analyzed by LC-MS/MS.  
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Ribonucleosides were resolved on a Thermo Hypersil aQ column (100 x 2.1 
mm, 1.9 μm particle size) with 0.1% (v/v) formic acid in water and in 
acetonitrile as mobile phase and a flow rate of 0.3 mL/min.  The solvent 
schedule for acetonitrile in 0.1% formic acid was as follows: 0-10 min, 5%; 10-
12 min, 30%; 12 min, 95%.  Electrospray ionization MS/MS analysis of the 
HPLC eluant was performed in positive ion mode with the following 
parameters for voltages and source gas: gas temperature, 350°C; gas flow, 
10 L/min; nebulizer, 20 psi; and capillary voltage, 3500 V.  The mass 
spectrometer was operated in MRM mode to quantify two ribonucleosides 
with the following parameters (retention time, m/z of the transmitted parent 
ion, m/z of the monitored product ion, fragmentor voltage, collision energy): 
[15N]-dA -- 3.0 min, m/z 257→141, 90 V, 10 V; and m62A -- 11.1 min, m/z 
296→164, 90 V, 15 V.  The dwell time for each ribonucleoside was 200 ms 
and these two ions were monitored throughout the whole HPLC run.  
Absolute quantification m62A was achieved by preparing external calibration 
curves using synthetic standard. Linear calibration curves were obtained 
using a fixed concentration (40 nM) of [15N]-dA and varying concentrations of 
m62A (5, 10, 50, 100, 500 nM) (Supplementary Figure 4.2). 
4.4. Results  
4.4.1. Identification of ribonucleosides in BCG tRNA  
As a critical feature of our platform for studying the complete set of 
ribonucleosides in an organism [7], liquid chromatography-coupled mass 
spectrometry has previously been demonstrated to be a powerful tool for 
characterizing the structure of ribonucleosides and for quantifying them in 
biological systems [10, 11].  Ribonucleosides from hydrolyzed tRNA were 
initially characterized using LC-MS/MS with neutral loss analysis.  During 
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CID, there is characteristic cleavage of the glycosidic bond between the 
nucleobase and either the ribose or 2’-O-methylribose moiety, which causes a 
loss of either 132 or 146 Da, respectively.  We used this property to search 
for modified nucleosides, with parallel analysis of a sample of prepared 
without added RNA to account for artifacts.  It should be noted that, since the 
C-C glycosidic bond in pseudouridine (Ψ) does not readily fragment to 
produce neutral loss of a ribose residue, the presence of Y was verified by 
CID fragmentation of the ribose to yield the nucleobase with the ribose C1 
methylene group attached (m/z 125) [27]. 
This analysis revealed several ribonucleoside candidates (Figure 4.2).  Of 
these, 12 were definitely identified by comparison of retention time, exact 
mass and CID fragmentation to synthetic standards, while another 5 were 
tentatively identified on the basis of exact mass comparisons to RNA 
modification databases [1, 2], with no specific structures that can be assigned 
to the isobaric methylated ribonucleosides (Table 4.1). In Chapter 6, this 
basic analysis was further enhanced with the addition of dynamic MRM 
scheduling, neutral loss scans and molecular feature extraction from high 
mass resolution scans on the quadrupole time-of-flight mass spectrometer to 
reveal the final repertoire of 40 distinct modified ribonucleosides (6.3 Material 
and methods, Figure 6.1A and Appendix 1).  
4.4.2. Structural characterization of the ribonucleoside with m/z 
296.1350 
One of the ribonucleosides identified in neutral loss analysis had an m/z value 
of 296.1350 ± 0.0011 (mean ± SD; Supplementary Figures 4.1A and B), 
which yields a chemical formula of C12H18N5O4
+ (m/z 296.1359).  This formula 
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Figure 4.2. Extracted ion chromatogram of ribonucleoside candidates in 
hydrolyzed BCG tRNA identified by LC-MS/MS in MRM mode.  The peaks 
of m1A (2.5 min) and m7G (3.9 min) are marked with ‘//’ to indicate that they 
are in different scales from other peaks.  The identities of ribonucleosides 
marked with ‘?’ are tentative and have not been confirmed against standards.  
‘mA’ denotes a monomethylated adenosine.
corresponded to an adenosine with 2 methyl groups or 1 ethyl group.  
Subsequent MS2 analysis confirmed the neutral loss of ribose to yield a 
fragment with m/z 164.0924 (Figure 4.3), which corresponds to an adenine 
nucleobase with an additional C2H4 (m/z 164.0936).  Pseudo-MS
3 analysis 
consisted of in-source fragmentation-induced loss of ribose to yield an ion 
with m/z 164.09, which was selected for CID in the second quadrupole.  The 
resulting mass spectrum shown in Figure 4.4A revealed a variety of fragment 
ions, many of which had m/z values associated with fragmentation of 
methylated adenosine [29].  Based upon this dissociation model and the 
fragmentation pattern, we concluded that the structure of the ion with m/z 
296.1350 was N6,N6-dimethyladenosine (m62A).  This was confirmed by 
comparison to synthetic m62A, which produced identical values for retention 
time, exact mass, and MS2 and pseudo-MS3 fragmentation (Figure 4.4B).
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Table 4.1. Ribonucleosides identified by mass 
















1.43 245.1 125.1 110 Ψ 
2.15 258.1 126.1 70 m
5
C 
2.45 258.1 126.1 279 m
3
C 
2.47 282.1 150.1 500000 m
1
A 
3.85 298.1 166.1 500000 m
7
G 
4.22 258.1 112.1 2500 Cm 
4.4 269.1 137.1 80000 I 
5.16 352 220 16000 io
6
A? 
5.27 322 190 24000 imG-14? 
8.22 259.1 127.1 30 m
5
U 
8.6 282.1 150.1 7000 mA, Am? 
10.69 298.1 166.1 3500 m
1
G? 
11.4 298.1 152.1 450 Gm 
12.9 282.1 150.1 17000 mA, Am? 
13.91 298.1 166.1 600 m
2
G 
20.1 296.1 164.1 25000 m
6
2A 




Neutral loss analysis (except for Y) was performed with a 
triple quadrupole mass spectrometer, as described in the 
Experimental section. 
2
RNA modifications noted in bold font were corroborated with 
synthetic standards.  “?” denotes tentative identification;  “mA, 
Am” denotes a monomethylated adenosine. 
 
 
Figure 4.3.  MS2 fragmentation of the ribonucleoside with m/z 296.1350.













Figure 4.4. Pseudo-MS3 fragmentation analysis of candidate 
ribonucleosides. (A) Fragmentation of m/z 164.0924 derived from the m/z 
296.1350 ribonucleoside. Tentative structures of fragment ions are based on 
a model proposed by Nelson and McCloskey [29]. (B) Pseudo-MS3 
fragmentation of m/z 164.0924 derived from the m/z 296.1350 ion of synthetic 
m62A. 
4.4.3. Quantification of m62A in tRNA from different organisms 
Since m62A had been described in rRNA previously but not in tRNA, we 
quantified this modification by LC-MS/MS in samples of tRNA from BCG, rat 
liver tissue, TK6 cell line, and yeast by using external calibration against [15N]-
dA (Supplementary Figures 4.2 and 4.3).  In BCG, the level of m62A was 
A 
B 
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0.88 pmol per μg of tRNA, while the level of m62A in rat liver, and TK6 and 
yeast cells was below the detection limit of the assay.  On average, the size 
of mycobacterial tRNA is ~65 nt, which suggests that m62A occurs once in 
every ~51 tRNA molecules.  The data in Table 4.2 also suggest that the 
presence of m62A in the small RNA isolates is not due to contamination with 
rRNA fragments, since we would have expected to detect m62A in the small 
RNA isolates from the other species if rRNA fragment contamination had 
occurred.  To further confirm this, tRNA was purified from samples of BCG 
small RNA by size-exclusion HPLC (Supplementary Figure 4.4) and m62A 
was again detected in the fraction containing only tRNA. 
Table 4.2. Level of m62A in tRNA from BCG, human, rat and yeast. 
 BCG Human TK6 Rat liver S. cerevisiae  




< 0.00092 < 0.00092 < 0.00092 
1 MS signal normalized to total tRNA (0.4 μg) 
2 Less that the limit of quantification 
 
4.5. Discussion 
Using an LC-MS platform developed for analysis of ribonucleoside 
modifications in yeast [7], we have begun to systematically characterize the 
spectrum of modified ribonucleosides in a variety of microorganisms, starting 
with Mycobacterium bovis BCG.  The platform that we have developed 
addresses all levels of highly quantitative analysis, including isolation of high 
quality RNA (Chapter 3: Figure 3.2), rigorous quantification of the RNA, and 
RNA processing under conditions that obviate modification artifacts caused 
by adventitious oxidation (addition of deferoxamine and butylated 
hydroxytoluene) and deamination (addition of coformycin and 
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tetrahydrouridine).  Subsequent resolution of the complete set of 
ribonucleosides by reversed-phase HPLC provides good separation (Figure 
2) for mass spectrometric characterization for both high mass accuracy and 
fragmentation.  Using this approach, we were able definitively identify 12 
modified ribonucleosides in BCG tRNA: Ψ, m5C, m3C, m1A, m7G, Cm, I, m5U, 
Gm, m2G, t6A, and m62A.  All of these species have been described 
previously in either tRNA or rRNA from other organisms [30, 31], which 
suggests conservation of function in mycobacteria.  Of these ribonucleosides, 
only 1-methyladenosine (m1A) has been previously identified in a 
mycobacterial species (Mtb), where is occurs at position 58 of tRNA [31, 32].  
While m1A and m7G are highly abundant in both BCG and yeast tRNA, the 
relative proportions of other ribonucleosides common to both organisms differ 
significantly, as judged from mass spectrometric signal strength for identical 
analytical conditions (Figure 4.2). 
In addition to the 12 defined ribonucleosides, we tentatively identified 5 other 
ribonucleosides on the basis of CID molecular transitions and exact mass 
comparisons with RNA modification databases: N6-(cis-
hydroxyisopentenyl)adenosine (io6A; m/z 352.1616; m/z 352220), 4-
demethylwyosine (imG-14; m/z 322.1146; m/z 322190), two adenosine 
species in which the nucleobase is methylated (m/z 282.1197; m/z 282150) 
and a species in which the guanosine nucleobase is methylated (m/z 
298.1146; m/z 298166).  The latter is likely to be m1G since no other mono-
methylated guanosines other than Gm, m2G and m7G have been described 
[30, 31].  Possible candidates for mono-methylated adenosine include Am, 
m2A m8A, m6A; m7A has not been described previously [30, 31].  These 
modifications have been observed in tRNA in other organisms [30, 31]. 
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Our initial analysis of ribonucleosides in BCG tRNA revealed an abundant 
ribonucleoside not previously identified in tRNA (Figure 4.2): an adenosine 
species with either an ethyl group or two methyl groups attached to the 
nucleobase.  Among the possible candidates for this species were 1,2-O-
dimethyladenosine (m1Am), N6,2-O-dimethyladenosine (m6Am) and N6,N6-
dimethyladenosine (m62A) [30, 31].  As shown in Figures 4.3 and 4.4, MS
2 
and pseudo-MS3 fragmentation suggested that the structure was m62A, a 
conclusion corroborated by comparison to a synthetic m62A standard (Figure 
4.4B).  The nucleoside m62A was discovered by Littlefield and Dunn in 
Bacterium coli, Aerobacter aerogenes, yeast, and rat liver tissues [33].  It was 
identified in the 16S and 23S rRNA of archaea and bacteria and the 18S 
rRNA of eukarya [34-38].  However, m62A has not been identified in tRNA 
from any organism or cell types other than BCG, including yeast, rat liver and 
human cells (Table 4.2).  That the m62A did not arise from contamination of 
small RNA isolates with 5S rRNA or fragments of larger rRNA species is 
supported by the results in Table 2, the Bioanalyzer results in Figures 1 and 
S4, and the analysis of HPLC-purified tRNA from BCG.   
While m62A has been observed previously only in rRNA, several features of 
its structure and biosynthesis may provide insights into its presence in tRNA.  
An examination of ribonucleoside databases reveals that adenosine species 
with N6 modifications (e.g., t6A, i6A) tend to be located at position 37 of tRNA, 
which suggests a possible location for the similarly hydrophobic m62A in tRNA 
in BCG and other mycobacterial species.  Orthologs of the methyltransferase 
KsgA catalyze the formation of m62A in the 3’-ends of the small subunit rRNAs 
in most organisms [39], while members of the Erm family of 
methyltransferases catalyze m62A formation in 23S rRNA in many bacteria 
[40, 41].  Homologs of both Erm and KsgA are present in BCG and Mtb [42, 
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43].  Given the precedent for m5U formation in both tRNA and 16S rRNA by 
the tRNA (m5U54) methyltransferase [44, 45], it is possible that the KsgA or 
Erm homologs also catalyze m62A formation in BCG tRNA. 
In conclusion, we have employed a chromatography-coupled mass 
spectrometric approach to systematically define the spectrum of modified 
ribonucleosides in Mycobacterium bovis BCG.  This approach revealed a 
variety of ribonucleoside candidates in tRNA from BCG, of which 12 were 
definitively identified based on comparisons to synthetic standards and 5 
were tentatively identified by exact mass comparisons to RNA modification 
databases.  Among the ribonucleosides observed in BCG tRNA was one not 
previously described in tRNA, which we have now characterized as N6,N6-
dimethyladenosine. 
4.6. Supplementary material 
4.6.1. Supplementary figures 
(next page) 
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Supplementary Figure 4.1.  Preliminary structural characterization of 
novel ribonucleoside candidate m/z 296.13. (A) Extracted ion 
chromatogram of ions with m/z 296.13 from the LC/TOF scan of the 




Supplementary Figure 4.2.  External calibration curve for quantifying 
m62A; performed as described in 4.3.Materials and methods. 
y = 13.061x + 0.9682 
































Amount of m62A (pmol) 
A 
B 
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Supplementary Figure 4.3.  Analysis of small RNA isolated from the 
yeast S. cerevisiae, rat liver, and human B lymphoblastoid TK6 cells 
(respectively, from top to bottom).  Samples were analyzed with an Agilent 
Bioanalyzer small RNA chips as described in Chapter 3 
Supplementary Figure 4.4: Purification of BCG tRNA from small RNA 
isolates by size-exclusion HPLC.  Fraction A (at 8.033 min) was collected 
and the tRNA analyzed for m62A content as described in the text.    
Page | 146  
 
4.7. Acknowledgements 
Co-authors: Dan Su,1 Clement T.Y. Chan,1 Chen Gu,1 Kok Seong Lim,1 
Megan E. McBee,2 Chia-Hua Ho,2 Lin Wenwei,4 Brandon S. Russell,1 I. 
Ramesh Babu,1 Sylvie Alonso,2,4 Thomas J. Begley3 and Peter C. Dedon1,2 
1 Department of Biological Engineering and Center for Environmental Health 
Science, Massachusetts Institute of Technology, Cambridge, MA 
2 Singapore-MIT Alliance for Research and Technology, CREATE, Singapore; 
3 College of Nanoscale Science and Engineering, University at Albany, State 
University of New York, Albany, NY 
4 Department of Microbiology and Immunology Programme, Center for Life 




1. Czerwoniec, A., et al., MODOMICS: a database of RNA modification 
pathways. 2008 update. Nucleic Acids Res, 2009. 37(Database 
issue): p. D118-21. 
2. McCloskey, J.A. and J. Rozenski, The Small Subunit rRNA 
Modification Database. Nucleic Acids Res, 2005. 33(Database issue): 
p. D135-8. 
3. Bennett, C.B., et al., Genes required for ionizing radiation resistance 
in yeast. Nat Genet, 2001. 29(4): p. 426-34. 
4. Kalhor, H.R. and S. Clarke, Novel methyltransferase for modified 
uridine residues at the wobble position of tRNA. Mol Cell Biol, 2003. 
23(24): p. 9283-92. 
5. Alexandrov, A., E.J. Grayhack, and E.M. Phizicky, tRNA m7G 
methyltransferase Trm8p/Trm82p: evidence linking activity to a growth 
phenotype and implicating Trm82p in maintaining levels of active 
Trm8p. Rna, 2005. 11(5): p. 821-30. 
6. Begley, U., et al., Trm9-catalyzed tRNA modifications link translation 
to the DNA damage response. Mol Cell, 2007. 28(5): p. 860-70. 
7. Chan, C.T., et al., A quantitative systems approach reveals dynamic 
control of tRNA modifications during cellular stress. PLoS Genet, 
2010. 6(12): p. e1001247. 
8. Grosjean, H., et al., Detection of enzymatic activity of transfer RNA 
modification enzymes using radiolabeled tRNA substrates. Methods in 
Enzymology, 2007. 425: p. 55-101. 
9. Köhrer, C. and U.L. Rajbhandary, The many applications of acid urea 
polyacrylamide gel electrophoresis to studies of tRNAs and 
aminoacyl-tRNA synthetases. Methods, 2008. 44(2): p. 129-38. 
10. Suzuki, T., et al., Mass spectrometric identification and 
characterization of RNA-modifying enzymes. Methods Enzymol, 2007. 
425: p. 211-29. 
11. Meng, Z. and P.A. Limbach, Mass spectrometry of RNA: linking the 
genome to the proteome. Brief Funct Genomic Proteomic, 2006. 5(1): 
p. 87-95. 
Page | 147  
 
12. Pomerantz, S.C. and J.A. McCloskey, Analysis of RNA hydrolyzates 
by liquid chromatography-mass spectrometry. Methods Enzymol, 
1990. 193: p. 796-824. 
13. Limbach, P.A., P.F. Crain, and J.A. McCloskey, Summary: the 
modified nucleosides of RNA. Nucleic Acids Res, 1994. 22(12): p. 
2183-96. 
14. Rozenski, J., P.F. Crain, and J.A. McCloskey, The RNA Modification 
Database: 1999 update. Nucleic Acids Res, 1999. 27(1): p. 196-197. 
15. Mandal, D., et al., Agmatidine, a modified cytidine in the anticodon of 
archaeal tRNA(Ile), base pairs with adenosine but not with guanosine. 
Proc Natl Acad Sci U S A, 2010. 107(7): p. 2872-7. 
16. Ikeuchi, Y., et al., Agmatine-conjugated cytidine in a tRNA anticodon 
is essential for AUA decoding in archaea. Nature chemical biology, 
2010. 6(4): p. 277-82. 
17. Suzuki, T. and K. Miyauchi, Discovery and characterization of tRNAIle 
lysidine synthetase (TilS). FEBS Lett, 2010. 584(2): p. 272-7. 
18. Miyauchi, K., S. Kimura, and T. Suzuki, A cyclic form of N(6)-
threonylcarbamoyladenosine as a widely distributed tRNA 
hypermodification. Nature chemical biology, 2012. 
19. Crain, P.F., Preparation and enzymatic hydrolysis of DNA and RNA 
for mass spectrometry. Methods Enzymol, 1990. 193: p. 782-90. 
20. Begley, U., et al., A human tRNA methyltransferase 9-like protein 
prevents tumour growth by regulating LIN9 and HIF1-alpha. EMBO 
Mol Med, 2013. 5(3): p. 366-83. 
21. Chan, C.T., et al., Reprogramming of tRNA modifications controls the 
oxidative stress response by codon-biased translation of proteins. Nat 
Commun, 2012. 3: p. 937. 
22. Patil, A., et al., Translational infidelity-induced protein stress results 
from a deficiency in Trm9-catalyzed tRNA modifications. RNA Biol, 
2012. 9(7): p. 990-1001. 
23. Patil, A., et al., Increased tRNA modification and gene-specific codon 
usage regulate cell cycle progression during the DNA damage 
response. Cell Cycle, 2012. 11(19): p. 3656-3665. 
24. Jasmer, R.M., P. Nahid, and P.C. Hopewell, Clinical practice. Latent 
tuberculosis infection. N Engl J Med, 2002. 347(23): p. 1860-6. 
25. World Health Organization, G.T.P., Global tuberculosis control : WHO 
report. 2009, Global Tuberculosis Programme: Geneva. 
26. Fine, P.E. and L.C. Rodrigues, Modern vaccines. Mycobacterial 
diseases. Lancet, 1990. 335(8696): p. 1016-20. 
27. Dudley, E., et al., Study of the mass spectrometric fragmentation of 
pseudouridine: comparison of fragmentation data obtained by matrix-
assisted laser desorption/ionisation post-source decay, electrospray 
ion trap multistage mass spectrometry, and by a method utilising 
electrospray quadrupole time-of-flight tandem mass spectrometry and 
in-source fragmentation. Rapid Commun Mass Spectrom, 2005. 
19(21): p. 3075-85. 
28. Chionh, Y.H., et al., A multidimensional platform for the purification of 
non-coding RNA species. Nucleic Acids Res, 2013. in press. 
29. Nelson, C.C.M., J. A., Collision-Induced Dissociation of Adenine. J Am 
Chem Soc, 1992. 114(1): p. 3661 to 3668. 
30. Brahmachari, V. and T. Ramakrishnan, Studies on 1-methyl adenine 
transfer RNA methyltransferase of Mycobacterium smegmatis. Arch 
Microbiol, 1984. 140(1): p. 91-5. 
Page | 148  
 
31. Varshney, U., et al., Mycobacterium tuberculosis Rv2118c codes for a 
single-component homotetrameric m1A58 tRNA methyltransferase. 
Nucleic Acids Res, 2004. 32(3): p. 1018-27. 
32. Bujnicki, J.M., In silico analysis of the tRNA:m1A58 methyltransferase 
family: homology-based fold prediction and identification of new 
members from Eubacteria and Archaea. FEBS Lett, 2001. 507(2): p. 
123-7. 
33. Littlefield, J.W. and D.B. Dunn, Natural occurrence of thymine and 
three methylated adenine bases in several ribonucleic acids. Nature, 
1958. 181(4604): p. 254-5. 
34. Brown, G.M. and G. Attardi, Methylation of nucleic acids in HeLa cells. 
Biochem Biophys Res Commun, 1965. 20(3): p. 298-302. 
35. Dubin, D.T. and A. Günalp, Minor nucleotide composition of ribosomal 
precursor, and ribosomal, ribonucleic acid in Escherichia coli. Biochim 
Biophys Acta, 1967. 134(1): p. 106-123. 
36. Fox, G.E., et al., Classification of methanogenic bacteria by 16S 
ribosomal RNA characterization. Proc Natl Acad Sci U S A, 1977. 
74(10): p. 4537-41. 
37. Lai, C.J., J.E. Dahlberg, and B. Weisblum, Structure of an inducibly 
methylatable nucleotide sequence in 23S ribosomal ribonucleic acid 
from erythromycin-resistant Staphylococcus aureus. Biochemistry, 
1973. 12(3): p. 457-60. 
38. Starr, J.L. and R. Fefferman, The Occurrence of Methylated Bases in 
Ribosomal Ribonucleic Acid of Escherichia Coli K12 W-6. J Biol 
Chem, 1964. 239: p. 3457-61. 
39. Inoue, K., S. Basu, and M. Inouye, Dissection of 16S rRNA 
methyltransferase (KsgA) function in Escherichia coli. J Bacteriol, 
2007. 189(23): p. 8510-8. 
40. Weisblum, B., et al., Erythromycin-inducible resistance in 
Staphylococcus aureus: requirements for induction. J Bacteriol, 1971. 
106(3): p. 835-47. 
41. Thakker-Varia, S., A.C. Ranzini, and D.T. Dubin, Ribosomal RNA 
methylation in Staphylococcus aureus and Escherichia coli: effect of 
the "MLS" (erythromycin resistance) methylase. Plasmid, 1985. 14(2): 
p. 152-61. 
42. Buriankova, K., et al., Molecular basis of intrinsic macrolide resistance 
in the Mycobacterium tuberculosis complex. Antimicrob Agents 
Chemother, 2004. 48(1): p. 143-50. 
43. Brosch, R., et al., Genome plasticity of BCG and impact on vaccine 
efficacy. Proc Natl Acad Sci U S A, 2007. 104(13): p. 5596-601. 
44. Gu, X., J. Ofengand, and D.V. Santi, In vitro methylation of 
Escherichia coli 16S rRNA by tRNA (m5U54)-methyltransferase. 
Biochemistry, 1994. 33(8): p. 2255-61. 
45. Auxilien, S., et al., Specificity shifts in the rRNA and tRNA nucleotide 
targets of archaeal and bacterial m5U methyltransferases. Rna, 2011. 
17(1): p. 45-53. 
 
 
Page | 148  
 
5.  Ketogenesis: An Achilles’ heel of persistent 
mycobacteria 
5.1. Abstract 
Many bacteria, including mycobacteria, respond to environmental stresses by 
entering a non-replicating antibiotic-tolerant state of persistence, yet the 
mechanistic underpinnings remain poorly understood. We used a data-driven 
approach to characterize the response of three mycobacteria, M. 
tuberculosis, M. bovis BCG and M. smegmatis, to starvation and subsequent 
resuscitation in terms of growth behavior, antibiotic susceptibility, lipid 
metabolism, nutrient utilization, reactive oxygen species (ROS) generation 
and global gene expression. Applying multivariate analysis to integrate the 
datasets, we found strong correlations among multi-drug tolerance, ROS 
production and a metabolic shift to triacylglycerol utilization and consequent 
ketogenesis, with strong Mg2+-dependence for persistence for all three 
bacteria. This novel ketone body metabolic pathway is mediated by 
cytochrome P450s that paradoxically generate significant ROS yet confer 
hypersensitivity to hydrogen peroxide by P450 inactivation. These results are 
especially pertinent for developing therapeutics against latent infections with 
high risk of post-treatment relapse. 
 
5.2. Introduction 
Having established an analytical platform for the isolation, purification, 
characterization and quantification of cellular RNA (Chapters 2-4), we now 
turn our attention to defining the stress response of mycobacteria; starting 
with nutrient statvation.  
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One of the most effective adaptations of bacterial pathogens to the stress of 
infection involves the ability to enter a persistent state characterized by a lack 
of cell growth and resistance to antibiotics [1]. The antibiotic tolerance of 
persisters is a non-heritable, reversible resistance to antibiotic-mediated 
killing that correlates with physiological adaptation to environmental stresses 
[2, 3] and often necessitates complicated and prolonged therapeutic regimens 
[4, 5]. Emerging evidence suggests that bacterial persistence results from 
active responses to physiological stress, rather than passive quiescence [6, 
7]. However, the challenge to effectively treating persistent bacteria lies in our 
lack of understanding of the molecular mechanisms underlying persistence 
and the multiplicity of overlapping and redundant pathways by which bacteria 
adapt to different environmental stresses. Here, we focus on the molecular 
mechanisms underlying mycobacterial persistence caused by nutrient 
deprivation. 
As a pathogen thought to asymptomatically infect one-third of the world’s 
population [8], Mycobacterium tuberculosis (Mtb) characteristically enters a 
state of persistence when challenged by a variety of stresses imposed by the 
human immune response, including nitric oxide exposure, hypoxia, and 
nutrient deprivation [9]. Mtb likely shares a number of features of stress 
response with other bacteria, including programmed shifts in metabolism and 
altered sensitivity to reactive oxygen (ROS) and nitrogen species (RNS) [9, 
10]. For example, the stringent response is an extensively studied bacterial 
reaction to carbon, amino acid or fatty acid deprivation. Central to this 
response is alarmone signaling mediated by guanosine pentaphosphate or 
tetraphosphate ((p)ppGpp), This signaling pathway, regulated by Rsh 
(RelA/SpoT homologs), coordinates starvation stress responses and 
tolerance to antibiotic killing by affecting the expression and activities of RNA 
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polymerases, sigma factors, toxin-antitoxin systems, chaperones and cAMP 
signaling [11-13]. Starvation of Mtb has been shown to cause global 
transcriptional reprogramming [14], modified metabolism and virulence 
through the induction of toxin-antitoxin modules [15], altered permeability to 
drugs and metabolites [16, 17] and phenotypic resistance to a wide range of 
first- and second-line antibiotics with varied mechanisms of action [18, 19]. Of 
particular relevance to our current studies is the observation that oxidative 
stress plays a definitive role in the killing of mycobacteria by antibiotics [20]. 
Yet, despite new viewpoints on the precise mechanism of antibiotic killing and 
its association to ROS [21, 22], the series of physiological, metabolic and 
gene regulation events required for mycobacterial persistence and antibiotic 
tolerance remains unclear.  
In the studies detailed in this chapter, we combined comprehensive 
measurements of ROS levels with biochemical assays, multiplexed 
phenotypic metabolic screens, and global analysis of gene expression before, 
during, and in recovery from prolonged nutrient deprivation to deduce that 
starved mycobacteria switch to a cytochrome P450 (CYP)-dependent 
ketogenic metabolic state. Cyp135A1, in particular, proved essential for 
surviving nutrient deprivation. Further, we show that these starvation-induced 
persister populations are sensitive to killing by hydrogen peroxide due to 
disruption of CYP-dependent metabolism and, paradoxically, an associated 
reduction in ROS production. Metadata analysis of these results suggests that 
the antibiotic tolerance of mycobacterial persistence is a multifactorial trait 
that integrates efflux pump expression, drug target down-regulation, and 
metabolism of xenobiotics. Mycobacterial ketogenesis thus represents both 
an adaptive strength and a potentially exploitable weakness for overcoming 
persistence. 
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5.3. Material and methods 
5.3.1. Bacteria strains and culture conditions 
M. tuberculosis CDC 1551, M. bovis BCG str. Pasteur 1173P2 and M. 
smegmatis mc2155 were grown in roller bottles with 7H9 broth or PBS (with 
0.05% (v/v) tyloxapol) at 5 rpm and 37 ○C. Serial dilution plating was used for 
colony-forming units (CFU) determination on 7H11 agar for Mtb and 7H10 
agar for BCG and SMG. Exponentially growing cultures (OD600 of 0.4-0.8) 
were starved by washing pellets twice with and resuspended in PBS-tyloxapol 
(0.05%). At indicated time points after starvation cultures were resuscitated 
for up to 10 days by re-suspension in 7H9. Specific compositions of 7H9 
broth, PBS, 7H11 and 7H10 agars are as follows: Middlebrooke7H9 (BD) 
supplemented with 0.5% (w/v) albumin, 0.2% (w/v) glucose, 0.085% (w/v) 
NaCl, 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80 as nutrient replete 
media; unless specified nutrient starvation media was phosphate buffered 
saline (PBS; 137 mM NaCl , 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) 
with 0.05% v/v tyloxapol, a non-hydrolysable detergent, adjusted to pH 7.4; 
where specified, Dulbecco’s PBS (DPBS, Sigma-Aldrich) containing 0.5 mM 
MgCl2, 0.9 mM CaCl2, 137 mM NaCl , 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM 
KH2PO4 was supplemented with 0.05% v/v tyloxapol and used as nutrient 
starvation media. For CFU determinations, serial dilutions were plated on 
7H10 or 7H11 agar supplemented with 10% (v/v) oleic acid-albumin-dextrose-
catalase (OADC). Prolonged starvation cultures were routinely assessed for 
contamination by microscopy (Gram, Ziehl-Neelsen, or auramine-rhodamine 
staining) and streaking on blood agar. 
5.3.2. Antibiotic, azole, formaldehyde and hydrogen peroxide 
susceptibility testing 
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Log, S4, S10, S20 and R6 cultures were treated at OD600 0.1 with 
streptomycin, rifampicin, ethambutol, isoniazid, clotrimazole, econazole, 
miconazole,  methanol-free formaldehyde or hydrogen peroxide at indicated 
concentrations in 96-well plates for up to 5 days. Technical replicates were 
sacrificially assayed for OD600 and CFU. CFU were obtained from plating 
serial dilutions at the various indicated time points post-treatment on 7H10 
agar after 3-4 weeks of incubation at 37 ○C for Mtb and BCG and 2-3 days for 
SMG. 
5.3.3. Flow Cytometry of Cellular Physiology 
At indicated time points bacilli were stained for esterase activity, ROS 
generation or intracellular pH in 96-well plates. Bacilli were stained with CFDA 
(10 ng/mL, Life Technologies) or CellROX® green (500 nM, Life 
Technologies) for 30 minutes at 37C followed by fixation in PBS+1% 
paraformaldehyde with DAPI (1 mg/mL, Life Technologies). Intracellular pH 
was measured using SNARF®-5F 5-(and-6)-carboxylic acid, acetoxymethyl 
ester, acetate (10 µM, Life Technologies) according to manufacturer’s 
instructions. Stained cells were analyzed on a LSRII HTS flow cytometer.  
For staining, 20 μl of sample was added to a well of a v-bottom 96-well plate 
containing 180 μl of 500nM CellROX™ Green (Life Technologies) in PBS 
then incubated at 37 °C for 30 minutes. Following incubation, bacteria were 
stained for DNA and fixed by addition of 50 μl of 4% PFA containing DAPI (1 
μg/mL) for 10 minutes. Samples were analyzed on an LSRII HTS flow 
cytometer (BD Biosciences) within an hour of staining. Data was analyzed 
using FlowJo software (TreeStar Inc). ROShi bacteria were identified based 
on a sequential gating scheme for 1) size (FSC and SSC, Supplementary 
Figures 5.2C and 5.2G), 2) DNA content (DAPI, Supplementary Figures 
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5.2D and 5.2H), 3) ROS detection dye uptake (CellROX® signal above 
unstained, Supplementary Figures 5.2E and 5.2I) and 4) ROShi above basal 
(CellROX® signal above untreated, Supplementary Figures 5.2F and 5.2J). 
CFDAhi cells were identified via a similar staining protocol (1 ng/mL CFDA, 
Life Technologies) and gating scheme (Supplementary Figures 5.2K-N).  
For pH determination, cells were pelleted, washed once with 100 mM 
phosphate buffer, pH 7.0, and resuspended at ~ 2 x 106 cells/ml in carboxy 
SNARF 5F-AM acetate (SNARF, 10 μM, Life Technologies) in 100 mM 
phosphate buffer, pH 7.0 or buffer only for 30 min. Additional aliquots of cells 
were used for a calibration curve in which SNARF plus nigericin (10 μM, Life 
Technologies) in 100 mM phosphate buffers at pH 5.5 to 8.0 was added to 
cells. Every condition and flow analysis had a separate calibration curve. 
DAPI (1 μg/mL, Life Technologies) was added to all cells for at least 10 min 
prior to flow cytometry. SNARF was excited at 561 nm with emission at 
585/15 and 610/20. Bacteria were identified by size and DNA content, as 
described above. pH was calculated according to manufacturer’s instructions 
using the ratios of median fluorescent intensity (MFI) of SNARF at the two 
wavelengths. Photon multiplier tube (PMT) voltage settings for the LSRII were 
SSC (250), FSC (400), DAPI ex 355/em 450/50 (550), CellROX® and CFDA 
ex 488nm em 525/50 (400), SNARF 585/15 (550), and SNARF 610/20 (550). 
A minimum of 50,000 events were collected for analysis from each sample. 
5.3.4. RNA Extraction and Composition Analysis 
Despite our findings on RNA yields with different extraction mixtures in 
Chapter 2, Trizol instead of Tris-EDTA saturated phenol-chloroform was used 
for bacterial lysis RNA extracted as it was compatible with downstream rRNA 
depletion and linker ligation processes. To ensure complete lysis of 
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mycobacteria, ~109 pelleted cells were combined with 1mL of TRIzol reagent 
(Life Technologies) and 100 µL of 0.1 mm silica/zirconium beads in a 2 mL 
screw-capped tube and shaken vigorously on a Qiagen Tissuelyser II 
(Qiagen) in pre-chilled chambers for 15 min at a frequency of 30 Hz. Lysates 
were chilled at -20 ○C and a second beat-beating cycle was performed in the 
presence of 16% chloroform (v/v). Phase separation and RNA extraction was 
performed using the PureLink® RNA Mini Kit (Life Technologies, Carlsbad, 
CA). A 2 column separation strategy was used. 35% ethanol (v/v) on the first 
column to enrich for long (> ~150 nt) RNA species. 70% ethanol (v/v) was 
used on the second to trap small (~150 nt - ~20 nt) RNA species. 
Concentration was then quantified by UV spectroscopy at 260/280nm. RNA 
integrity and composition was determined using the appropriate Bioanalyzer 
RNA chips (Agilent Technologies) (See Chapter 3). Thereafter, we performed 
DNA elimination using a TURBO DNA-free™ Kit (Ambion, Life Technologies).  
For RNA-seq, rRNA is depleted using the Ribo-ZeroTM Magnetic Kit for 
Bacteria (Epicentre, Illumina) as per manufacturer’s instructions. 
5.3.5. Biochemical plate assays 
For catalase determination, pellets from 10 mL of culture at indicated time 
points were resuspended in 0.5 mL of 50 mM phosphate buffer plus 0.1 mM 
phenylmethylsulfonyl flouride PMSF and added to ~100 uL of 0.1 mm 
silica/zirconium beads in 2 mL screw-cap tubes with o-rings. Cells were bead-
beaten with a Tissuelyser II (Qiagen) with pre-chilled chambers at ambient 
temperature for 10 min at 50 Hz. Lysate (supernatant) was collected after 
centrifuging at 12,000 g for 15 min at 4 °C to pellet the beads and cellular 
debris. Lysate was aliquoted and stored at -80 °C until use. Catalase activity 
in the lysate was measured using a catalase assay kit (Sigma-Aldrich) 
adapted for a 96-well plate. Protein content in the lysates was measured the 
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same day as catalase using a BCA assay according to manufacturer’s 
protocol (Pierce, Thermo Scientific). Catalase levels were normalized to the 
protein content of each lysate. 
ATP levels were quantified in cell lysates as mentioned above. ATP levels in 
lysates were compared with a standard curve of ATP (Promega) with the 
BacTiter Glo Assay (Promega) following manufacturer’s instructions. ATP 
levels were normalized to CFU in the culture. 
Levels of 3HB were quantified using a b-Hydroxybutyrate (Ketone Body) 
Colormetric Assay Kit (Cayman Chemical). Lysates were prepared as 
described except the pellets were resuspended in assay buffer (100 mM Tris-
HCl, pH 8.5) plus 10% ethanol for bead-beating. 3HB levels were measured 
directly after bead-beating and normalized to CFU in the culture. 
5.3.6. Triacylglycerol analysis by thin layer chromotography 
Thin layer chromatography was used for semi-quantitative analysis of lipid 
content as described in [23]. To extract lipids for triacylglyceride analysis, 
lyophilized and weighed cell pellets were lysed in methanol/petroleum ether 
(2:1) with 0.02% (w/v) sodium chloride with the volume proportional to dry-
weight. Soluble extracts were dried, dissolved in petroleum ether then spotted 
onto silica TLC plates with hexane/ethyl ether/acetic acid (45:5:1) as running 
buffer and iodine vapor as developing agent. Densitometry was performed 
using ImageJ (v1.49) (NIH), calculating pixel density based on the Rf of TAG 
standards. 
5.3.7. Metabolic phenotype assay development 
To adapt the standard GENIII microplate protocol (Biolog) to provide relative 
quantifications of metabolite usage, we first optimized for the survivability and 
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tetrazolium reduction of BCG in either IF-C or IF-B media (Biolog) in the 
presence or absence of 7H9 (0-20% (v/v)) at various cell densities (from 
starting OD600 of 0.01 – 0.2) and for periods from 1-7 days at 37
 oC based on 
reported protocols [24, 25]. Full UV-VIS spectroscopic scans from 300 nm – 
700 nm were performed on a Synergy 4 Multi-Mode Microplate Reader 
(BioTek) at 25 oC every 8 hours to track the conversion of tetrazolium to 
formazan and changes in culture turbidity. Data was loaded unto Origin (v8.5) 
(OriginLab) for background substraction, normalization, deconvolution 
(between tetrazolium reduction and optical density) and peak integration. 
Design of Experiments (DOE) was computed on Unscrambler® X (Camco) 
and a starting OD600 of 0.05 with 5 days of incubation was optimal while A565 
and OD660 were determined to minimize spillover from between tetrazolium 
reduction to optical density. Test plates were then performed to ascertain the 
sensitivity (limit of detection, LOD) for A565 and OD660 based on their initial 
values prior to incubation, by spiking in known volumes of reduced dye or 
varying the cell density. Metabolites that induced had A565 readings below 
LOD were arbitrarily assigned a null value, while those that had OD660 at or 
below the initial values, but A565 readings above LOD were considered to 
induce abiotic reduction of the dye.  
5.3.8. Metabolic phenotype screens 
Utilization of metabolites was measured with Gen III Microplates (Biolog) for 
BCG at indicated time points. A custom phenotypic fingerprinting assay was 
developed to compare metabolite usage of different carbon sources (see 
above). Cultures were resuspended in assay media at OD600 0.05. 100 µL of 
the bacilli suspension was inoculated onto Gen III Microplates. Each plate 
sealed and placed in an air-tight container with wet napkins to prevent 
evaporation. After 5 days incubation at 37 ºC the color density at A565 and 
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OD660 was determined. Technical duplicated were performed for each 
samples (in biological triplicate for each time point), content of wells were 
plated onto 7H10 agar after incubation and A565 and OD660 reads to determine 
culture survivability. We noted that several wells which assayed for chemical 
sensitivity gave A565 readings below that of the negative control and a design 
decision was made to exclude these data from subsequent statistical 
modeling. 
5.3.9. RNA sequencing and transcriptome analysis 
Coding sequences were enriched through the depletion of rRNAs and tRNAs 
and converted into template libraries using TruSeq® RNA Sample 
Preparation v2 kit (Illumina) as described by the manufacturer.  Pre-
sequencing quality controls for fragment sizes, dsDNA concentrations and 
loading molarities were performed. Samples were then pooled, loaded onto 
MiSeq® Reagent Kit v2 cartridges (Illumina) and ran on a MiSeq® System set 
at paired ends 151 base pair reads. Data from technical replicates were 
pooled, and post-sequencing quality controls of transcriptome coverage, RNA 
purity and quality were determined (Supplementary Table 5.2). Sequencing 
reads were mapped using the BWA-MEM algorithm (http://bio-
bwa.sourceforge.net) referenced against Mycobacterium bovis BCG Pasteur 
1173P2, complete genome (GenBank: AM408590.1). Gene expression level 
was determined based on sequencing coverage of the gene boundaries 
defined.  
5.3.10. Quantitative real-time PCR (qPCR) 
DNA-free RNA was diluted to a concentration of 50 ng/µl and reverse-
transcribed using the iScript cDNA synthesis kit (Bio-Rad) according to the 
manufacturer’s instructions. The reverse transcription program was run as 
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follows: 25oC for 5 minutes, 42oC for 30 minutes and 85oC for 5 minutes, 
followed by a cooling step at 4oC. Two-step real-time qPCR was performed by 
using the Sso Advanced Universal SYBR Green Supermix (Bio-Rad). The list 
of primers and their respective sequences and melting temperatures can be 
found in Table S3. The qPCR program was run as follows. 95oC for 30 
seconds followed by 40 cycles of denaturation at 95oC for 15 seconds and 
annealing/extension at 60oC for 30 seconds. A melt curve analysis consisting 
of 0.5oC increments from 65oC to 95oC was performed for all reactions to 
ascertain the specificity of the primers. Sample CT values were normalized 
against endogenous sigJ expression (whose levels were shown to be 
invariate across the starvation time course) and analyzed using the 
comparative CT method (see Chapter 2). 
5.3.11. Data handling, processing and statistical methods 
Data from survival and susceptibility assays were normalized as percentages 
of their respective untreated or initial CFU as determined by experimental 
design. Data from biochemical measurements, metabolite utilization and gene 
expression assays were deflated as fold changes against Log values. 
Logarithmic transformations were used for datasets with skewed or wide 
distributions and indicated in their respective figures legends. Single cell 
features quantified by flow cytometry were summarized as median 
fluorescence intensities for their respective gated subpopulations. Gated 
features represented as percentages of the total population. Comparisons 
between 2 samples were made using the appropriate two-tailed t tests after 
equality of variances were tested using F-tests. Comparisons between 
multiple samples were determined using One-way or Two-way ANOVA when 
comparing 1 or 2 factors respectively. Bonferroni’s or Dunnett’s Multiple 
Comparison or Tukey’s HSD post-hoc tests were used where it best reflects 
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how sample means were compared and stated in their respective figure 
legends. Trends in antibiotic tolerances were determined using Mann-Kendall 
trend test. Unless otherwise stated, all data are represented as arithmetic 
means± SE. To aid interpretation on statistical significances, p< 0.05, p < 
0.01 and p < 0.001 are denoted as *, ** and *** respectively. 
Descriptive, univariate, one- and two-way ANOVA were performed on Prism 
v.5.1 (GraphPad). Hierarchical clustering was performed using background-
subtracted, mean-centered data of tetrazolium dye reduction based on 
colormetric measures at A565. Heat-maps plotted using MultiExperiment 
Viewer (Dana-Farber Cancer Institute). One and two-sample Kolmogorov-
Smirnov test, Mann-Kendall Trend analysis, Grubb’s Test for Outliers, Box-
Cox transformations and RDA were performed using XLSTAT (Addinsoft). 
PCA and PLS-DA were performed using Unscrambler® X. 
For metabolic phenotypes, data was computed as fold-changes against the 
mean values of each respective metabolite across all Log cultures. Samples 
were assigned groupings based on their respective timepoints. To better 
quantify the contributions of each PLS-DA predictor, orthogonal projections to 
latent structures discriminate analysis (OPLS-DA) was performed using 
SIMCA-P+ v12 (Umetrics) and the VIP values presented in Table S1 [26, 27]. 
Differential expression analyses were carried out using DeSeq 
(http://genomebiology.com/2010/11/10/r106). The 3 replicates in each 
timepoint were compared against 3 control replicates as independent DeSeq 
statistical tests. Local fit option was used to estimate dispersions in order to 
reach convergence.  Genes of interest are defined with at least 1.5 fold up- or 
down-regulation, and with multi-testing adjusted p values ≤0.05.  
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GSEA (Broad Institute) was performed for targets identified by RNA-seq by 
pair-wise comparisons of Log samples against S4, S10, S20 and R6 samples. 
1000 permutations were performed. The genes, which are associated with the 
ketone body-CYP reactome are identified by RNA-seq based on a 
combination of significant gene expression change upon starvation (absolute 
fold change > 1.5 at any one time point; p <0.05) and comprehensive 
functional annotation searches against the DAVID 
(http://david.abcc.ncifcrf.gov/), Reactome (http://www.reactome.org/), TbDB 
(http://www.tbdb.org/), Tuberculist (http://tuberculist.epfl.ch/), BioCys 
(http://biocyc.org/) and KEGG (http://www.genome.jp/kegg/) databases. 
Genes whose functions and expressions fits previously reported phenotypes 
were defined as the high-confidence ketone body-CYP reactome genes and 
used as a gene set.  
To integrate the various datasets for exploratory analysis, gene expression 
and metabolic phenotype and antibiotic tolerance data were expressed as 
fold changes against the means of Log samples. Fold change of gene 
expressions was further log2 transformed, while fold change of antibiotic 
tolerances were log10 transformed. Due to negative values after 
compensation, cell populations detected with flow cytometry were Box-Cox 
transformed. Prior to PCA, Kolmogorov-Smirnov test and Grubb’s Test for 
Outliers were used to identify and remove samples with values deviating from 
the norm or group that likely came from technical errors. 
Cluster analysis was performed using two-way hierarchical clustering with 
Euclidean distances and complete linkages. Exploratory data analysis was 
performed with PCA using the NIPALS method. Metabolic utilization 
predictors for cell state were determined using PLS-DA and tested on 
independent S30 and Log samples. Multiple regression was performed using 
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RDA after parsimonious canonical correspondence analysis was used to 
determine the minimal number of genes that explain observed variances in 
population phenotypes. Gradient lengths of variables were estimated by 
detrended correspondence analysis (DCA). 
Screening PCAs were performed with gene expression of all 3138 genes 
significantly up-or down- regulated as the explanatory variable and antibiotic 
tolerance and population characteristics (measured by flow cytometry) as the 
response variable. The “find outlier” function in Unscrambler® X was used to 
eliminate genes that caused over-fitting while a second application on the 
remaining genes identified putative influencers. There were manually 
inspected using residue-variance plots and T2 statistics to remove erroneous 
data. 235 genes remain. Similarly, metabolic phenotypes were used to 
explain antibiotic tolerance and population characteristics. 7 metabolic 
phenotypes were selected. Thereafter, to characterize antibiotic tolerance and 
population characteristics and metabolite utilization in terms of gene 
expression a gradient analysis was performed with DCA. A PCA triplot was 
made using these datasets using centered and standardized data on the 
same measurement scales (Supplementary Figure 5.5M).  
The 235 genes were then subjected to RDA. The amount of variation in 
observed phenotypes uniquely explained by each variable in the model and 
the amount of variation explained by all explanatory variables in common 
were assessed with the method of 'variation partitioning' according to the 
procedure of Borcard [28]. Significant variables were selected using the 
Canoco 5 (Microcomputing Power) with p < 0.05 as the significance threshold 
over 1000 Monte Carlo Permutations. 68 genes which together explained 
96% of the observed variance were selected. To aid visualization, a RDA 
triplot was plotted with the observed antibiotic tolerance, metabolic utilization 
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and population phenotypes as independent variables and gene expression as 
the dependent variable. 
5.4. Results 
5.4.1. A data-driven approach to characterize starvation-induced 
persistence in mycobacteria 
How does starvation lead to persistence in mycobacteria? We addressed this 
problem with a three-pronged approach that started with defining growth 
kinetics and cytotoxicity of rapid nutrient deprivation in three species of 
mycobacteria – the epidemic Mtb strain CDC1551 [29], the attenuated 
vaccine M. bovis BCG (Pasteur 1173P2; BCG) and the fast-growing M. 
smegmatis (mc2155; SMG) – in simple phosphate-buffered saline (PBS). 
Using these models, we then pursued a data-driven analysis of the 
mycobacterial stringent response – hallmarks of a coordinated 
reprogramming of metabolic pathways [6, 30]. This data-driven approach was 
divided into exploratory and confirmatory phases (Figure 5.1A). The 
exploratory phase involved the acquisition, mining and analysis of flow 
cytometry to assay enzyme activity and ROS levels in persister populations 
(McBee et al., unpublished), phenotype arrays to determine metabolic 
potential [31, 32], and RNAseq to characterize gene expression. An 
integrative analysis revealed previously uncharacterized pathways and 
generated several testable hypotheses. In the confirmatory phase, these 
hypotheses were tested by targeted measurements of physiological and 
biochemical properties of starved mycobacteria.  
5.4.2. Evaluating mycobacterial models for starvation-induced 
persistence 
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From its inhalation as aerosols to phagocytosis by alveolar macrophages in 
the lung and subsequent containment in granulomas during latent infection, 
mycobacteria are exposed to drastic changes in their microenvironments 
including nutrient availability. Compared to well-defined hypoxic stress 
models [33, 34] few studies have addressed biochemical characterization and 
phenotypic profiles of starved mycobacteria outside of the Mtb H37Rv strain 
[19, 35]. To this end, we defined growth kinetics and cytoxicity of rapid 
nutrient deprivation Mtb, BCG and SMG in PBS.  As shown in Figures 5.1B-
H, starvation in PBS caused a classic biphasic decline similar to that 
observed in other bacteria [36, 37]; [38, 39]. This is defined by a rapid 
decrease in both optical density (OD600) and culturable colony forming units 
(CFU) in the initial phase (~4 d for Mtb, BCG; ~2 d for SMG) and subsequent 
stabilization at ~16%, 10% and 31% of initial CFUs for Mtb (days 10-22), 
BCG (days 10-30) and SMG (days 2-6), respectively (Figures. 5.1B-5.1G). 
The steep decrease in OD600 and CFU in the first phase of starvation led us to 
address cannibalism as a source of biomass for bacterial population 
maintenance in nutrient deprivation models [36]. Unlike Bacillus subtilis, in 
which starvation induced cannabalism [40], we found no evidence of this in 
terms of additional cell death caused by washing starved bacteria and 
resuspending them in fresh PBS (see 5.5.1. Extended results and 
Supplementary Figure 5.1A). While previous reports suggested no loss of 
Mtb viability during starvation in vaguely defined medium [14, 19], we found 
that this phenotype was strictly dependent on the presence of Mg2+ and Ca2+ 
ions, which are components of Dulbecco’s PBS (DPBS) but not true PBS 
used here (see 5.5.1. Extended results and Supplementary Figures 5.1B, 
C). Divalent cations thus represent a major determinant of survival of 
mycobacteria under nutrient starvation in vitro and possibly in vivo. 
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Throughout the starvation period, Mtb, BCG and SMG all retained their ability 
to regrow when transferred in nutrient replete 7H9 media (Figure 5.1H). To 
rule out a stress-induced transition into a viable but  non-culturable (VBNC) 
state [1, 41], we compared growth profiles of exponentially growing BCG 
(denoted as Log) to BCG starved for 4, 10, 20 and 30 d (denoted as S4, S10, 
S20 and S30) and then, for each time point, placed in 7H9 medium for 2, 4, 6, 
and 10 d of resuscitation growth (denoted as R2, R4, R6 and R10). As shown 
in Figure 5.1H, we observed no significant changes in doubling times, which 
ranged from 23 to 29 h (p > 0.05). This suggested a minimal contribution of 
VBNC bacteria to the overall starvation-induced persistent phenotype.  
To address the second feature of persistence, we assessed antibiotic 
tolerance in BCG cultures with 4 clinically relevant antibiotics: isoniazid (INH), 
rifampicin (RIF), streptomycin (STM) and ethambutol (EMB). Compared to 
log-phase cells, starved BCG at S4, S10 and S20 were refractory to antibiotic 
killing by INH, RIF, STM to EMB across a wide range of antibiotic 
concentrations (Figures 5.2A-D, ranges of drug concentrations tested 
provided in figure legends). Their non-replicating nature and high levels of 
tolerance – often beyond the solubility of these antibiotics in PBS (within non-
cytotoxic concentrations of DMSO) – made direct comparisons by MIC50 and 
MBC90 impracticable. Nonetheless, there was a striking, time-dependent 
increase in antibiotic tolerance as cells adapted to nutrient deprivation. When 
treated with a minimal bactericidal dose of INH (MBC99), 96% of killing occurs 
within 24h. By 48h, another 75% of the surviving bacteria are lost. In contrast, 
at S10 and S20, only 39% of the viable cells were lost on the first day and 
only an additional 17% were lost on the second day. Cells at S4 displayed an 
intermediate phenotype. Similar trends can be observed with RIF, STM and
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Figure 5.1. Mycobacterial persistence study design based on the 
survival and recovery of Mtb, BCG and SMG during and after starvation. 
(A) Experimental workflow starting with the development of a starvation-
induced mycobacteria persistence model, followed by characterizations of 
cellular physiology, metabolite utilization and gene expression. Data was 
pooled and exploratory data analyses performed. Hypotheses were 
generated, validated on targeted biochemical measures and explicitly tested 
for predicted stress susceptibilities. (B-G) Survival profiles (OD600 and CFU) of 
Mtb (B and C), BCG (D and E), SMG (F and G) under nutrient deprivation in 
PBS. (H) Recovery profiles of BCG after 4, 10, 20 and 30 days of starvation in 
PBS (denoted as S4, S10, S20 and S30 respectively) followed by 2, 6 and 10 
days of resuscitation in 7H9 broth (R2 , R6  and R10 ); Mtb after 20 
days of starvation (S20) and followed by 2 and 6  days of resuscitation (R2 
 andR6 ); SMG after 6 days of starvation (S6) and followed by 9 and 
24 hours of resuscitation (R9h  and R36h ). No significant differences 
in doubling times observed; p > 0.05 (one-way ANOVA with post-hoc Tukey's 
HSD). Data shown as arithmetic means of ≥ 3 independent experiments ± 
SE.
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EMB exposures (Supplementary Figures 5.1D-G). These results indicated 
that starvation shifts this dynamic toward a drug tolerant phenotype prior to 
antibiotic exposure, rather than as a response to the exposure. Of relevance 
to tuberculosis relapse, we tested whether the drug tolerant state was 
reversible. Indeed, the susceptibility to all 4 drugs reverts in resuscitated (R6) 
cells (Figures 5.2A-D). Thus, starvation induces a state of reversible 
persistence with phenotypic drug tolerance in mycobacteria. 
5.4.3. Biphasic modulation of the molecular hallmarks of starvation 
survival 
Having established the mycobacterial models of starvation-induced 
persistence, we next interrogated key modulators of the stringent response in 
relation to the biphasic mycobacterial growth behavior. While nutrient 
deprivation induces characteristic alterations in physiology through the up-
regulation of Rsh homologs (RelBCG in BCG) that regulate the intracellular 
levels of pp(p)Gpp [13, 42, 43], there are several ubiquitous hallmarks of 
starvation stress including loss of rRNA, toxin-antitoxin induction, and 
cessation of cell division. Consistent with these findings, we observed that the 
stringent response dominated the initial adaptive phase to nutrient deprivation 
(Log to S4) in BCG. Using RNAseq and qPCR, we observed that relBCG 
transcription peaked at S4 (Figure 5.2E) and was associated with a 
concomitant 40% reduction in total RNA content compared with log-growing 
bacilli. After S4, no further decreases in total RNA occurred (p < 0.05 for Log 
vs S4, S10 and S20; p > 0.05 for S4 vs S10 and S20). However, RNA 
returned to pre-starvation steady-state levels within 6 d of resuscitation (R6) 
(Figure 5.2F). These changes in total RNA could be parsed into individual 
species of non-coding RNA, with rRNAs (23S, 16S, 5S) all exhibiting the 
same pattern (Supplementary Figures 5.1H-J). However, tRNA levels only 
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decreased at S10 and S20 (Supplementary Figure 5.1K). Similar to relBCG, 
synchronous induction of toxin-antitoxin modules (relBE2, mazEF6, vapBC3, 
vapBC31) and repression of ftsZ, which encodes a major cytoskeletal protein 
essential for cell division [44], occurred at S4 (Figure 5.2E). In line with these 
observations, we detected a decrease in intracellular ATP at S4 but not at 
S10, S20 or R6 (Supplementary Figure 5.1L). Thus, we refer to the 
“adaptive phase” of starvation as the initial decrease in cell viability, the 
activation of the stringent response, and the development of drug tolerance. 
The “persistent phase” is characterized by population stability, greater drug 
tolerance, and a rebound in intracellular ATP (Supplementary Figure 5.1L). 
Interestingly, subpopulations of cells had increases in basal intracellular ROS 
(CellROXhi) generation of ~8% at S4 and S10 and ~40% above Log and R6 
basal levels at S20 (Figure 5.2G, Supplementary Figures 5.2C-J). 
Additionally, no accompanying changes in catalase activities or katG 
expression were detected (Supplementary Figure 5.1M, Figure 5.6C). 
Collectively, these results suggest a transition from the adaptive phase 
leading to an altered metabolic state in the persistent phase. 
5.4.4. Lipid catabolism and ketone body usage define the metabolic 
transition from the adaptive to the persistent phase 
We next sought to unravel the progression of metabolic events leading from 
the adaptive to the persistent phase of starvation-induced persistence. Here 
we used flow cytometry for analysis of intracellular metabolism at single-cell 
resolution and phenotypic arrays for population-based assessment of cellular 
metabolic potential. Flow cytometric analysis supported the notion of a 
dynamic shift in persisters formation during starvation, with coalescence in 
the population forward- and side-scatter parameters (Supplementary 
Figures 5.2A and B) implying a greater uniformity in cell size and granularity 
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Figure 5.2. Development of antibiotic tolerance coincides with stringent 
response induction and increased basal ROS levels. (A-D) Starvation of 
BCG induces viable but reversible persisters. Antibiotic susceptibility profiles 
of Log, S4, S10, S20 and R6 BCG after 48h of exposures to 0.05 - 1.6 µg/mL 
of isoniazid (A), 0.13 - 4.0 µg/mL rifampicin (B), 0.5 - 16 µg/mL streptomycin 
(C) and 1.0 - 32 µg/mL ethambutol (D). Starved (S4, S10 and S20) bacilli 
tend to be drug tolerant, seldom killing > 90% within these ranges of drug 
concentrations (n ≥ 6). (E) Induction of the stringent response, mediated by 
relBCG, its associated effectors including toxin-antitoxin systems relBE2, 
mazEF6, vapBC3 and vapBC31 and repression of its targets such as cell 
division marker ftsZ measured by RNA-seq. (F) Reduction in total cellular 
RNA levels at S4, S10 and S20 and its restoration at R6. Changes in major 
non-coding RNA components are found in Supplementary Figures 5.1H-K. 
(G) Percentage of cells with elevated steady-state ROS production 
(CellROXhi) during and after starvation. For (E-G), n ≥ 3; *, ** and *** denotes 
p-values (see Experimental Procedures) determined by One-way ANOVA 
with Dunnett's test vs Log. 
in the starved state. Moreover, starvation enriched for cells possessing high 
esterase activity (CFDAhi; Log – 16%, S4 – 75%, S20 – 82%), which reverted 
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upon resuscitation (Figure 5.3A, Supplementary Figures 5.1K-Q). 
Contributing to the increased esterase activity are lipases active on 
triacylglycerols (TAGs), which are a known carbon source during resuscitation 
from a hypoxia-induced non-replicative state [23, 45]. As shown in Figure 5.4, 
we detected starvation-induced up-regulation of several lipases, including 
PE/PPE family lipases lipY and lipX, as previously reported [14], with LipY 
active on TAGs [46]. These observations were further confirmed using thin 
layer chromatography (TLC) to reveal that TAG stores were depleted within 1 
day of starvation and replenished within 2 days of resuscitation (Figure 5.3B, 
Supplementary Figure 5.1N). TAGs are thus a potential carbon source in 
the adaptive phase of mycobacterial starvation. 
Since TAG metabolism generates toxic intermediates [47] and TAG depletion 
early in starvation raises questions about metabolism in the persistent phase, 
we assessed the capability of persistent BCG to metabolize various 
substrates using phenotype arrays. We surveyed 71 different metabolites for 
growth and metabolic activity and found that 41 were metabolized and 32 of 
these also supported growth (Figure 5.3C). Hierarchical clustering (Figure 
5.3C) and principle component analysis (Figures 5.3D and E) of the 
metabolic phenotypes again revealed the biphasic behavior in starvation 
survival observed in earlier studies, with the adaptive phase (S4) and 
persistent phase (S10 and S20) clearly distinguished from exponentially 
growing cells (Log, R6) based on their metabolite utilization capabilities 
(Figures 5.3C-E). One notable feature of the persistent phase bacilli was 
their ability to utilize the ketone bodies acetoacetate (AcAc) and 3-
hydroxybutyrate (3HB) for growth. Partial least squares discriminate analysis 
(PLS-DA) of the 41 metabolitically active substrates selected AcAc and 3HB 
utilization as predictors of the persistent phase (S10 and S20) (Figure 5.3E; 
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see Supplementary Table 5.1 for contributions from each predictor). 
Furthermore, the model successfully discriminated between Log and S30 
samples obtained from independent experiments (Log-4 and S30-1 in Figure 
5.3E). The validity of this model was confirmed in direct assays of intracellular 
3HB, which showed accumulation in S20 persisters (Supplementary Figure 
5.1O). 
 
Figure 5.3. Starvation induces shifts in lipid and ketone body 
metabolism. (A) Percentage of cells with elevated esterase activity (CFDAhi) 
during starvation and resuscitation. A greater number of cells in S4 and S20 
BCG cultures (day 0) show significant shifts in esterase activity (assayed by 
flow cytometry). n = 6; #: p < 0.001; starvation accounts for 46.9% of total 
variance (two-way ANOVA with Bonferroni post-tests comparing starvation 
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and time interactions). Esterase activity changes upon resuscitation for S4 
and S20 but not Log cultures (n = 6; ns: not significant; **, one-way ANOVA 
with post-hoc Tukey's HSD). (B) TAG content of BCG during starvation ( ) 
and resuscitation ( ) analyzed by TLC. Densitometric means of 3 
independent experiments ± SE. Representative TLC images in Figure S1N. 
For (A) and (B) **p < 0.01, one-way ANOVA with Dunnett's test (sample 
means vs day 0). (C) Hierarchical cluster analysis of the metabolic 
phenotypes of Log, S4, S10, S20 and R6 cultures on carbon sources that 
induced growth. Carbon source utilization measured by the reduction of 
tetrazolium dye. Red (higher), black (equal) or green (lower) blocks represent 
dye reduction relative to the positive control. (D) PCA scores plot and (E) Bi-
plot of PLS-DA scores and loadings of metabolic phenotype based on carbon 
sources with significant dye reduction (one-way ANOVA with Bonferroni post-
test). The positions of eigenvectors ( Log,  S4,  S10,  S20 and ▼R6) 
in relation to each other have similar metabolic phenotypes (Log and R6; S10 
and S20). S4 cultures are dissimilar to both groups. 96% of observed 
variance can be explained by 3 principle components (n = 3, PC-1: 69%, PC-
2: 22%, PC-3: 5%). The PLS-DA model shown in Panel E is based on 
correlation coefficients between PCA scores and loadings contributions by 
carbon sources (●), wherein proximities of phenotypic eigenvectors (scores) 
and metabolite utilization activities (loadings) represent the contributions 
(relative weights) of the carbon source utilizations that characterize the 
Log/R6, S4, S10/S20 states. These predictors were used to successfully 
differentiate independent Log and S30 samples. 
5.4.5. RNAseq identifies novel ketone body metabolic pathways in 
nutrient-deprived BCG 
To gain further insights into the molecular mechanisms underlying lipid 
metabolism in starvation-induced persistence, we performed RNAseq on Log, 
S4, S10, S20 and R6 BCG to characterize changes in gene expression 
caused by starvation. Appending the reads from independent technical 
duplicates of each of 3 biological replicates, 1-2 million read pairs with a 3’-to-
5’ ratio of 1.02 ± 0.03 for each sample and >90% coverage of the 
transcriptome for all time points were obtained (Supplementary Table 5.2). 
Amidst the global reduction of transcriptional activity (Supplementary Figure 
5.3A), we noted characteristic changes several well-studied genes altered by 
carbon starvation, including relBCG, sigma factors sigA and sigF (rpoS 
homolog) and molecular chaperones hspX and dnaK (Figure 5.4) [14, 48, 
49]. We also observed contributions from WhiB-family transcription factors, 
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cAMP signaling, Lsr2 repressor, PhoPR, TrcPR and KdpDE two-component 
signaling, which could facilitate global transcriptional reprogramming (Figure 
5. 4). Further, we performed DAVID functional annotation and gene functional 
classification on 511 up-regulated genes (fold-change ≥1.5 and p ≤0.05) and 
680 down-regulated genes (fold-change ≤0.66 and p ≤0.05) and cross-
validated these pathway enrichments using KEGG Pathway Mapper [50, 51]. 
Specifically, analysis of core sets of genes either up-regulated during 
starvation and down-regulated during resuscitation, or down-regulated during 
starvation and up-regulated during resuscitation, revealed altered carbon and 
nitrogen metabolism, substrate translocation across membranes, 
environmental and intracellular signal transduction, increased DNA repair and 
RNA, protein, lipid and xenobiotic degradation (Supplementary Figures 5.3B 
and C). Of particular interest here was the selective enrichment of pathways 
involved in ketone body synthesis and degradation during starvation 
(Supplementary Figure S3C). Ketone bodies are products of fatty acid β-
oxidation and their accumulation causes a toxic ketoacidosis (3HB, pKa 
=4.70; AcAc, pKa = 3.58; cytoplasmic pH = 6.1-7.2) [52]. Given the utilization 
of intracellular lipid stores during starvation, ketone body generation was not 
surprising.  
Ketone body detoxification has not been characterized in mycobacteria or 
annotated in databases. An analysis of the RNA-seq and other data, along 
with literature precedent, suggested a novel pathway for detoxification of 
ketone bodies in mycobacteria. The analysis starts by considering two 
annotated pathways operant in other prokaryotes but not mycobacteria. First, 
AcAc can be avoided by conversion of acetoacetyl-CoA (AcAc-CoA) to 3-
hydroxy-3-methylglutaryl-CoA (HMG-CoA) through the mevalonate pathway 
or by breakdown of AcAc-CoA to acetyl-coA (Ac-CoA) that then enters the 
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TCA cycle via the action of acetyl-CoA C-acetyltransferase (thiolase II; FadA - 
A6). However, mycobacteria do not utilize the mevalonate pathway and 
acetyl-CoA acetyltransferase also catalyzes the reverse Claisen condensation 
(Ac-CoA to AcAc-CoA) in a substrate-dependent manner [53, 54]. Second, 
3HB can be polymerized into poly-3-hydroxybutyrate (PHB) granules [55]. 
However, the RNA-seq data do not show any changes in expression of very 
long chain acyl-CoA dehydrogenases and synthases that would catalyze this 
reaction, or changes in expression of homologs of PHB depolymerase that 
would catalyze the subsequent breakdown of PHB in BCG. We propose a 
novel third detoxification pathway in mycobacteria, in which AcAc is 
decarboxylated to acetone that is further oxidized by cytochrome P450s 
(CYPs) to acetol. Baeyer-Villager monooxygenases (BVMO) then convert 
acetol to hydroxymethylene acetate, which decomposes spontaneously into 
formaldehyde and acetic acid. Formaldehyde is further detoxified by 
formaldehyde dehydrogenases into formate, which is utilized in 
tetrahydrofolate (THF) based one-carbon metabolism (Figure 5.4). 
This ketone body metabolic pathway is supported by our experimental data. 
First, there is strong evidence for up-regulation of the key metabolic enzymes, 
including significant up-regulation in the expression of 3 class II thiolases, 11 
CYPs, 3 P450-linked oxidoreductases and 5 BVMOs (Figure 5.4; 
Supplementary Figure 5.4), previous reports on mycobacterial acetol 
metabolism [56, 57], and current observations on 3HB utilization and 
accumulation (Figure 5.3C; Supplementary Figure 5.1O). Moreover, 
metabolism of alcohols and acetone by mammalian CYPs is well established 
and known to produce superoxide anion radicals [58-62], which fits our 
observation of increased basal ROS production in persisters (Figure 5.2G). 
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 Figure 5.4. Transcriptome analysis reveals ketone body metabolic pathways linking β-oxidation of fatty acids to C1 cycling by 
tetrahydrofolate. Starvation induced global transcriptional reprogramming. Canonical effectors, such as relBCG, sigma factors (sigA and sigF) 
and chaperones (hspX and dnaK) together with transcriptional regulators (whiB-family proteins, cmr and lsr2) and two-component signalers 
(phoPR, trcPR and kdpDE) are implicated. Transcript levels of a number of enzymes involved in fatty acid β-oxidation increased transiently. 
echA2, echA5, fadA, fadA4, fadA5 and fadA6, involved in the hydration and thiolysis steps are shown. Correspondingly, transitory up-
regulations of succinyl-CoA:3-ketoacid-CoA transferase, putative 3-hydroxybutyrate dehydrogenase, putative acetoacetate decarboxylase, 
CYPs, BVMOs and putative formaldehyde dehydrogenases were observed. Metabolism of formate and acetate (Pathway [A] and [B]) are 
further supported by up-regulations of enzymes functioning in interacting pathways. 3HB alternately, could be oxidized directly by CYPs (Figure 
S4A) and participate in lactate metabolism (Supplementary Figure 5.4B, Pathway [C]). Heat maps show expression levels of various 
enzymes at Log, S4, S10, S20 and R6. Orange, blue and white blocks represent up-regulation, down-regulation and no change in transcript 
levels relative to Log respectively. Putative functions of BCG_1967c, BCG_3583, BCG_1818, BCG_0610c, BCG_0944, BCG_1454c, 
BCG_3073c, BCG_3019 and BCG_0498 predicted through homology.
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Unlike the metabolism of AcAc to methylglyoxyl in mammalian liver 
microsomes, mycobacterial BVMOs prevent the formation of this bactericidal 
electrophile [63]. Furthermore, we detected a coordinated increase in acetyl-
CoA synthase (acs), and alcohol and aldehyde dehydrogenases (adhD, 
adhE1, aldA and BCG_0498) that metabolize acetate and formaldehyde, the 
breakdown products of acetol, to acetyl-CoA and formate, respectively 
(Figure 4; Supplementary Figure 5.4). The RNA-seq data also revealed up-
regulation of folD, a multi-functional enzyme that sequesters formate for one-
carbon transfer reactions (Supplementary Figure 5.4). Thus, the data point 
to a coordinated gene regulatory response for a CYP-based ketone body 
detoxification pathway in the persistent phase of mycobacterial starvation. 
5.4.6. Meta-data analysis builds consensus for a model of starvation-
induced ketosis 
The exploratory phase of the studies (Figure 5.1A) continued with meta-
analyses of the various datasets. To determine if this ketone body 
detoxification pathway and its associated interactions were significantly 
enriched during starvation, we mapped the pathway onto the intermediary 
metabolism reactome, and performed Gene Set Enrichment Analysis (GSEA) 
[64]. This revealed a gradual enrichment of 45 of the 63 genes in the 
reactome as high confidence targets, cumulating at S20 (NES = 1.6, FDR = 
0.055) (Figures 5.5A-C). Three CYP genes, cyp51, cyp125, cyp128, cyp132 
and cyp135A1, were featured in the core enrichment with rank metric scores 
(signal-to-noise ratios) greater than 3. In addition to confirming the previously 
reported shutdown of the TCA cycle [14], we also noted transient enrichment 
of the SigF and Lsr2 regulons peaking at S10 and S20, respectively (see 
5.6.1. Extended results and Supplementary Figures 5.5A-K). Furthermore, 
all gene set enrichments reverted at R6 (Figure 5.5D and Supplementary 
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Figures 5.5D, H and L), demonstrating the plasticity of transcription control 
mechanisms of the starvation stress response.  
We next pursued a multivariate analysis of the data. Unconstrained principle 
component analysis (PCA) of 3138 genes deferentially up- or down-regulated 
during starvation (>1.5 fold change; p < 0.05) identified cyp124, cyp128, 
cyp132 and cyp135A1 as strong influencers of the starvation phenotypes 
(Supplementary Figure 5.5M). Not only was cell state discriminated based 
on metabolic utilization, but antibiotic tolerance was correlated with the ketone 
body metabolism, increased basal ROS production, and esterase activities 
(Figure 5.5E and Supplementary Figure 5.5M). Importantly, we determined 
the genes that contributed to the drug tolerant phenotypes. When 235 highly 
influential genes (ascertained from PCA leverage and residue plots) were 
regressed against the observed phenotypes, 68 genes were correlated 
(squared cosines of > 0.5) with ethambutol, isoniazid, rifampicin and 
streptomycin tolerance (Figure 5.5E). These include known markers of drug 
resistance (inhA, embB, rpoB, rpsL, gidB, aphD, and katG), efflux 
transporters (mmpS5, mmpL5, BCG_1316c, BCG_2699c and BCG_2700c), 
enzymes involved in xenobiotic biodegradation (BCG_0610c, BCG_0944 and 
BCG_1454c), and CYPs (cyp51, cyp125, cyp128, cyp132 and cyp135A1). 
Multivariate regression by redundancy analysis (RDA) showed that cyp128 
and cyp135A1 were strongly correlated with both increased basal ROS 
production and 3HB metabolism (Figure 5.5E). Thus, by consensus, CYPs, 
particularly cyp128 and cyp135A1, play a role in ketone body degradation and 
antibiotic tolerance in persistence.  
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Figure 5.5. Ketone bodies utilization is associated with ROS production and 
CYP up-regulation. (A-D) Gene Set Enrichment Analysis (GSEA) determining 
the correlation between ketone body metabolism and gene expression change 
upon starvation. The GSEA plot indicates the degree to which members of the 
predicted ketone body-CYP reactome are over-represented at the extreme left, 
up-regulated at S4 (A), S10 (B), S20 (C) or R6 (D), or on the extreme right (up-
regulated at Log) of the entire gene set. Solid bars represent bound genes. NES: 
normalized enrichment score. FDR: false discovery rate. (E) Redundancy 





 : size of subpopulation with greater than basal 
steady-state ROS production or esterase activity; green arrows), tolerance to 
INH, RIF, EMB and STM (orange arrows), metabolite utilization for D-trehalose, 
glycerol, Tween 40, acetic acid, propionic acid, AcAc and 3HB (black arrows) and 
gene expression (blue circles). cyp135A1 and cyp128 () are highlighted through 
consensus to play a role in ROS generation (discussed in the text). Axes 
represent the distribution of samples (S4, S10, S20 and R6). 96% of total 
variance is explained by canonical axes RDA-1 (56%) and RDA-2 (40%). 
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5.4.7. Multivariate regression correlates antibiotic exposure, ROS 
production, and starvation  
To explore the relationship between antibiotic tolerance, ROS production and 
starvation, we extended the RDA mentioned earlier. In RDA correlation 
triplots, the cosine of the angle between two vectors is approximately equal to 
the correlation between the corresponding variables [65]. The cosine between 
the vectors representing INH, EMB, RIF and STM tolerance in starvation and 
starvation-induced CellROXhi were 0.89, 0.92, >0.99, and 0.71, respectively, 
suggesting that RIF is more likely than STM to induce ROS, especially in 
starved bacilli (Figure 5.5E). The predictions were assessed by measuring 
steady-state levels of ROS in antibiotic treated Log cells, which revealed that 
treatment with RIF, INH, and EMB, but not STM, induced cells to generate 
higher than basal levels of ROS in a dose-dependent manner (Figure 5.6A). 
Interestingly, only RIF induced ROS generation above basal levels in S20 
BCG (Figure 5.6B). S4 and S10 cells behaved in a similar manner 
(Supplementary Figures 5.6A-D). These findings are of biological 
significance as they parallel previous observations that antibiotic susceptibility 
is linked to oxidative stress [20, 66]. Indeed, 24 of the 68 genes selected for 
RDA by parsimony are involved in antioxidant defense, including thioredoxins, 
superoxide dismutases and enzymes involved in mycothiol and ergothioneine 
biosynthesis (Figure 5.6C). However, these genes explain only ~40% of the 
observed variance in the CellROXhi phenotype. Therefore, differential 
responses in ROS production upon antibiotic treatments could not be 
explained solely by the regulation of these antioxidant genes, indicating the 
involvement of other metabolic factors in the generation of ROS under 
antibiotic stress in starved mycobacteria.
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 Figure 5.6. ROS production under antibiotic stress. (A and B) 
Percentage increments in cells with CellROXhi phenotype after 48h of 
exposure to INH (), EMB (), RIF () or STM () at the indicated 
concentrations in Log (A) and S20 (B) cultures (n ≥ 8). (C)  Transcript levels 
of genes involved in antioxidant defense across the starvation time course. 
Gene expression heat maps of antioxidant defense genes featured by 
parsimonious RDA (Figure 5.5E). Similar to Figure 5.4, colors of blocks 
represent extent of transcriptional regulation.
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5.4.8. Biochemical and genetic validation of the CYP-mediated ketone 
body metabolism model of mycobacterial persistence 
With only ~40% of the starvation-induced phenotype attributable to oxidative 
stress response pathways we initiated the confirmatory phase of our studies 
(Figure 5.1A) by testing the hypothesis that altered metabolic processes 
contribute to increases in basal ROS generation. RDA highlighted a strong 
correlation between 3HB metabolism and the number of cells with increased 
basal ROS production (CellROXhi) (Figure 5.5E), which was validated by 
starvation-induced increases in 3HB levels (Fig. S1O). Since a ketotic state is 
also characterized by ketoacidosis, we measured the intracellular pH of BCG 
before, during and after starvation using flow cytometry with SNARF-5F. 
Starved cells in the persistent phase had a decrease in intracellular pH 
compared with cells in nutrient replete media (6.9 ± 0.1 vs 7.5 ± 0.1, Figure 
5.6A). As a corollary, we mined the data from phenotype arrays for the 
sensitivity of Log, S4, S10, S20 and R6 cells to low pH. As expected, starved 
cultures were more resilient at pH 5.0 than Log and R6 cells (see 5.5.1. 
Extended results and Supplementary Figures 5.7A-C). Thus, despite a 
>2.5-fold increase in intracellular 3HB levels, persistent BCG were better able 
to handle acidic pH stress. 
The CYP-mediated ketone body metabolism model also entails breakdown of 
acetol to formaldehyde, a toxic alkylating agent, with the formaldehyde 
converted to formate and subsequently shunted into THF-mediated one 
carbon metabolic reactions, as discussed earlier. Consistent with this model, 
we observed up-regulation of several NAD+-linked dehydrogenases that could 
oxidize formaldehyde to formate (Figure 5.4), as well as a coordinated up-
regulation in the enzymes involved in B12 biosynthesis for one-carbon (C1) 
metabolism (Supplementary Figure 5.4B). This detoxification pathway would 
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render starved bacilli less sensitive to killing by formaldehyde. Indeed, S20 
BCG were significantly more resistant to formaldehyde-induced cytotoxicity 
than Log BCG (Figure 5.7B).  
With CYP activity as a well-established source of ROS [59, 62], we assessed 
the role of CYP up-regulation in ketone body metabolism and ROS 
generation. We could not use the azole-based CYP inhibitors clotrimazole, 
econazole or miconazole for these studies since the drugs elicited modest 
killing (<10%) at relevant doses (see Supplementary Figures 5.7D-F). 
However, exposure to millimolar concentrations of H2O2 proved to be 
bactericidal to S10 and S20, but not to Log or R6 BCG (Figure 5.7C).  Hence, 
the cross-protection from acidification and formaldehyde did not extend to the 
biocidal activities of H2O2. Seemingly paradoxical, this idiosyncratic behavior 
can be explained as H2O2-facilitated killing through CYP inactivation [67]. 
While H2O2 specifically can be used as an electron donor to drive CYP activity 
by generating Cpd 0 directly from the ferric enzyme through the peroxidase 
shunt (Figure 5.4), the CYP heme group and catalytic cysteine residues are 
exquisitely susceptible to H2O2 inactivation by Fe-mediated reduction to 
generate locally damaging hydroxyl radicals or ferryl-oxo species (i.e., Fenton 
chemistry) [58]. This is especially plausible as all the preconditions for Haber-
Weiss or Bray-Gorin catalysis were met within the confines of the reactome, 
including an acidic pH, availability of ferric and ferrous ions, steady-state 
generation of superoxide anion radical (O2
●-) from CYP activity, except one – 
the presence of excess H2O2 [44, 68]. Of relevance here, genes coding for 
H2O2-producing enzymes were down-regulated in starved bacilli 
(Supplementary Figure 5.7G). Furthermore, H2O2 treatment significantly 
lowered steady-state ROS levels in starved but not Log or R6 BCG (Figure 
5.7D). More importantly, we found that 3HB accumulates within 4 h of H2O2 
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exposure, reaching over 600% of its initial levels 48 h post-treatment in S20 
but not Log or R6 cells (Figure 5.7E). Correspondingly, greater killing was 
observed at 48 h than at 4 h following H2O2 treatment (Supplementary 
Figure 5.7H). These results directly link H2O2 cytotoxicity to the inhibition 
ketone body degradation through CYP inactivation. 
Finally, to assess the relevance of our findings to Mtb, we quantified the 
expression of cyp128, cyp135A1, relA, and fdxA in Log, S4, S20 and R6 Mtb 
by qPCR. Similar to BCG, cyp128 and cyp135A1 expression levels were 
elevated during starvation compared with Log cells (Figure 5.7G). Elevated 
transcription of relA and fdxA were also confirmed in Mtb (Supplementary 
Figure 5.7I). Considering these findings, we propose a novel mechanism for 
the survival of persistent mycobacteria under nutrient deprivation, which 
implicates the accumulation and detoxification of ketone bodies by CYPs as a 
consequence of TAG utilization (summarized in Figure 5.7H). Signatures of 
these metabolic changes can be observed in the gene expression, 
metabolism and basal ROS production of these starved mycobacteria. 
5.5. Discussion 
The concept of persistence was presaged over 70 years ago when Bigger 
noted that prior exposure to physiological stresses in general (starvation, 
temperature, cytotoxic agents) “predestined” a larger bacterial subpopulation 
for enhanced survival [69]. For persisters, their antibiotic resistance profile is 
underscored by adaptive metabolic shifts required for stress survival [13, 30]. 
Here, we demonstrated that nutrient deprivation by culture in PBS 
predisposed mycobacterial populations to persister formation. And unlike 
previous studies
Page | 184  
 
 
Figure 5.7. CYPs contributes to ROS production and play an essential 
role in ketone body metabolism during nutrient deprivation. (A) pH of 
Log, R6, S17, S20 and S23 cells determined by SNARF-5F flow cytometry. 
Each symbol denotes the median pH of a sample of 50,000 cells (**, 
unpaired, two-tailed t-test with Welch’s correction). (B) Survival of Log and 
S20 cells to 4h formaldehyde exposures at indicated concentrations (*, 
unpaired, two-tailed t-test). (C) Survival of Log, S4, S10, S20 and R6 cells to 
48h of H2O2 (0.5 mM) exposure. BD: below assay detection limit of 1000 
CFU/mL (n = 6; one-way ANOVA with Bonferroni post-test). (D) Percentage 
of Log, S4, S10, S20 and R6 cells with elevated steady-state ROS production 
(CellROXhi) after 48h of either 0.5 mM H2O2 or mock (PBS) exposure (n = 8; 
*,**, ***, unpaired, two-tailed t-test between H2O2 or mock treatment groups 
with Welch’s correction). (E) Intracellular 3HB levels in Log, S20 and R6 cells 
after 4h and 48h of H2O2 exposures at the indicated concentrations. n ≥ 3; 
metabolic state of cells accounts for 32.3% and 54.4% of the total variance at 
4h and 48h respectively ( *,**, ***, two-way ANOVA with Bonferroni post-tests 
comparing cell state and H2O2 dose interactions). (F) Regulation of cyp128 
and cyp135A1 in Mtb and BCG at Log, S4, S20 and R6 as determined by 
qPCR (n = 3; *,**, ***, one-way ANOVA with Dunnett's test (sample means vs 
Log)).(G) Model of starvation induced ketone body metabolism in 
mycobacterial persisters. Upon nutrient deprivation, mycobacteria increase 
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the utilization of their triacylglycerol stores. A portion of the acetyl-CoA from β-
oxidation of fatty acids is converted to AcAc and 3HB (ketogenesis). These 
products lower the intracellular pH (acidosis). Over time, these ketone bodies 
are oxidized by CYPs and used to generate formate required for one-carbon 
cycling. The loss of CYP activity through H2O2 exposures causes persisters, 
otherwise able to survive for prolonged periods with little or no nutrients even 
in the presence of antibiotics, to lose viability. 
 in mycobacteria, these populations are generated according to a biphasic 
survival profile that follows well described double-exponential kinetics 
observed in other bacteria [70], and a starvation-induced antibiotic tolerance. 
However, these persisters are not transcriptionally or metabolically quiescent. 
Rather, we found signatures for a stringent response-initiated global 
transcriptional reprogramming associated with an altered metabolic state 
(Figure 5.3). By linking published disparate observations on lipid, lactate, 1,2-
propandiol, acetol, methylglyoxal, formate and carbon dioxide metabolism 
[24, 56, 57, 63, 71-75] with our analysis of persister physiology, biochemistry 
and gene expression, we conclude that a central feature of the response of 
mycobacteria to starvation involves a reliance on CYPs for protection from 
cytotoxic ketosis. Correspondingly, CYP disruption by H2O2-based 
inactivation renders the cells susceptible to the cytotoxic effects of nutrient 
deprivation (Figure 5.7). 
The transcriptional and metabolic remodeling underlying this starvation-
induced ketosis provide a context for understanding several unique features 
of the mycobacterial persistent state revealed by our data, including drug 
tolerance, the metabolic phenotype, and the interplay between nutrient 
deprivation and endogeneous acidosis. Several mechanisms have been 
proposed to explain the antibiotic tolerance of persisters [76]. First, the 
complex mycolic acid-containing cell wall of mycobacteria serves as an 
intrinsic pharmacokinetic barrier to antibiotics under normal growth conditions 
[77], with the structure and permeability of the cell wall changing significantly 
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under starvation conditions [16, 17, 78]. We observed a similar reduction in 
ROS-sensitive dye uptake in starved compared to exponentially growing 
mycobacteria, which we accounted for in the flow cytometric analyses 
(Supplementary Figure 5.2) (McBee et al, unpublished data). A second 
mechanism of drug tolerance involves ATP-binding cassette (ABC) 
transporters and other drug efflux pumps [79, 80], several of which we 
observed to be up-regulated during starvation (Supplementary Figures 5.3C 
and Figure 5.5E). RIF tolerance is facilitated through BCG_1316c efflux 
pumps (Mtb Rv1258c homolog) [81], which was significantly upregulated 
during starvation and highlighted by redundancy analysis (Figure 5.5E). 
Incidentally, clotrimazole, miconazole and econazole, which pentacoordinate 
heme and block the CYP catalytic cycle [82, 83], have unexceptional killing 
activities on mycobacterial persisters (Supplementary Figures 5.7D-F) 
possibly due to the strong up-regulation of transmembrane transporters 
mmpL5 and mmpS5 [84]. Third, persistence may repress or down-regulate 
drug targets [85]. For instance, the efficacy of aminoglycosides, such as 
streptomycin, is limited in starved mycobacteria (Figure 5.2C) possibly due to 
reduced translational activities, evident the decrease in cellular rRNA and 
tRNA content (Supplementary Figures 5.1H-K), and the transcriptional 
down-regulation of genes coding for ribosomal proteins such as rpsL 
(Supplementary Figure 5.6E), together with a change in cell wall 
permeability (McBee et al, unpublished data). Furthermore, GidB, embB, inhA 
and rpoB, genes associated with antibiotic susceptibility [86] were highlighted 
in our redundancy analysis and repressed during starvation (Figure 5.5E and 
Supplementary Figure 5.6E). We propose a fourth mechanism, whereby 
exogenous stresses cause metabolic shifts that induce xenobiotic 
degradation pathways leading to antibiotic tolerance. Network mapping of our 
RNA-seq data revealed that the degradation pathways for bisphenol, 
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chloroalkane and chloroalkene, aminobenzoate and polycyclic aromatic 
hydrocarbons were enriched in starved BCG (Supplementary Figure 5.3C). 
With parallels in human drug metabolism, these degradation and 
detoxification pathways often involve oxidative biotransformation by CYPs 
[87]. Another parallel to human drug metabolism arises in the starvation-
induced upregulation of mycobacterial conjugating enzymes, such as 
arylamine N-acetyltransferase (nat; 1.7-fold increase in S20 BCG, p = 1.4 x 
10-6), which uses INH as a substrate [88, 89]. Jointly, our results underscore 
the importance of bacterial pharmacodynamics and pharmacokinetics in 
antibiotic design and development. 
Antibiotic tolerance in persisters strongly parallels the novel metabolic 
phenotype of increasing steady-state levels of ROS and dependence on 
ketone body degradation, with lipolysis and ketogenesis as metabolic 
signatures of the mycobacterial adaptive and persistent phases of starvation, 
respectively (Figure 5.3). These processes lead to an accumulation of AcAc 
and 3HB, which acidifies the cytoplasm (Figure 5.7A). In turn, cells 
progressively up-regulate CYP-mediated ketone body detoxification pathways 
(Figures 5.5A-D) that inherently generate ROS [60, 62, 90]. Our models 
predict cyp135A1 and cyp128 as vital enzymes in ketone body detoxification. 
Cyp128 activity is predicted, based on proximity to the stf3 gene, to be the 
terminal oxidase of dihydromenaquinone-9 synthesis – the essential 
mycobacterial respiratory chain quinol electron carrier [91]. The precise 
reaction(s) catalyzed by Cyp135A1 is unclear. Based on Hausinger’s (2007) 
speculations, Cyp135A1 would catalyze the conversion of acetone to acetol. 
The lack of significant up-regulation in AcAc decarboxylase (BCG_3583) 
expression (Figure 5.4) led us to consider the possibility that 3HB could be 
oxidized by CYP135A1 instead. This would result either in the formation of 
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1,2-propandiol or acetol through a second oxidation event (Supplementary 
Figure 5.4A). This alternate reaction pathway fits previous observations of 
lactate, 1,2-propandiol and acetol metabolism in mycobacteria [57, 71, 75]. As 
mycothiol-dependent formaldehyde dehydrogenase mscR/adhE2 is down-
regulated during starvation (Figure 5.4), subsequent alkylating damage from 
the accumulation of formaldehyde is likely mitigated by its conversion to 
formate, not S-formylmycothiol. However, the fate of formate is uncertain. 
Due to down-regulation in fdhF, it is unlikely that formate is oxidized to carbon 
dioxide, resulting in the generation of NADH [92]. Hence, we propose a model 
in which formate is used for acetogenesis through carbon fixation. Dissimilar 
to the Eastern Woods-Ljungdhal pathway [93], formate from ketone 
degradation (rather than carbon dioxide reduction) is used by FolD and MetH 
to methylate THF then fix carbon monoxide to generate acetyl-coA 
(Supplementary Figure 5.4B). Carbon fixation was previously demonstrated 
to occur in mycobacteria in glycerol-limited chemostat cultures, though 
Woods-Ljungdhal acetogenesis was not implicated due to the lack of an 
annotated formate-THF ligase [72]. BioCys’ PathoLogic predicts that FolD 
possesses this activity [94]. Additionally, we observed coordinated up-
regulation in the genes required for cobalamin (coenzyme B12) synthesis, 
which is consistent with the generation of corrinoid proteins required for these 
methyl group transfers [93]. Though 5,10-methylenefolate could be siphoned 
off for amino acid and pyrimidine biosynthesis, we also noticed an up-
regulation in acetyl-coA synthetase (acs) transcription during starvation, 
which is suggestive of acetate buildup from acetogenesis (Supplementary 
Figure 5.4B). Though speculative, formate could be a potential source of C1 
for methylated THF in persisters. This warrants further investigation as it 
would not only expand the known metabolic plasticity of mycobacteria, but 
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also provide further insights into the underlying metabolic transitions required 
for the long-term survival of Mtb in hypoxic and nutrient-limiting granulomas. 
 
One might conclude, given the ability of mycobacteria to fix carbon dioxide 
under nutrient limited conditions [72], that pathogens of the Mtb complex 
could potentially persist indefinitely in granulomas. By reevaluating the 
interplay between acid stress and starvation our results highlight an 
unassuming limiting factor to survival – the availability of magnesium cations 
(Mg2+). In vivo, the macrophage compartment in which Mtb resides early in 
infection, ranges from pH 4.5-6.2, depending on the activation state of the 
macrophage [95]. In vitro, Mtb and BCG grow at pH 5.8-6.5 with growth 
retardation observed at ~pH 5.0 and below [96, 97]. Against a decreasing 
external pH, intracellular pH is maintained between pH 6.1 and 7.2 [52]. 
Survival, however, is contingent on population density, carbon sources in the 
test medium and the presence of Mg2+ ions [95, 98]. For instance, there is 
evidence that short starvation in phosphate-citrate buffer improves survival of 
mycobacteria at low pH [99, 100]. Conversely, when incubated in buffered 
media at the same pH with utilizable carbon sources, such as Tween 80, 
lactate or acetate, survival is compromised [95, 99, 101]. Our results 
confirmed that starved mycobacteria survive better during acidic pH stress 
(Supplementary Figures 5.7A-C). Starved cells accumulate acidic AcAc and 
3HB, while sustaining their intracellular pH above 6.0 (Figure 5.7A); below 
which is lethal for BCG and SMG [52]. Reminiscent of the phoP independent 
metabolic remodeling required for acid stress survival [102], we noticed a 
down-regulation of phoP during starvation (Figure 5.4), suggesting that there 
are common features to the adaptive responses to starvation and acid stress.  
One commonality is the need for Mg2+. Several actinomycetes have been 
shown to retain Mg2+ during starvation [38]. Furthermore, Mg2+, but not Ca2+, 
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Mn2+ or Zn2+, supplementation is required for growth of Mtb at pH 6 [98]. And 
veritably, we observed that more mycobacteria survived prolonged starvation 
in Mg2+-containing DPBS than in PBS (5.5.1. Extended results and 
Supplementary Figures 5.1B and C). Altogether, these results support a 
role for Mg2+ ions in intracellular pH homeostasis and thus, starvation survival.  
Just as Achilles possessed high-invulnerability to physical harm, persistent 
mycobacteria are extremely tolerant to physiological stressors, including 
prolonged starvation, antibiotics, acidic pH and formaldehyde. Yet, a deadly 
weakness lies in its formidable defenses – ketogenesis. The heavy reliance 
on cytochrome P450 for ketone body metabolism, while protective against 
ketosis, predisposes the cells to lethal oxidative challenges. These enzymes 
are widespread across bacterial pathogens, with E. coli being a notable 
exception, and utilized in a wide variety of biosynthetic and degradation 
pathways [58, 103]. Their essentiality to persister phenotype switching [104, 
105], however, has, until now, been unexplored. Thus, the challenge remains 
to convert these new insights into drug development approaches and 
practical clinical applications. 
5.6. Supplementary material 
5.6.1. Extended results 
5.6.1.1. Cannibalism is not a major source of nutrients for starved 
mycobacteria  
We evaluated the possibility that starved BCG found sustenance from the 
non-viable cells (~95% of initial CFU) in culture. After 20-days, cultures were 
split, pelleted and either washed and reconstituted to its prior volume in fresh 
PBS or re-suspended in its own (native) supernatant then starved for another 
20 days. The ratios of CFU recovered from cultures in fresh PBS against 
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those in their native supernatant did not differ (Supplementary Figure 5.1A). 
Conceivably, cannibalism would cause a further reduction in the population of 
washed cultures, hence, no cannibalization was observed. This suggests 
either metabolic quiescence or cellular autophagy as a means of subsistence 
during extended starvation.  
5.6.1.2. Divalent cations support survival during the adaptive phase of 
starvation 
Two forms of PBS are commonly used in research, PBS and Dulbecco’s PBS 
(DPBS; contains Mg2+ and Ca2+). In addition to starving BCG in PBS, DPBS 
was also evaluated as a carbon and nutrient deprivation media. When starved 
in Mg2+- and Ca2+-ion containing DPBS significantly more BCG survived when 
compared to PBS (Supplementary Figure 5.1B). This phenomenon was 
reproducible in SMG whereby >99% of the inoculum was recovered under 
DPBS starvation compared with 30% in PBS (Supplementary Figure 5.1C). 
This survival profile of SMG under nutrient deprivation in PBS is similar to 
prior characterizations performed by Stallings et al [106].  
5.6.1.3. Starvation adaptation alters antibiotic killing kinetics 
When Log bacilli were treated with a minimal bactericidal dose of INH 
(MBC99), 96% of killing occurs within 24h. By 48h, another 75% of surviving 
bacteria died. In contrast, at S10 and S20, only 39% of the viable cells were 
killed within 24 h followed by an additional 17% by 48 h. Cells at S4 displayed 
an intermediate phenotype. Similar trends were observed with RIF, STM and 
EMB (Supplementary Figure 5.1D-G). These findings indicate that the drug 
tolerant phenotype is linked to dynamic changes during adaption to starvation 
rather than as a response to the antibiotic exposure. 
5.6.1.4. Acid tolerance in BCG persisters 
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The detection of acidosis in BCG persisters led us to investigate if starved 
bacilli are better adapted to survive lower pH environments. We retrieved data 
regarding pH sensitivity from the GENIII microplates metabolic phenotype 
screen (see Discussion in main text and Figure 5.3). Whereas no changes 
in cellular viability (recoverable CFU) were detected in pH 6.0 media, starved 
BCG were more tolerant to pH 5.0 than Log and R6 (Supplementary Figure 
5.7A). This is also reflected in the optical densities and tetrazolium reduction 
capabilities (used as an indicator of cellular respiration [31, 32]) 
(Supplementary Figure 5.7B and C). 
5.6.1.5. Features of interest in the starvation transcriptome 
Our rRNA and tRNA depletion strategy greatly enriched for multi-gene operon 
cluster mRNAs for RNAseq. However, some non-coding RNA (ncRNA) still 
remained (Supplementary Table S2). Nonetheless, this provided a glimpse 
of how ncRNA contributes to the overall molecular phenotype. One of the 
most prominent and quantifiable ncRNA was the ribozyme rnpB 
(Supplementary Figure 5.3A). Together with rnpA, they form the RNaseP 
complex, which catalyzes the removal of the 5'-leader sequence from pre-
tRNAs in the presence of divalent cations (Mg2+ or Ca2+) to produce the 
mature tRNAs [107, 108]. Continued rnpB transcription supports the 
observation of tRNA maintenance during early starvation (Supplementary 
Figure 5.1K), and provides evidence against translational quiescence in 
starved mycobacteria. Another prominent ncRNA found throughout the 
starvation time course is tmRNA, coded by ssr (Supplementary Figure 
5.3A). tmRNA is involved in trans-translation by releasing mRNA from stalled 
ribosomes, thus ensuring protein fidelity [109]. Its maintenance during 
starvation, once again, suggests active protein translation in persisters. 
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In bacteria, RNA synthesis is initiated by sigma factors. Specialized sigma 
factors, such as SigF, are induced under stress, bind their target promoters 
and induce the transcription of stress related genes. During starvation the 
SigF regulon became significantly enriched at S10 despite peak sigF up-
regulation at S4 (Figure 4 and Supplementary Figures 5.5E-H). A plausible 
explanation for this phenomenon may be the spikes in rsbW-usfY 
transcription at S4 (Supplementary Figure 5.3A).  rsbW codes for an anti-
sigma factor protein that binds and negatively regulates SigF activity [110]. 
This suggests a layer of regulation governing the temporal expression of gene 
transcripts. 
In addition to the SigF regulon, CYPs, antioxidant defense and antibiotic 
sensitivity genes, PCA also identified several genes involved with the TCA 
cycle or members of the Lsr2 regulon to co-vary with metabolic utilization 
phenotypes at various time points. These include sucD, fum, acn, aceA and 
glcB (TCA cycle), sigF, canA, cyp128, BCG_2905 (SigF regulon), and 
moaD1, PPE16, PE9, celA2b (Lsr2 regulon) (Supplementary Figure 5.5M). 
GSEA further showed that in comparison to Log cultures, TCA cycle genes, 
generally, are significantly de-enriched at S4 but were indifferently expressed 
at R6 (Supplementary Figures 5.5A-D). One notable exception is aceA 
which is up-regulated at S4. In contrast, Lsr2 regulon genes are significantly 
enriched at S20 but became equally de-enriched at R6. It is important to 
consider that Lsr2 is a repressor of gene expression, thus, its targets become 
up-regulated only upon its suppression and down-regulated upon its 
restoration at R6 (Figure 4 and Supplementary Figures 5.I-L). We also 
observed contributions from whiB-family transcription factors, cAMP signaling, 
PhoPR, TrcPR and KdpDE two-component signaling, which could facilitate 
global transcriptional reprogramming (Figure 5.4). Overall, RNA-seq provided 
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evidence for the global reprogramming of the transcriptome affected through 
active translation processes which enabled metabolic remodeling during 
prolonged starvation. 
 
5.6.2. Supplementary figures 
(Next page)
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(Legend – next page) 
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Supplementary Figure 5.1. Physiological and molecular features of mycobacterial starvation and persistence.  
 
(A) CFU ratios of BCG recovered from 20-day cultures re-starved for 20 days in fresh PBS versus native supernatant. N = 6; p > 0.05; one-way 
ANOVA with Tukey’s HSD.  
(B and C) Survival curves of BCG (B) and SMG (C) starved in Mg2+ and Ca2+ ions containing DPBS () or PBS (). For BCG, PBS data also 
presented in Figure 1; n = 6; p < 0.01; maximum cumulative D = 0.52 (two-sample Kolmogorov-Smirnov test). For SMG, n = 6; p < 0.001; 
maximum cumulative D = 0.77; two-sample Kolmogorov-Smirnov test.  
(D-G) Starvation enriched for the proportion of persisters in BCG populations. Survival of BCG cultures at Log, S4, S10 and S20 to MBC99 
concentrations; i.e. 99% killing after 5 days post-exposure, of INH (D), RIF (E), STM (F) and EMB (G). Save for STM at S4, antibiotic 
susceptible cells were mostly killed the first 24h while proportions of drug tolerant survivors at 48h became enriched over the starvation time 
course (from Log-S20). 
(H-K) Intracellular levels of 23S (H), 16S (I), 5S (J) rRNA and tRNA (K) at Log, S4, S10, S20 and R6 (n = 3; * 0.01< p < 0.05, ***p < 0.001; one-
way ANOVA with Dunnett's test vs Log). 
(L) Intracellular ATP levels at Log, S4, S10, S20 and R6 (n ≥ 6; * 0.01< p < 0.05; one-way ANOVA with Dunnett's test vs Log). 
(M) Catalase activity in Log, S4, S10, S20 and R6 cultures (n ≥ 6; p > 0.05; one-way ANOVA with Dunnett's test vs Log). 
(N) Representative thin layer chromatograms of starved (left panel) and resuscitated (right panel) BCG at indicated time points (TAG: 
Triacylglycerol standard; d: days). 
(O) Concentrations of intracellular 3HB for Log, S20 and R6 cultures (n = 6; * 0.01< p < 0.05; one-way ANOVA with Dunnett's test vs Log).
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Supplementary Figure 5.2. Representative histograms and contour plots 
from flow cytometric analysis of BCG in Figures 5.2 and 5.3. 
(A and B) Comparison of FSC and SSC histogram profiles of BCG during 
starvation, resuscitation, and log growth shows starvation in PBS decreases 
the heterogeneity of both FSC and SSC profiles indicating smaller overall cell 
size and reduced cellular complexity. 
(C-J) Contour plots of Log and S20 BCG depicting gating scheme used to 
identify CellROXhi (ROS-producing) cells. Cells in the “size” gate (C and G) 
were gated for “DNA content” (D and H). Those with DNA were further 
identified as having intracellular CellROX® (E and I). CellROXhi cells were 
designated as those with fluorescence greater than basal levels (gate set at 
~1%, F and J).  
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(K-Q) Contour plots depicting gating scheme used to identify CFDAhi 
(elevated esterase activity) cells. Cells within the “size” gate (K) were gated 
for “DNA content” (L). Cells were further gated for intracellular CFDA 
presence or esterase activity (M) followed by a threshold set for basal activity 
in Log (N). Representative CFDA contour plots for S4 (O), S20 (P), and R6 
(Q) depict shifts in esterase activity during starvation.
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Supplementary Figure 5.3. RNA-seq and differential pathway analysis of 
the starvation transcriptome.  
(A) Visualization of RNA-Seq coverage across the BCG genome. Each 
sequencing track represents the one biological replicate consisting of 2 
appended technical replicate runs. Peaks heights indicate read coverage. 
Arrows (from left to right) highlight the prominent transcripts from 16S-23S-5S 
rRNA, rnpB, ssr and rsbW-usfY respectively. Time points are color coded 
consistently as Log ( ), S4 ( ), S10 ( ), S20 ( ) and R6 ( ) 
throughout the figure. 
(B) Venn diagram of significantly up- and down-regulated genes in S4, S10, 
S20 and R6 compared against Log cultures (>1.5 fold change; p < 0.05; De-
seq multi-testing). A total of 680 down-regulated transcripts and 511 up-
regulated transcripts fulfill these criteria. The individual and overlapping areas 
represent the number of uniquely or co-expressed transcripts at the indicated 
time points.  Areas highlighted in blue ( ) show genes down-regulated at 
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R6 but up-regulated during starvation (S4, S10 and S20) – core set 1. 
Conversely, areas highlighted in yellow ( ) show genes up-regulated at R6 
but down-regulated during starvation – core set 2. These core gene sets were 
subjected to pathway analysis (C). 
(C) Pathway analysis showing canonical pathways (KEGG annotation) 
modulated by the genes whose expression differed among R6 and starved 
cultures (S4, S10 and S20). Specificity was determined by selecting for 
pathways that fit the condition: 
               
               
          
               
               
       Blue 
and yellow bars: core sets 1 and 2 respectively. Insert: Illustrated example of 
pathway enrichment with ABC transporters. 4 groups of hits were identified. I. 
multidrug-efflux transporter BCG_1316c (Mtb Rv1258c homolog). II. ATP-
binding cassette, subfamily C (ABCC) cytochrome biosynthesis permeases 
cydC and cydD. III. Fluoroquinolones transport system permease proteins 
BCG_2699c and BCG_2700c (Mtb Rv2686c and Rv2687c homologs). IV. 
Multiple sugar transporters (sugC and BCG_2057c) and sn-glycerol 3-
phosphate transporters (ugpA and ugpC). Transcripts from all aforementioned 
genes possess similar patterns of expression (bars graph with indicated time 
points).
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Supplementary Figure 5.4. Proposed reaction schemes for the 
decomposition of 3-hydroxybutyrate (3HB) by cytochrome P450s (CYP) 
and the contributions ketone body degradation products to carbon 
cycling.  
(A) Scheme 1: Terminal decarboxylation of 3HB generating vicinol diol (1,2-
propanediol) products based on the proposed mechanisms of oxidative 
decarboxylation [111, 112]. 1,2-propanediol then feeds into pathway C 
(Figure S4B) or reaction Scheme 2. 
Scheme 2: β-hydroxylation of 1,2-propanediol to acetol based on the 
proposed mechanism by Rude et al (2011) and observations of 1,2-
propanediol and acetol metabolism in mycoabcteria [57, 113]. Acetol would 
be further oxidized by Bayer-Villager monooxygenases (BVMOs; see Figure 
4). More detailed experimental work is needed to confirm these mechanisms. 
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(B) Proposed carbon cycling pathways in starved BCG. Formate [A], acetate 
[B] and 1,2-propanediol [C] are derived from the decomposition of 
hydroxymethylene acetate (Figure 4) and 3HB (Scheme 1). These feed into 
metabolic pathways mediated by folD, acs and 1,2-propandiol dehydrogenase 
respectively and lead to the anaplerotic node (See Discussion).  Enzymes 
catalyzing each reaction are named in blue. Assignment of gene functions 
based on KEGG and BioCys mapping. Colors in heat maps denote up- and 
down-regulation of transcripts.
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Supplementary Figure 5.5. Dynamic shifts in the expression of TCA 
cycle enzymes, SigF and Lsr2 regulon genes underline their covariance 
with observed phenotypes.  
(A-L) GSEA determining the transcriptional enrichments of TCA cycle 
enzymes (A-D), SigF (E-H) and Lsr2 regulon (I-L) genes during starvation. 
GSEA plots indicates the degree to which members of each gene sets are 
overrepresented at the extreme left, up-regulated at S4 (A, E and I), S10 (B, 
F and J), S20 (C, G and K) or R6 (D, H and L), or on the extreme right (up-
regulated at Log) of the entire gene set. Solid bars represent bound genes. 
NES: normalized enrichment score. FDR: false discovery rate. 
 (M) PCA triplot showing the covariance between time points (), gene 
expression () and phenotypes (“environmental” variables). , and 
symbols are used for TCA cycle, SigF and Lsr2 regulon genes respectively. 
Filled symbols are CYPs referred to in the main text. Arrows represent 
severity of phenotypes: orange (INH, EMB, RIF or EMB tolerance), green 
(CellROXhi or CFDAhi), and black (ability to utilize indicated metabolite for 
growth). 235 strong influencers of the phenotypes plotted. 79% and 12% of 
the total observed variances are accounted for by the principle components 
axes (PC-1 and PC-2).
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Supplementary Figure 5.6. Dependency of steady-state ROS production 
on antibiotic dose under nutrient replete and nutrient deprived 
conditions.  
(A-D) Percentage of cells with the CellROXhi phenotype after 48h of exposure 
to INH (A), EMB (B), RIF (C) or STM (D) at the indicated doses for Log, S4, 
S10 and S20 cultures. Data shown as arithmetic means ± SE; n ≥ 8. 
(C)  Transcript levels of genes associated with antibiotic sensitivity across the 
starvation time course. Gene expression heat maps of antibiotic sensitivity 
genes features by parsimonious RDA (Figure 5.5E). Similar to Figure 5.4, 
colors of blocks represent extent of transcriptional regulation. Orange: up-
regulation. Blue: Down-regulation.
Page | 205  
 
 
Supplementary Figure 5.7.  Phenotypic acid resistance, azole 
indifference, hydrogen peroxide sensitivity and gene expression in Mtb 
supports the role of ketone body metabolism in mycobacterial 
persisters.  
(A-C) Growth phenotypes and metabolic activities of Log, S4, S10, S20 and 
R6 BCG at pH 6 and pH 5. Viability – CFU (A), ΔOD (B) and reductive 
respiratory potential (C) – after 5 days of exposure to pH 6 and pH 5 media. n 
= 3, 0.01< *p < 0.05, 0.001< **p < 0.01, ***p < 0.001 (one-way ANOVA with 
Dunnett’s Multiple Comparison). 
(D-F) Survival of Log, S20 and R6 BCG to azole-based CYP inhibitors. 
Cultures treated for 48h at indication clotrimazole (D), econazole (E) or 
miconazole (F) concentrations. n ≥ 3. 
(G) Transcript levels of H2O2-producing enzymes during starvation. Gene 
expressions at indicated time points determined using RNA-seq. Enzymes 
catalyze the following reactions: 
Cholesterol oxidase (choD): Cholesterol + O2 ↔ Cholest-4-en-3-one + H2O2 
D-amino acid oxidase (aao): D-Amino acid + H2O + O2 ↔ 2-Oxo acid + NH3 + 
H2O2 
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L-aspartate oxidase (nadB): L-Aspartate + O2 ↔ Iminoaspartate + H2O2 
Protoporphyrinogen oxidase (hemY): Protoporphyrinogen IX + 3 O2 ↔ 
Protoporphyrin + 3 H2O2 
n = 3, 0.01< *p < 0.05, 0.001< **p < 0.01, ***p < 0.001 (one-way ANOVA with 
Dunnett’s Multiple Comparison for each gene compared across time points). 
(H) Killing of S20 BCG when exposed to H2O2. Unlike in Figure 5.7C, 25 mL 
of S20 cultures (starting with ~108 CFU/mL) were treated in 50 mL conical 
tubes at the indication H2O2 concentrations and proportion of the bacteria 
population killed was determined through CFU plating at neat - 103 dilutions. 
n = 3; 0.01< *p < 0.05 (unpaired, two-tailed t-test with Welch’s correction). 
(G) Regulation of relMTB and fdxA in Mtb at Log, S4, S20 and R6 as 
determined by qPCR (n = 3; one-way ANOVA with Dunnett's Multiple 
Comparison).
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5.6.3. Supplementary tables 
Supplementary 






DA model of the 
metabolic 
phenotypes of 
Log, S4, S10, S20, 
and R6 cultures 
a Induced abiotic 
reduction of 
tetrazolium dye 
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Supplementary Table 5.2. Replicate numbers, sequencing depth and 
quality control parameters for RNA-seq of BCG transcriptome before, 
during and after starvation
 
Supplementary Table 5.3. Primers used for qPCR 
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6.  Reprogrammed tRNAs read a code of codons to 
regulate mycobacterial dormancy 
6.1. Abstract 
Codon usage bias and RNA modifications are ubiquitous features of life; yet, 
the manner in which these genetic and epigenetic traits interact to influence 
gene expression remains elusive. For members of the Mycobacterium 
tuberculosis Complex especially, persistence in the presence of cell-mediated 
immunity is dependent upon the timely regulation of dormancy programs 
within hypoxic granulomas. Seeking to understand the mechanism behind the 
selective translation of stress response genes when M. bovis BCG is exposed 
to hypoxia, we examined the molecular factors contributing to translation 
efficiency.  Of the 40 modified ribonucleosides in BCG tRNA, levels of wobble 
5-oxyacetyl-uridine (cmo5U) in tRNAThr(UGU) herald changes in DosR 
abundance – the transcription factor critical to the establishment of hypoxic 
dormancy. Translation of dosR and other transcripts biased in ThrACG usage 
are synchronously enhanced during hypoxia. Recombinant BCG with dosR 
coded by other threonine codons showed varied fitness during and after 
hypoxic exposures in accordance with the availability of modified tRNAs. Our 
results connect previous observations on mycobacterial dormancy with 
mechanistic insights as to how synonymous codon substitutions affect protein 
abundances and cellular phenotype.  
6.2. Introduction 
The consistent and meticulous manner in which organisms choose one of 
several synonymous codons to code for an amino acid is unlikely a quirk of 
biology. Instead, this suggests that a ‘code of codons’ exists [1]. This code 
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impacts protein translation and could serve to regulate gene expression by 
prioritizing the translation of specific transcripts over others [2-4]. This 
secondary feature of genetic coding is frequently obscured in piece-wise 
measurements of gene transcript and protein abundance and in species-to-
species genome-wide comparisons, but easily observed by gene-specific 
codon usage of the transcriptome [5-7]. Similarly, the role tRNA modifications 
play in biology cannot be fully appreciated without considering that it a 
dynamic system that responds to cellular stress [5, 8, 9]. These post-
transcriptional modifications to the four canonical ribonucleosides are capable 
of altering base-pairing interactions between codons and anticodons and 
thus, expand or limit tRNA decoding capabilities [10-12]. How do these 
genetic and epigenetic traits come together to affect gene expression? One 
possibility is that stress reprograms tRNAs by transiently altering their 
modifications. Changes in wobble modifications on anticodons, particularly, 
would facilitate increased or restricted decoding of cognate and near-cognate 
codons which are over- or under-used in transcripts. Consequently, 
translational elongation of transcripts bearing preferentially read codons are 
enhanced, in rate, accuracy, or both, leading to the selective up-regulation of 
these genes [1, 3].  
In Chapters 2-4, we developed an analytical platform for the isolation, 
purification, characterization and quantification of cellular RNA and its 
biochemical modifications. In Chapter 5, we dissected the phenomenon of 
persistence in nutrient starved mycobacteria and revealed how stress 
responses could cause metabolic shifts that determine phenotypic antibiotic 
resistance. Here, we move from transcriptional to translational control of 
stress responses, wherein our knowledge of RNA biology and 
mycobacteriology come together to help us understand how mycobacterial 
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pathogens use tRNA modifications to control gene expression by the 
selective translation of gene transcripts necessary for surviving hypoxic 
stress. 
6.3. Material and methods 
6.3.1. Reagents 
Unless otherwise stated, chemical reagents were purchased from Sigma-
Aldrich, bacterial culture reagents from BD Biosciences, Purelink RNA 
extraction kits were purchased from Life Technologies, LC-MS grade solvents 
from Thermo-Fisher, RNA and DNA oligonucleotides from Integrated DNA 
Technologies, restriction enzymes from New England Biolabs and peptide 
standards from Genescript. 
6.3.2. Bacterial cultures 
For mycobacteria pre-cultures, M. bovis Bacille Calmette-Guérin (str. Pasteur 
1173P2; BCG) were grown at 37 oC in a shaking incubator in Middlebrook 
7H9 broth supplemented with 0.5% (w/v) albumin, 0.2% (w/v) glucose, 
0.085% (w/v) NaCl, 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80 to an OD600 
of 0.6 – 0.8. For exponential growth, BCG pre-cultures were innoculated into 
Dubos broth (supplemented with 10% Dubos medium albumin, and 0.03% 
Tween 80) and passaged in roller bottles for balanced growth. A non-
replicating state was induced in BCG by subjecting them to the slow 
withdrawal of oxygen as described by Wayne and Hayes [13] with 
modifications made by Ravindran et al. [14] for a ~40 fold expansion of batch 
cultures. Briefly, a culture of exponentially growing BCG in Dubos broth was 
diluted to an OD600 of 0.005 and placed in a tightly-sealed (latex-lined cap) 1 L 
glass flask (Duran) with stirring at 80 rpm and air headspace ratio of 0.5. For 
resuscitation of dormant cultures by re-aeration, hypoxic cultures were 
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transferred to 1.5 L vent-capped Erlenmeyer flasks (Corning) and shaken at 
180 rpm. Levels of oxygen were tracked by methylene blue decolorization, 
oxygen indicator strips (BD) and dissolved oxygen probe sensor (Vernier). 
Cultures with added methylene blue were not used in further experiments. At 
indicated time points (Fig. S1), flasks were sacrificially opened; and bacteria 
with pelleted, washed, and flash frozen in liquid nitrogen. For CFU 
determinations, serial dilutions were plated on 7H11 agar supplemented with 
10% (v/v) oleic acid-albumin-dextrose-catalase (OADC). Cultures were 
routinely assessed for contamination by microscopy (Gram, Ziehl-Neelsen, 
and auramine-rhodamine staining) and streaking on blood agar. When 
appropriate, hygromycin and kanamycin, were added at 80 and 30 µg/mL 
respectively to broth and agar. 
One Shot® TOP10 Escherichia coli (F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(araleu)7697 galU galK rpsL (StrR) 
endA1 nupG; Life Technologies) were grown in Luria-Bertani (LB) broth and 
agar. When appropriate, hygromycin and kanamycin were added at 150 and 
50 µg/mL respectively. 
6.3.3. RNA extraction and purification 
Total RNA was extracted from BCG pellets as described previously [15]. To 
prevent the formation of Tris-RNA adducts [16], TRIzol (Life Technologies) 
instead of Tris-EDTA buffer saturated phenol:chloroform:isoamyl alcohol was 
used with bead-beating for cell lysis. Additionally, on-column DNAse I 
(Qiagen) digest was performed in the presence of 10 mM ammonium acetate 
(pH 7.0) instead of Tris-buffer. Multi-dimensional HPLC for the separation and 
isolation and quantification of RNA species was performed as previously 
described [17]. RNA composition and integrity was determined using the 
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appropriate Agilent Bioanalyzer RNA chips. Total RNA samples with a RNA 
Integrity Number (RIN) of 8.0 or greater were used for qPCR experiments. 
tRNA samples that were >99.9% pure by size exclusion chromatography 
were used for LC-MS/MS analysis. 
6.3.4. Identification and quantification of tRNA modifications 
Purified BCG tRNA (0.5 μg per sample) was hydrolyzed enzymatically as 
detailed in [18]. To prevent the formation of Tris-RNA adducts, HEPES buffer 
(pH 8.0) was used instead of Tris-HCl buffer (pH 8.0). Furthermore, all 
enzymes were dialyzed against HEPES buffer (pH 8.0) immediately prior to 
use. Reverse phase-LC of the hydrolyzed tRNA was performed as preciously 
described [18, 19]. Neutral loss scan (NLS), molecular feature extraction 
(MFE) and targeted ion fragmentation (targeted MSn) were used to identify 40 
modifications in BCG tRNA. Neutral loss scan was performed on an Agilent 
6460 LC-QQQ spectrometer with ESI Jetstream ionization, searching for 
compounds with loss of ribose (-136 m/z) or 2’-O-methyl-ribose (-146 m/z) 
upon fragmentation. High accuracy masses for molecular ions and CID 
fragment were obtained using either Agilent 6520 LC-QTOF spectrometer 
with an ESI ionization or LTQ Orbitrap XL (Thermo-Scientific). Untargeted 
feature finding was performed using molecular feature extraction (Agilent 
Workstation Qualitative Analysis vB05.06). Molecules reproducibly observed 
(by retention time, molecular mass, features of MS2 fragmentation) in all 
biological replicates at one time point were validated by comparisons with 
commercially available standards (See Table S1), comparisons with 
theoretical molecular masses of ribonucleosides found in ChemSpider 
(http://www.chemspider.com/), Modomics (http://modomics.genesilico.pl/) and 
the RNA modifications database (http://mods.rna.albany.edu/), targeted MSn, 
isotopic envelope analysis and salt adduct analysis. Dynamic multiple 
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reaction monitoring (dMRM) on an Agilent 6460 LC-QQQ spectrometer was 
used to quantify these modifications [18]. Quantitative comparisons between 
biological replicates from various time points were made possible by 
correcting for biological variation in total tRNA quantities by dividing raw peak 
area for the ribonucleoside by the UV absorbance (in-line detector) peak 
areas for the 4 canonical ribonucleosides and normalizing spectra signals 
against that of the spiked internal standard ([15N]5-deoxyadenosine) to adjust 
for day-to-day fluctuation in MS sensitivity. All mass spectrometers were 
operated in positive ion mode. 
6.3.5. Sequencing and quantification of tRNA-specific oligonucleotides 
We developed a LC-MS/MS-based platform to map tRNA modifications, 
perform label-free absolute quantification of tRNA copy numbers and 
determine the extent of modification on those tRNA copies by combining the 
principles of bottom-up shotgun proteomics, amide-HILIC oligonucleotide 
liquid chromatography, and response factor calibration outlined in previous 
studies [20-22]. However, the following alterations were made:  
The tRNAThr pool was characterized and quantified using Agilent 6520 QTOF 
and Agilent 6460 QQQ spectrometers coupled with an Agilent 1290 infinity LC 
system with online diode array for UV-Vis spectrometry, operated in negative 
ion mode. BCG tRNA sequences were downloaded from the Genomic tRNA 
database (http://gtrnadb.ucsc.edu/) and RNase U2, T1 and A digestion 
products were predicted using Mongo Oligo Mass Calculator 
(http://mods.rna.albany.edu/masspec/Mongo-Oligo). >6 mer digestion 
products were evaluated for sequence uniqueness (by BLASTn against 
genomic tRNA sequences) and RNAse U2 selected for further experiments 
as it generates unique products from the anticodon stem-loop of all 3 tRNAThr. 
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We eliminated sequences with positional isomers that could be generated 
from RNAse U2 digests with or without missed cleavages, and identified a 
unique oligonucleotide tag for every RNAThr. RNA and DNA oligomers with the 
same sequences (with the exception of U>T for DNA) were purchased and 
used to optimize LC and MS parameters for maximal chromatographic 
separation (by retention times), sequence coverage and signal strength of the 
fragments, unique transitions with high signal to noise ratios (S/N > 10) and 
minimal source fragmentation.   
RNAse U2 (Thermo-Scientific) digestion of BCG tRNA was performed 
followed by the removal of 5’ and 3’ phosphates by bacterial alkaline 
phosphatase (Life Technologies). Reaction performed in 10 mM ammonium 
acetate pH7.0 at 37°C for 4 h (2.5h of U2 digest and 1.5h of 
dephosphorylation) in the presence of deaminase inhibitors (0.5 µg/mL 
coformycin, 5 µg/mL tetrahydrouridine) and antioxidants (50 μM 
desferrioxamine, 50 μM butylated hydroxytoluene). Enzymes were dialyzed 
against 10 mM ammonium acetate prior to use to prevent the formation of 
Tris-RNA adducts. Proteins were removed by filtration (Microcon YM-10), 
desalted by ZipTipC18 (Millipore) and concentrated by vacuum centrifuge. The 
extent of digestion and size of products were assessed by small Bioanalyzer 
chips (Agilent) and by MALDI-MS (Voyager DE, AB SCIEX) using 2,4,6-
trihydroxyacetophenone (THAP) as matrix. RNA fragments were reconstituted 
in 70% acetonitrile (v/v) for LC-MS/MS. 
Amide-HILIC LC separation was performed on a TSK-gel Amide-80 column 
(2.0 mm ID x 150 mm, 3 μm particle size) using a binary solvent system 
consisting of 8 mM ammonium acetate in ultrapure water (solvent A) and 
acetonitrile (solvent B). HPLC was performed at a flow rate of 0.1 mL/min.  
The gradient of solvent A was as follows: 0-2 min, held at 10% (v/v); 2-3 min, 
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10%-15%; 3-5.5 min, 15%-30%; 5.5-20.5 min, 30%-60%; 20.5-25 min, 60%-
70%; 25-28 min, 70%-10%. The HPLC column was maintained at 50 ºC.  
QTOF mass spectrometer was operated at gas temperature 325 °C, gas flow 
8 L/min, nebulizer 30 psi, Vcap 3800 V, Fragmentor 250 V, Skimmer 1 65 V, 
octopole RF peak of 750. Targeted MS2 performed every 5V from collision 
energies from 25V to 45V and products scanned from 100 m/z to 1500 m/z. 
QQQ mass spectrometer operated at gas temperature 325 °C, gas flow 10 
L/min, nebulizer 32 psi, sheath gas temperature 300 °C, sheath gas flow 11 
L/min, capillary 4000V, Vcharging 500. For MRM, MS1 acquisition was 
performed at wide resolution and MS2 acquisition at unit resolution. Dwell 
time per transition at 150 ms, fragmentor between 130-160 V, collision energy 
between 30-40V and cell accelerator voltage between 5-7V.  
As the positions of BCG tRNA modifications had not been mapped, we 
generated a list of potential modified oligomers by taking into account the 40 
modifications identified in BCG tRNA (Figure. 1), predicted modifications by 
tRNAmod (http://crdd.osdd.net/raghava/trnamod/) and comparisons with 
tRNA sequences catalogued in Modomics (http://modomics.genesilico.pl/). 
The exact masses of these potential modified oligomers and their c1 and y1 
ion fragments were calculated. Selected reaction monitoring (SRM) worklists 
were created to screen the tRNA pool of Log, H18 and R6 cells for oligomers 
with these predicted c1 and y1 transitions. SRM screen for c1 and y1 
transitions were performed separately and in technical duplicate on the LC-
QQQ. Oligomers with matching the retention times for their predicted c1 and 
y1 transitions were sequenced by targeted MS2 on the LC-QTOF at collision 
energies of 0, 15, 30 and 45V. Fragment analysis, aided by SOS [23] and 
RoboOligo (https://u.osu.edu/paulsample/robooligo/), enabled us to map the 
exact location of each modification based on their a-B, c, w, and y ions. 
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Analysis of free bases and internal fragments (mainly matching ion fragments 
with w type cuts at the 3’ end or a-B type cut from the 5’ end, generating a 
pNpf or NpNf fragment) further validated our structural assignments [24]. The 
two strongest signals (Fig S4A, table S2) were selected to quantify and 
identify each modified oligomer by MRM in the same run (Supplementary 
Figure 6.4A).  
Response factors for RNA oligomers against DNA oligomers of the same 
sequence were computed by external calibration (Figure S4B). With the 
assumption that these response factors are applicable to modified oligomers 
of the same length and sequence, we quantified the amounts of each tRNA 
species by the ratios of peak areas between the quantifier transitions of the 
modified RNA fragment to 1 pmol of spiked DNA oligomers of the same 
length and sequence  (Supplementary Figure 6.4B). 
6.3.6. Protein extraction and processing 
Six replicate samples of BCG pellets at 8 experimental time points (Log, H4, 
H6, H9, H14, H18, R3 and R6) were extracted with 8 M urea, 1 M thiourea 
with 2% SDS supplemented with protease inhibitor complete cocktail (Roche) 
by bead beating (50 Hz for 3 five-minute cycles, TissueLyzer II (Qiagen)) with 
0.2 mm silica beads. Bead beating chambers were chilled at -20 °C before 
and between cycles. Extracts were centrifuged at 14 000 g for 15min at 4 °C 
and the supernatant collected. Supernatant were diluted with equal volumes 
of ultra-pure water and supplemented with HALT protease inhibitor cocktail 
(Pierce BioSciences), MgCl2 (2mM final) and Tris-HCl (pH8.0, 10 mM final) for 
Benzonase digestion (25 Units per mL lysate) at 20 °C for 3 h. Samples were 
chilled on ice and sonicated at (20% maximum amplitude, five 10 second 
cycles, Fisher-Scientific FB15061) to break up any aggregates that might had 
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formed. Overnight trichloroacetic acid/acetone precipitation was performed 
with 2D Clean-Up kits (GE Healthcare) as instructed by the manufacturer. Air-
dried protein pellets were resuspended in 10 mM triethylammonium 
bicarbonate (TEAB) buffer (pH 8.5) and protein concentrations determined by 
BCA assay (Pierce BioSciences). Protein quality and quantities was checked 
by SDS-PAGE electrophoresis (12% polyacrylamide gels) and purity by UV 
spectrometry (Nanodrop, Thermo Scientific). Protein aliquots (100 µg) were 
collected, lyophilized, and stored at –80 °C prior to further processing. 
Lyophilized proteins were reconstituted in 100 mM TEAB and 10% acetonitrile 
(v/v) by bath sonication. Samples were reduced and alkylated using the 
iTRAQ kit (Applied Biosystems) according to the manufacturer’s instructions. 
Protein concentrations were estimated using Bradford assays (Bio-Rad). 50 
µg of protein was precipitated by cold acetone, redissolved in 6 M urea, 
diluted with five volumes of 100 mM TEAB with 10% (v/v) acetonitrile and 
digested with trypsin in a 1:30 (w/w) ratio overnight at 37 °C. Samples were 
dried by vacuum centrifugation and stored at –20 °C prior to analysis. 
6.3.7. iTRAQ labeling and peptide fractionation 
Aliquots of digested protein (from 50 µg of total protein) were split into 3 
portions as technical replicates and labeled with 8-plex iTRAQ reagents 
according to the manufacturer’s instructions. To avoid bias from any one tag 
during analysis, labels for samples from each time point were randomized 
and unblinded post-analysis. After iTRAQ labeling, samples were desalted 
with Sep-Pak Plus C18 cartridges (Waters), dried by vacuum centrifugation 
and reconstituted in IPG buffer (Agilent) without glycerol. Isoelectric focusing 
was performed from pH 3-10 over 24 wells on an Agilent 3100 OFFGEL 
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fractionator according to the manufacturer’s protocol (OG24PE00). All 24 
fractions were collected and analyzed by nano-LC-MS/MS. 
6.3.8. LC-MS/MS analysis of the BCG proteome 
iTRAQ proteomics experiments were performed on an Agilent 1200 nano-LC-
Chip/MS interfaced to an Agilent 6510 QTOF LC/MS. The LC system 
consisted of a capillary pump for sample loading, a nanoflow pump and a 
temperature-controlled microwell-plate autosampler. The HPLC-Chip 
configuration consisted of a 160 nL enrichment column and a 150 mm x 75 
μm analytical column (G4240-62001 Zorbax 300SB-C18). Mobile phases 
employed were: 0.1% formic acid in water (solvent A) and 0.1% formic acid in 
acetonitrile (solvent B). A 120 min long gradient LC separation was used with 
10 minutes for column wash and equilibration between runs. Samples were 
loaded unto the enrichment column at 1% (v/v) B at flow rates of 3 µL/min. On 
the nano-flow pump, the gradient of solvent B was as follows: 0-1 min, held at 
1% (v/v), flow rate from 0.4-0.2 µL/min; 1-101 min, 1%-45%, flow rate held at 
0.2 µL/min; 101-121 min, 45%-75%, flow rate held at 0.2 µL/min; 121-122 
min, 75%-98%, flow rate from 0.2-0.4 µL/min; 122-126 min, held at 98%, flow 
rate held at 0.4 µL/min; 126-127 min, 98%-1%, flow rate held at 0.4 µL/min; 
127-130 min, held at 1%, flow rate held at 0.4 µL/min. LC-QTOF was 
operated at high resolution (4 GHz) in positive ion mode with the following 
source conditions: gas temperature 325 °C, drying gas 5 L/min, fragmentor 
225 V. Capillary voltage was adjusted between 1500-2100 V manually to 
achieve a steady spray. Data was acquired from 200–1700 m/z with an 
acquisition rate of 4 spectra/s in MS mode and from 50–2200 m/z with an 
acquisition rate of 2 spectra/s in MS/MS mode. 
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LC/MS data were extracted and evaluated using the molecular feature 
extractor (MFE) algorithm in MassHunter Qualitative Analysis software 
(B04.00). Test injections (3-4) from each fraction of the first technical replicate 
were made to optimize injection volumes for the second and third biological 
replicates for maximal extracted molecules with peptide-like features. For 
each fraction, the MFE list of molecular ions was exported and used to 
exclude the acquisition of spectra from these ions in subsequent runs. As 
such, every fraction from each technical replicate was run twice, first without 
and later with the exclusion list. Data from MassHunter Qualitative Analysis 
was exported to Mass Profiler Professional (version B02.02) for analysis of 
technical reproducibility. This process was repeated for all 3 biological 
replicates. 
6.3.9. Proteomics data processing and database searching 
Tandem mass spectra were extracted, charge state deconvoluted and 
deisotoped by Spectra Mill (Agilent; v B.04.00.127). All MS/MS samples were 
analyzed using Spectrum Mill and X!Tandem (The GPM, thegpm.org; version 
CYCLONE (2010.12.01.1)). Spectrum Mill and X!Tandem were set up to 
search the SwissProt.BCG.Pasteur.1173P2 database (selected for all curated 
and non-curated proteins. Retrieved Apr 27 2014, 3891 entries) with tryptic 
digest fragments with an ion mass tolerance of 50 PPM and a parent ion 
tolerance of 20 PPM. Carbamidomethyl of cysteine and iTRAQ 8plex of lysine 
and the n-terminus were specified in Spectrum Mill and X!Tandem as fixed 
modifications. Ammonia-loss of the n-terminus, deamidated of asparagine 
and oxidation of methionine were specified in Spectrum Mill as variable 
modifications. Glu->pyro-Glu of the n-terminus, ammonia-loss of the n-
terminus, gln->pyro-Glu of the n-terminus, deamidated of asparagine, 
oxidation of methionine, acetyl of lysine, carbamidomethyl of cysteine, 
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phosphorylation of serine, threonine and tyrosine and iTRAQ8plex of lysine 
and the n-terminus were specified in X!Tandem as variable modifications. 
6.3.10. Criteria for protein identification 
Scaffold (version Scaffold_4.3.0, Proteome Software Inc.) was used to 
validate MS/MS based peptide and protein identifications. Peptide 
identifications were accepted if they could be established at greater than 
95.0% probability by the Scaffold Local FDR algorithm. Protein identifications 
were accepted if they could be established at greater than 95.0% probability 
and contained at least 2 identified peptides. Protein probabilities were 
assigned by the Protein Prophet algorithm [25]. Proteins that contained 
similar peptides and could not be differentiated based on MS/MS analysis 
alone were grouped to satisfy the principles of parsimony. Proteins sharing 
significant peptide evidence were grouped into clusters. Annotated with GO 
terms from 25994.M_bovis_Pasteur_1173P2.goa (downloaded from NCBI 
May 5, 2014) was performed [26]. 
6.3.11. Relative protein quantification by iTRAQ 
Scaffold Q+ (version Scaffold_4.3.4, Proteome Software Inc.) was used to 
quantify iTRAQ Label Based Quantitation peptide and protein identifications. 
Peptide identifications were accepted if they could be established at greater 
than 90.0% probability by the Scaffold Local FDR algorithm. Protein 
identifications were accepted if they could be established at greater than 
99.0% probability and contained at least 2 identified peptides. Protein 
probabilities were assigned by the Protein Prophet algorithm [25]. Proteins 
sharing significant peptide evidence were grouped into clusters. Channels 
were corrected by the matrix as: 
[0.000,0.000,0.929,0.0689,0.00220];  










in all samples according to the i-Tracker algorithm [27].   Acquired intensities 
in the experiment were globally normalized across all acquisition runs. 
Individual quantitative samples were normalized within each acquisition run. 
Intensities for each peptide identified were normalized within the assigned 
protein. The reference channels were normalized to produce a 1:1 fold 
change. All quantitative calculations were performed using means of the 
multiplicatively normalized data. Differentially expressed proteins were 
determined using one-way ANOVA using Bonferroni multiple testing 
correction. 
6.3.12. Strain construction 
Strains, derivatives of BCG (str. Pasteur 1173P2), used in this study are listed 
in Supplementary Table 6.1. dosSR knockout and complementation are 
constructed by the methods of Lin et al., Bartek et al., Bardarov et al. and 
Stover et al. [28-31]. Briefly, primers dosRhrFR, dosShrFR and dosRregFR 
(sequences in Supplementary Table 6.1) were used to amplify the dosR 3’ 
flanking region, dosS 5’ flanking region and dosSR promoter regions 
respectively (Supplementary Figure 6.7A). The promoter regions 
encompass all identified promoter and transcription factor binding elements 
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identified [32-34]. These regions were sub-cloned into TOPO® vector by TA 
cloning (TOPO® TA cloning kit, Life Technologies), propagated in TOP10 
chemically competent E. coli, and sequenced to select for vectors that 
correctly amplified the PCR fragment. Inserts were excised by the appropriate 
restriction enzymes and ligated into pYUB854 (for dosShrFR and dosRregFR 
inserts) or pMV306 (for dosRreg FR insert) vectors using the DNA Ligation Kit 
Mighty Mix (Takara) according to the manufacturer’s instructions. 
Transfection of WT BCG with pYUB854 containing the dosRhrFR and 
dosShrFR inserts generated the ΔdosSR strain. ΔdosSR was in turn 
complemented with pMV306 containing the dosRregFR insert and 1 of 5 
possible dosSR constructs (synthesized by g-blocks (IDT) and altered by site-
directed mutagenesis (Genescript). This generated the ΔdosSR::dosSR(WT), 
ΔdosSR::dosSR(ACA), ΔdosSR::dosSR(ACC), ΔdosSR::dosSR(ACG) and 
ΔdosSR::dosSR(ACT) strains. Deletion at the correct locus was verified by 
hygromycin resistance, gel electrophoresis of PCR products and by qPCR. 
Successful complementation was determined by kanamycin resistance, 
restriction mapping, sequencing and qPCR. 
6.3.13. Reverse transcription-qPCR 
Quantification of targeted mRNA sequences was performed as described in 
[15], using primers in Supplementary Figure 6.7A. sigA served as internal 
loading control. 
6.3.14. Data processing and statistical analysis 
Data from mass spectrometric measurements and gene expression were 
deflated as fold changes against Log values. Logarithmic transformations 
were used for datasets with skewed or wide distributions and indicated in their 
respective figures legends. Data from bacterial growth were curve-fitted to an 
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order 5 polynomial curve using Excel’s LINEST function (Microsoft). 
Comparisons between 2 samples were made using the appropriate two-tailed 
t tests after equality of variances were tested using F-tests. Comparisons 
between multiple samples were determined using One-way or Two-way 
ANOVA when comparing 1 or 2 factors respectively. Bonferroni’s or Dunnett’s 
Multiple Comparison or Tukey’s HSD post-hoc tests were used where it best 
reflects how sample means were compared and stated in their respective 
figure legends. These statistical tests were performed using Prism 5 
(Graphpad). Unless otherwise stated, all data are represented as arithmetic 
means ± SE. To aid interpretation on statistical significances, p< 0.05, p < 
0.01 and p < 0.001 are denoted as *, ** and *** respectively. 
Differential abundance of tRNAs, tRNA modifications and proteins was 
analyzed by a random effects Bayes model using the BETR algorithm in MeV 
(http://www.tm4.org/mev.html). Percentages of modified tRNA species are 
determined by peak area normalization with response factors. Cluster 
analysis was performed using two-way hierarchical clustering with average 
distances and complete linkages and visualized using MeV. Shifts in 
proteome of BCG were analyzed by principle component analysis (PCA) 
using the NIPALS algorithm. Interpretations of the relationships between 
codon usage predictors (codon frequency) and protein up-or down- regulation 
(log2 median fold change) was analyzed by partial least squares regression 
(PLS). Alternate start and stop codons were treated as categorical variables. 
Outliers which could cause over-fitting were removed by inspection of variable 
residuals and leverages. Validation was performed using cross-validation and 
the significance of variables determined by Marten’s uncertainty test. The 
Root Mean Square Error of Prediction (RMSEP), slope and correlation 
coefficient of predicted versus measured correlation line was used to evaluate 
Page | 231  
 
the efficiency of applied regression model. Eigenvector based multivariate 
statistics performed using UnscramblerX® (v10.3, Camo). 
 
6.4. Results 
6.4.1. A systems-level analysis to characterize translational control of 
mycobacterial dormancy responses 
Undoubtedly, coordinating gene expression to facilitate stress responses is 
essential for human pathogens like M. tuberculosis to survive the host 
immunity and persist in hypoxic lung granulomas [35, 36]. Hence, we sought 
to determine if tRNA modifications and codon usage bias, previously shown 
to be essential in the stress response of S. cerevisiae [5, 8, 19], play 
significant roles in the hypoxia-induced dormancy response of mycobacteria 
[37, 38]. To do this, we pursued a systems-level analysis of the mycobacterial 
dormancy response. This systems-level approach is divided into two parts 
(Figure 6.1). The first involves the exposure of M. bovis BCG to hypoxia to 
induce dormancy, extraction, purification and quantification of cellular RNA, 
qualitative and quantitative study of tRNA modifications and the mapping of 
these modifications. The second involves the global analysis of hypoxia-
induced changes in the proteome, codon usage across all protein coding 
genes, targeted quantification of the tRNA pool and mRNA levels of key 
regulatory genes, such as dosR, followed by integrating both datasets to build 
quantitative models of genetic decoding and translation efficiency; and finally 
test our hypothesis of tRNA modification-mediated selective translation of 
codon biased, stress response genes using synthetic biology approaches. 
6.4.2. Hypoxia induces a systemic reprogramming of tRNA 
modifications in BCG 
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For selective translation of codon-biased genes to occur, there needs to be 
stress-induced shifts in either tRNA abundance or modification. These 
changes would select groups of genes which over-or under uses synonymous 
 
 
Figure 6.1. Experimental workflow for the systems-level analysis of 
translational control of hypoxia-induced dormancy responses. This 
analysis involves the induction of mycobacterial dormancy through hypoxia 
exposures [13, 39]; extraction, purification and quantification of cellular RNA 
[15, 17]; identification and characterization of all RNA modification in BCG 
building an organism-centric ribonucleoside (rN) database [40]; quantitative 
analysis of the dynamic changes of these modification under hypoxic stress 
by multivariate statistics (MVS) [18]; mapping key modification and 
determining wobble occupancy on tRNA species; global profiling of the 
hypoxic proteome and codon usage over time [3]; target analysis of the 
transcript levels of critical stress response regulators and the tRNAs that 
decode them; building mechanistic models  of genetic decoding and selective 
translation and finally testing  the predictions of this model through codon re-
engineering experiments.  
codons. Therefore, we began by characterizing the full repertoire of tRNA 
modifications in BCG. Combining high mass accuracy with fast scan speed 
liquid chromatography tandem mass spectrometry (LC-MS/MS) techniques 
[40], we identified 40 distinct chemical modifications spanning a 1000-fold 
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dynamic range (Figure 6.2A and Appendix I). Next, we quantified the 
changes in these modifications as BCG entered and exited a non-replicating 
state by dynamic multiple reaction monitoring (dMRM) [18]. We found that 
each stage of hypoxic dormancy in a classical Wayne model experimental 
setup can be defined by a signature set of tRNA modifications [13]. In addition 
to exponentially dividing cells in aerated cultures (aerated growth -AG), 
dormant BCG (non-replicating persistence stages 1 and 2 – NRP1 and 2) 
possessing unique patterns of tRNA modifications (Log and R6, H6 and H9, 
H14, 18 and 21; representing days 0, 24, 6, 9, 14 and 21 of the experimental 
time course), hierarchical clustering (HCL) also distinguished two transitional 
phases at the entry, H4 (day 4), and exit ,R1-R3 (days 19 and 21), of hypoxia-
induced dormancy. These phases we termed hypoxic transition (HT) and 
early resuscitation (ER) respectively (Figure 6.2B and Supplementary 
Figure 6.1A). Therefore, hypoxia induced tRNA reprogramming; and this 
could affect gene expression through selective translation of stress response 
transcripts. 
6.4.3. dosR, the master regulator of the initial hypoxic response, is 
biased in ThrACG usage – a feature shared by Group I genes 
One potential modification tunable transcript is dosR, a transcription factor 
that activates a 48 member regulon involved in development of the dormant, 
non-replicating state (Supplementary Figure 6.1B) [41, 42]. Gene-specific 
codon counting (GSCC) analysis showed that this gene is significantly 
enriched in ThrACG codons and impoverished in ThrACC codons 
(Supplementaty Figure 6.3). G-ending codons in 4-fold degenerate codon 
boxes (for Leu. Val, Ser, Pro, Thr and Ala) could be read by modified wobble 
uridines (Supplementary Figure 6.2), and interestingly, we observed that 
levels of 5-oxyacetyl-uridine (cmo5U), noted for its ability to decode G-ending 
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codons [43, 44], increase by >350% at H4, 6 and 9 (Fig 1B). Expanding 
GSCC to all 3951 protein-coding genes, we observed that dosR lies at the 
periphery of a set of ~90 genes (Group 1 genes, Supplementary Figure 6.3), 
sharing several codon biases including an over-usage of ThrACG and an 
under-usage of the optimal codon ThrACC (for ThrACG Cohen's d = 0.70; for 
 
Figure 6.2. Dynamics of tRNA modifications as BCG enter and exit 
hypoxic dormancy. (A) Composite extracted ion chromatogram of 40 
modified ribonucleosides in BCG tRNA. Full names, structures and LC-
MS/MS characterizations found in Appendix I. (B) HCL analysis of changes in 
the relative levels of BCG tRNA modification induced by hypoxia and re-
aeration on days 0, 4, 6, 9, 14, 18, 21 and 24 of the Wayne Model 
(Supplementary Figure 6.1A). HCL was performed on mean-centered data 
(n = 6) and visualized as a heatmap of log2 fold-changes relative to Log 
cultures.  
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ThrACC Cohen's d = -1.19; z-test: p < 0.05). Thus, the BCG genome contains 
sets of genes with biases in codon usage which could be acted upon by 
differentially modified tRNAs. 
6.4.4. Remodeling of the tRNAThr pool during hypoxia 
Abundances of tRNA modifications, however, are neither the sole 
determinants of translation elongation efficiency, nor are 5-oxyacetyled 
uridines the only wobble base capable of decoding G-ending codons. 
Conventionally, the effects of codon usage bias on translation have been 
attributed to of the copy numbers of available tRNAs [45, 46], and, contrary to 
experimental evidence [47], tRNA modifications are thought to be all-or-none 
events. This excludes the possibility of populations of tRNA isoacceptors 
possessing several different modification states. Furthermore, 5-methoxy-
uridine (mo5U) had also been identified in BCG and this modification has 
been found on the wobble position of tRNAThr(UGU) in Bacillus subtilis [8, 48]. 
To directly assess the tRNAThr pool, and determine the wobble occupancy of 
tRNAThr(UGU), we applied the principles of shotgun proteomics to sequence and 
quantify RNAse U2 digestion products which uniquely identify a tRNA 
isoacceptor (see Materials and methods). We appraised unique 
oligonucleotide fragments from the 3 tRNAThr isoacceptors in the BCG 
genome (Figures 6.3A, E and I) and found modest changes (from 0.5- 2.1 
folds against Log levels) in tRNA abundances across the experimental time 
course (Figures 6.3C, G and K). The magnitude of these changes are in line 
with previous quantification of stress induced perturbations in tRNA copy 
number by tRNA-seq [49].  
Moreover, we detected time-dependent changes in the extent of cmo5U 
(Figure 6.3B), mo5U and 5-hydroxy-uridine (ho5U) modifications on position 
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Figure 6.3. Hypoxia induces remodeling of the tRNAThr pool. Total tRNA 
was digested with RNAse U2 generating oligoribonucleotides 
containing unique fragments (arrows) from (A) tRNA46Thr(UGU), (E) 
tRNA31Thr(UGU) and (I) tRNA7Thr(UGU) which were analyzed by LC-MS/MS. 
Positions of conserved 4-thiouridine (s4U), dihydrouridine (D), pseudouridine 
(Ψ), 7-methylguanosine (m7G), 5-methyluridine (m5U), wobble (U*) and 
adenosine37 (A*) are shown in brown. (B) CID spectra of 
CUCGCCUcmo5UGUmt6t6A (m/z 907.613, z = -4,), (F) CUCGUct6A (m/z 
979.644, z = -2,) and (J) GCGUUUCCA (m/z 929.121, z = -3,). a-B, c, w 
and y ions series presented as defined by nomenclature. IF: internal 
fragments. *: Quantifier ion. ^ Identifier ion. Abundances of (C) tRNA46Thr(UGU), 
(G) tRNA31Thr(UGU) and (K) tRNA7Thr(UGU) as determined by targeted MRM. 
Values are fold changes relative to quantities at Log (mean ± SEM, n = 4; NS: 
not significant, p< 0.05, p < 0.01 and p < 0.001 are denoted as *, ** and *** 
respectively determined by One-way ANOVA with Dunnett's test vs Log). 
Ratios of (D) Modified oligonucleotides from the anticodon stem-loop of  
tRNA46Thr(UGU) and (H) tRNA46Thr(CGU) at indicated time points expressed as 
percentages of  their sum total. 
34 (wobble) of tRNAThr(UGU), and N6-methyl-N6-threonylcarbamoyladenosine 
(m6t6A) and cyclic N6-threonylcarbamoyladenosine (ct6A) on position 37 of 
tRNAThr(UGU) and tRNAThr(CGU), respectively (Figures 6.3D, F and H). These 
results are reaffirmed by previous tRNA mapping studies and together 
indicate a widespread remodeling of the tRNAThr pool as cells enter and exit 
hypoxic dormancy [16, 48, 50]. 
6.4.5. Gene transcripts overusing ThrACG but not ThrACC are selectively 
translated during the hypoxia transition  
Are the effects of tRNAThr pool remodeling reflected in the proteome? If so, 
transcripts, like dosR, which over-uses ThrACG while under-using ThrACC would 
be differentially translated before, during and after hypoxic exposures. When 
selective translation occurs, protein abundances would change independent 
of mRNA levels but in accordance with the availabilities of tRNAThr species 
capable of decoding them [1]. We performed 8-plex iTRAQ proteomics to 
compare the relative quantities of proteins across the experimental time 
course at Log, H4, H6, H9, H14, H18, R3 and R6. Cross-validating protein 
identifications between Spectrum Mill and X!tandem, we matched 122,546 
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spectra to 36,751 unique peptides which mapped onto 2,455 proteins (62% 
proteome coverage at 4.9% peptide FDR) (Supplementary Figures 6.5A 
and B). Of these, 965 could be consistently quantified by 2 or more peptides 
in all samples at >99% confidence (protein FDR < 0.01%; no missing values) 
(Figure 6.4A and Supplementary Figure 6.5C). These proteins are 
distributed across all major gene ontology categories and principle 
component analysis (PCA) of their relative abundances recapitulated all 5 
stages of hypoxia-induced dormancy and resuscitations upon re-aeration 
visualized by HCL of tRNA modification (Figures 6.2B, 6.4A, 6.4B and 
Supplementary Figures 6.5E-G). Changes in the level of DosR protein 
significantly diverge from its mRNA counterpart: whereas levels of dosR 
transcripts drop rapidly after H4, DosR reached its maximal levels at H9 and 
was maintained until re-aeration (post-H18). In contrast, changes in 
tRNAThr(cmo5UGU) levels more closely matched those of DosR (Supplementary 
Figure 6.5H). Moreover, dosR is not alone. We applied partial least squares 
(PLS) regression to determine if there was a fundamental relationship 
between the most significantly up- or down-regulated proteins (> 2 fold-
change and with p < 0.05, Supplementary Figures 6.6A, C, D, G, J, M and 
P) and their codon usages. Interestingly at H4, not only could up- or down-
regulated proteins be distinguished based on their codon usages, up-
regulated proteins tended to use ThrACG over ThrACC and down-regulated 
proteins the reverse (0.83 < R2 < 0.91 for Factor-1 which contributes to 38% 
of overall variance) (Figures 6.4C,D and Supplementary Figure 6.6B). At 
other time points, codon choices between AsnAAT/AsnAAC, AspGAT/AspGAC, 
CysTGT/CysTGC, HisCAT/HisCAC, LysAAA/LysAAG and TyrTAT/TyrTAC contributed to 
the separation between up- or down-regulated proteins (Supplementary 
Figure 6.6). These results highlight the subtle but pervasive influence of 
codon usage on gene expression. 
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Figure 6.4. Choice between ThrACG amd ThrACC influences protein up- 
or down-regulation. PCA (A) scores and (B) loadings plots showing the 
clustering of samples (scores) based on fold changes in the 965 most 
quantifiable proteins (loadings).  Groupings of sample eigenvectors (Log ■, 
H4●, H6▲, H9, H14▼,H18 , R3○ and R6□) and protein variables (●) 
highlighted using data eclipses. These reflect growth phenotypes 
(Supplementary Figure 6.1A) and HCL sample clusters (Figure 6.2B). 72% 
of observed variance can be explained by 3 principle components (n = 3, PC-
1: 37%, PC-2: 24%, PC-3: 11%). Acronyms for growth stage explained in text. 
PLS regression analysis of significantly up- (●) or down- (■) regulated 
proteins and their codon usages (●) at H4 visualized by (C) scores and (D) 
X,Y correlation loadings – representing codon usage (X) against extent of 
protein up- or down-regulation (Y).   Protein selected show >2 fold-change 
and p < 0.05 (n = 3; unpaired, two-tailed t-test). Eclipse in (C) represents 
Hoteling T2 limit at p-value of 0.05 (F-test) while those in (D) indicate the 
explained variance. Outer and inner ellipses indicate 100% and 50% 
explained variance respectively. Codons contributing significantly to the 
regression (cross validation, by Marten’s uncertainty test) are circled in black. 
61% of observed variance can be explained by 2 latent factors (n = 3, 
Factor1: 38%, Factor-2: 23%). 
6.4.6. Choice between synonymous threonine codons affects dosR 
expression and hypoxia survival 
To determine if the choice between Thr codons affects translation efficiency 
and the dormancy response, we generated a series of recombinant BCG with 
dosR using solely 1 of 4 possible codons (ACA, ACC, ACG and ACU) to 
encode threonine (See Material and methods, Supplementary Figure 
6.7A). These are termed ΔdosSR::dosSR(ACA) ΔdosSR::dosSR(ACC), 
ΔdosSR::dosSR(ACG) and ΔdosSR::dosSR(ACT) respectively. dosS and 
dosR belong to the same operon and our previous RNAseq analysis 
confirmed that they are co-transcribed on the same mRNA (submitted to 
NCBI GEO). Knocking out both genes (ΔdosSR) is deleterious for 
mycobacteria during hypoxia and upon re-aeration, but its restoration through 
complementation under transcriptional control of its native promoters and 
transcription factors (ΔdosSR::dosSR(WT)) restored fitness (Figure 6.5D and 
Supplementary Figure 6.7B) [51]. Conversely, overexpression of dosR 
retarded growth [52]. In exponential phase growth, under aerobic conditions, 
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these synonymous Thr codon mutations were silent. We observed neither 
discrepancy in growth rate nor altered levels of dosR expression (Figures 
6.5A and B). These mutants also possessed similar transcription efficiency 
for dosR relative to dosS (Figure 6.5C). However, at points in time when we 
observed shifts in translation efficiency for DosR relative to DosS – that is, at 
the hypoxic transition (from H4-H6) and at early resuscitation (From H18 - R3) 
(Figure 6.5C), the mutants diverged in fitness. More ΔdosSR::dosSR(ACC) 
and ΔdosSR::dosSR(ACT) bacilli were recovered at H6, suggesting that 
growth arrest at NRP1 was retarded. This momentary growth advantage was 
lost by H18 where a loss of viability brought the bacteria numbers (CFU/mL) 
back to wild type levels. Upon re-aeration, however, the ability to resuscitate 
ΔdosSR::dosSR(ACC) and ΔdosSR::dosSR(ACG) mutants was diminished 
and cultures had reduced viability at R6 (Figure 6.5D). dosR expression was 
higher than wild-type for ΔdosSR::dosSR(ACA) and ΔdosSR::dosSR(ACG) at 
H6 and H18, while ΔdosSR::dosSR(ACC) and ΔdosSR::dosSR(ACT) 
possessed lower than wild type dosR expression at H6. Intriguingly, while 
dosR expression was decreased for all mutants upon re-aeration, higher than 
wild type levels of dosR were observed for ΔdosSR::dosSR(ACC) and 
ΔdosSR::dosSR(ACG) (Figure 6.5E). Simultaneously, we tracked DosR 
activity by measuring hspX expression. hspX is a prominent member of the 
dosR regulon, and its induction by dosR slows growth [53]. We found that 
hspX expression mirrors that of dosR mRNA levels implying that all 4 
synonymous Thr mutants produced functional DosR protein that was 
translated in a timely manner (Supplementary Figure 6.7C).  
6.5. Discussion 
The seemingly paradoxical phenotypes of these dosR synonymous threonine 
mutants under hypoxic stress could be explained by taking  
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Figure 6.5. dosR mutants re-engineered to used synonymous Thr 
codons showed altered growth phenotypes and dosR expression. 
Notations used for each strain explained in text, figure S7A and table S2. (A) 
Strains had similar growth profiles and (B) dosR mRNA levels (save for 
ΔdosSR – negative control; One-way ANOVA with Tukey’s HSD). Dashed 
line shows mean dosR expression in WT (C) Relative efficiencies of dosR 
transcription relative to dosS (black trace; left y-axis) and DosR translation 
relative to DosS (blue trace, right y-axis). Dashed lines show the 95% 
confidence boundary for  dosR/doss ratios being y = 1 (by ANCOVA),thus 
DosR/DosS ratios beyond this boundary are diverging significantly from 1 
(indicated by *). (D) Difference in fitness and (E) dosR expression of mutant 
strains relative to WT at H6, H18 and R6.( n ≥ 5; mean ± SEM; NS: not 
significant, p < 0.05, p < 0.01 and p < 0.001 are denoted as *, ** and *** 
respectively determined by two-way ANOVA with Bonferroni post-tests (vs. 
Log) considering interactions between mutations and hypoxia.) (F) Schematic 
for selective translation of codon biased transcripts where changes in tRNA 
abundance and modifications regulate protein abundance. 
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into account the changes induced by hypoxia in the tRNAThr pool and that 
DosR activation, through phosphorylation by DosS or DosT (Supplementary 
Figure 6.1A), is necessary and sufficient for dosR transcriptional up-
regulation  [32, 33]. At the hypoxic transition, (H4) tRNAThr(UGU) levels 
increased while levels of tRNAThr(CGU) and tRNAThr(CGU) decreased (Figure 
6.3). tRNAThr(UGU), in turn, was reprogrammed by cmo5U wobble modifications 
to preferably decode ThrACG. Thus, selective translation of transcripts over-
using ThrACG was achieved. Reading of the cognate, but rare, ThrACA was 
permitted, but the ability to decode ThrACC and ThrACU was reduced with 
decreasing tRNAThr(GGU) levels. Hence, translation of ACG- and ACA-enriched 
but not ACC- or ACU-enriched dosR transcripts was enhanced. Since DosR 
positively regulates its own transcription [32, 41], we observed increased 
dosR levels for ΔdosSR::dosSR(ACG) and ΔdosSR::dosSR(ACA) mutants 
which induced hspX expression. This contributed to growth arrest at NRP1 
(H6). Over-production of dosR in ΔdosSR::dosSR(ACG) mutants, however, 
impeded the resuscitation of cultures at R6. In early resuscitation (R3-R6), 
tRNAThr(UGU) and tRNAThr(CGU) returned to their Log-phase levels while 
tRNAThr(GGU) momentarily increased. Wobble uridines were methoxylated to 
mo5U instead. These changes enhanced the reading of ThrACC codons while 
transcripts over-using ThrACG suffer from negative selection. dosR and hspX 
expression thus reverted to their Log-phase levels. In dosSR::dosSR(ACC) 
mutants, translation of ACC-enriched dosR was diminished at H6 but 
enhanced at R6, thereby, selective translation of dosR was mistimed, which 
led to reduced resuscitability (Figure 6.5F). Hence, we teased apart the 
effects synonymous mutations on gene expression and elucidated the 
molecular mechanism for selective translation of codon-biased genes through 
tRNA pool modulations. 
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The studies presented here also provide insights into the biosynthesis of 
mo5U and cmo5U in mycobacteria. In prokaryotes, cmo5U is one of the most 
prevalent wobble base modifications involved in decoding 6 of the 8 fully 
degenerate 4-codon boxes – or up to 24 of the 61 amino acid coding codons 
(Supplementary Figure 6.2) [12, 44].  Our results indicate that wobble 
uridine modifications in the tRNAThr pool are in a state of flux and that the 
steady-state of wobble cmo5U increases under hypoxia, which is in 
agreement with early studies in E. coli, S. typhimurium, and B. subtilis 
showing that cmo5U is preferentially formed under anaerobic conditions 
(Figure 6.3) [54]. The precise biochemical pathway required for its formation 
remains a mystery. Chorismic acid is a key metabolite in its formation and the 
loss of its biosynthetic pathway (AroA-E) prevented the formation of wobble 
cmo5U [54]. Indeed, iTRAQ proteomics detected a spike in chorismate 
synthase (AroC) levels at the hypoxic transition (between H4-H9) – reaching 
over ~1.5 folds of its levels at Log (Appendix II).  How chorismate used in the 
synthesis of cmo5U is unknown. It was assumed based on the phenotype of 
cmoB mutants which possessed wobble ho5U but not cmo5U or mo5U that the 
enzyme CmoB methylates  ho5U to mo5U which is then carboxylated by a 
second enzyme, CmoA,  thought to be a S-adenosyl-methionine (SAM) 
dependent methyltransferase, to cmo5U (Supplementary Figure 6.8A) [55, 
56]. In agreement, null mutation of CmoA results in the accumulation of tRNA 
containing mo5U34 and ho5U34 [55]. However, recent structural studies on 
CmoA and CmoB revealed that chorismate is presumably converted to 
prephenate which is used by CmoA to generate the ylide carboxy-S-
adenosyl-L-methionine (Cx-SAM) [56, 57]. CmoB then uses the sulfonium 
heteroatom to directly acetylate ho5U in a single step reaction without the 
formation of mo5U intermediate [57].  This finding together with our 
observation that levels of mo5U and cmo5U move in opposite trends strongly 
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indicates that either CmoB itself in the absence of Cx-SAM, or a third hitherto 
undiscovered enzyme, can catalyze the methylation of ho5U to mo5U in 
competition to the tRNA 5-oxyacetyluridine(34) synthase activity of CmoB 
(Supplementary Figure 8B). Hypoxia shifts the equilibrium between these 
two competing pathways towards the formation of cmo5U by modulating 
CmoA activity. Though these had not been annotated in BCG, however, we 
noted that their closest homologs BCG_06121 (55% coverage of CmoA, E-
value = 4e-4 by blastp) and BCG_2975c (51% coverage of CmoB, E-value = 2 
e-5 by blastp) increased by ~6.4 and ~1.5 folds respectively in the hypoxic 
transition (Appendix II). 
At any one point in time, there are between 3000-8000 mRNA molecules in a 
bacterial cell [58, 59]. With copy numbers as low as 0.6 - 2 per gene, finding 
the appropriate transcripts (such as those for dosR and cmoA) for translation 
under the pressure of a rapidly changing external environment could prove to 
be a monumental task. In this chapter, we showed that BCG elegantly 
scheduled transcripts for translation by reprogramming tRNAs to better read 
specific codons over their synonymous counterparts. Genes, such as dosR, 
using a set of complementary codons are transiently prioritized and their 
translation enhanced. Hence, while the genetic code is universal, genetic 
coding and decoding are not; and choices like those between codons like 
ThrACG and ThrACC help coordinate stress responses through selective 
translation. The challenge, once again, is to convert these newfound insights 
into drug development approaches and practical clinical applications. 
6.6. Supplementary material 
6.6.1. Supplementary figures 
                                                          
1
 We also note that BCG_0612 is heavily biased in ACA usage (Z = 2.75, p < 0.01) – a rare codon 
decoded solely by tRNA
Thr(UGU) 
and its modified derivatives (Supplementary Figure 6.2) and preferably 
read during the hypoxic transition (Figure 6.5F). 
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Supplementary Figure 6.1. Hypoxia-induced dormancy in M. bovis BCG. 
(A) Growth of BCG in the Wayne culture system adapted by Ravindran et al. 
[14]. Diamonds, circles, squares and triangles each represent the means of 
≥3 biological replicate cultures grown in the same batch. Error bars represent 
relative error of means. Growth curve plotted by joining geometric means of 
all samples across time points. Top panel: Intensity plot of methylene blue 
decolorization upon reduction. The formation of leucomethylene blue was 
tracked by absorption at 665 nm and correlated to color intensity between 
blue (100% - initial A665) and white (0% - A665 = 0). Flasks were sealed and 
opened at days 1 and 18 (black arrows), complete methylene blue 
decolorization and recolorized was observed at days 7 and 18.5 (white 
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arrows). To determine if cultures remained dormant and viable if flasks 
remained sealed, one flask from each batch remained sealed for another 3 
days till day 21 (denoted H21`). Time points are denoted as Log (day 0), H4 
(day 4), H6 (day 6), H9 (day 9), H14 (day 14), H21` (day 21- dashed lines), 
R3 (day 21) and R6 (day 24). Stage of growth are denoted in italics aerobic 
growth, HT (hypoxic transition), NRP2 (non-replicating persistence stages 1), 
NRP2 (non-replicating persistence stages 2) and ER (early resuscitation). No 
statistical changes in CFU/mLwere detected for H4, H6, H9, H14, H18, R1, 
R3 and H21` samples by one-way ANOVA with Tukey’s HSD.  
(B) Model for the regulation of hypoxia-induced non-replicating persistence by 
DosR. Under hypoxic conditions, DosS and DosT are sensor histidine kinases 
that activate DosR. Induction of DosR up-regulates the dos regulon (which 
dosR and dosS are members of), leading to changes in cellular metabolism, 
protein homeostasis and nucleotide repair. A subsequent enduring hypoxic 
response is induced, enabling the cell to enter non-replicating persistence 
[41, 42, 60-62]. Adapted from Figure 1.2. 
(C) Usage frequencies of threonine codons, ACG, ACA, ACT and ACC, 
across all protein-coding genes in the genome and in genes dosS, sigA and 
dosR. 
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Supplementary Figure 6.2. Presumptive genetic decoding in BCG.  
In this coding chart, symbols connected with lines indicate codons which are read by the same tRNA. Stacked symbols in AUH and GCN boxes 
represent isodecoder pairs for tRNAIle(GAU) and tRNAAla(UCC) respectively. Squares denote cognate Watson-Crick base pairings while circles 
denote non-cognate pairings. Filled symbols denote productive pairings between codon and anticodons that had been validated experimentally 
in prokaryotes [44, 63-67]. Codon-anticodon pairings assigned based on wobble rules of Crick [68], and observations of Yokoyama and 
Nishimura [69], Agris et al. [70], Grosjean et al.[12] and Roth [71]. Xnmn5(s2)Um: 5-iminomethyl-U34 family of hypermodified uridines in which 
mnm5U, mnm5s2U, cmnm5s2U and cmnm5Um had been found in BCG tRNA. Xo
5U: 5-oxyU34 family of hypermodified uridines in which ho
5U, 
mo5U, cmo5U and mcmo5U had been found in BCG tRNA. (G?): Quenosine (G34) family of hypermodified guanosines; however no members 
had been detected in this study. Full names, chemical structures and LC-MS/MS characteristics of all modifications can be found in table S1. 
Amber, Ochre and Opal are stop codons. Only F-metATG, the cannonical start codon, is featured in this scheme.
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Supplementary Figure 6.3. Heat map of codon usage patterns across the 
BCG transcriptome.  
The gene-specific codon counting (GSCC) algorithm was used to analyze all 
3951 protein-coding genes in BCG for all codons choices (including alternate 
start ‘+1’ and stop codons) [72]. Visualization by heat map of over-(yellow) 
and under-(purple) used codons revealed 580 open reading frames that 
possessed codon usages that significantly deviated (Cohen’s d > 0.5) from 
the genome average. Group 1 genes overuse AlaGCT, AsnAAT, AspGAT, CysTGT, 
GlyGGT, HisCAT, IleATA, IleATT, LeuTTA, LeuTTG, PheTTT, ProCCT, ThrACG, TyrTAT, 
ValGTT while under-using AlaGCC, ArgCGC, AsnAAC, AspGAC, CysTGC, GlyGGC, 
HisCAC, IleATC, LeuCTC, LeuCTG, PheTTC, ProCCC, ThrACC, TyrTAC, ValGTC. Group 2 
genes overuse AlaGCC, ArgCGC, AsnAAC, AspGAC, GlyGGC, HisCAC, IleATC, LeuCTG, 
PheTTC, ThrACC while under-using AlaGCA, AlaGCT, ArgCGA, AsnAAT, AspGAT, 
GlyGGT, HisCAT, IleATA, IleATT, LeuTTG, LeuCTT, PheTTT, ProCCA, ProCCT, SerAGT, 
ThrACA, ThrACG, ThrACT, ValGTA and ValGTT. 12 of these codon choices feature 
as determinants of protein up- or down-regulation during hypoxic and 
normoxic shifts (Figure 6.4C and Supplementary Figure 6.5). 
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Figure 6.4. Label-free absolute quantification of the tRNAThr pool in BCG. 
(A) Composite extracted ion chromatograms of the MRM transitions used to 
quantify unique RNAse U2 fragments which define each tRNAThr species. 
Oligonucleotides labeled 1-11 by sequence identity (Precursor ion). Each 
peak is labeled with the identity of its product ion monitored. Dashed line 
shows the elusion gradient of ammonium acetate. 
(B) Calibration curves for the response of RNA oligonucleotides against 1 
pmol of their DNA counterparts of the same sequence. Calibration was 
performed across 2 orders of magnitude (25-2000 fmol RNA). The mean peak 
area ratios were fitted to linear equations where correlation coefficient (R2) 
was determined to >0.995 for all 3 curves. The reproducibility of the 
instrument response was studied by triplicate injections, showing RSD < 11 % 
for all concentrations. Response factors were calculated from the gradient of 
these curves. MRM transitions used are found in Supplementary Table 6.1. 
  
Page | 255  
 
Supplementary Figure 6.5. iTRAQ-based proteomic analysis of BCG 
entering and emerging from hypoxia-induced dormancy.  
(A) Scatterplot of spectrum to peptide matches between X!Tandem and 
Spectrum Mill.  The x and y axes of the scatter plot are the search engines’ 
discriminant scores determined by Scaffold. Vertical and horizontal dashed 
lines define the 95% peptide probability filer. Correct peptide to protein 
assignments are in red; incorrect in blue.  
(B) Peptide receiver operator curve (ROC) plot for the selection of global 
peptide false discovery rate (FDR). Sensitivity is defined as the number of 
correctly identified spectra (y-axis; true positives); fall-out is defined as the 
peptide false discovery rate (FDR) (x-axis, false positives). Blue, red and 
black traces are the ROCs for Spectrum Mill, X!Tandem and combined 
Spectrum Mill and X!Tandem scores respectively. At 4.9% FDR (plateau in 
X!Tandem scores), 2455 proteins were identified.  
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(C) Scatter plot for intensities of the iTRAQ labels (randomized for each 
biological replicate) for all proteins in Log samples. The x-axis plots the 
quantitative values for the first biological replicate; y-axis plots the quantitative 
values for the second (□) and third (●) biological replicate. The 965 most 
quantifiable proteins fall within the 95% confidence interval of the optimal 45° 
reporter ion correlation line which represents a 1:1 ratio between the selected 
quantitative samples.  
(D-F) Gene ontology analysis of the 965 most quantifiable BCG proteins. The 
classification of the protein set was performed according to the 1st level gene 
ontology terms: (D) "Cellular component", (E) "Molecular function" and (F) 
"Biological process". Pie charts show the breakdown according to 2nd level 
classifications. Molecular function in (E) could be further parsed into 
categories for binding, electron carrier activity, enzyme regulator activity, 
guanyl-nucleotide exchange factor activity, metallochaperone activity, nutrient 
reservoir activity, receptor activity, receptor regulator activity.  
(G) MS2 spectra of VFLVDDHEVVR, 1 of 11 peptides which uniquely 
identifies DosR. b and y ion series shown in red and blue respectively. 
Relative quantities of DosR across each experimental time point were defined 
by the iTRAQ intensities in green.  
(H) Changes in the abundances of DosR protein, dosR mRNA and 
tRNAThr(cmo5UGU) across the experimental time course (Fig. S1A). All 
abundances normalized to their values at day 0 (Log) as fold changes. 
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Supplementary Figure 6.6. Entry and exit from a hypoxia-induced dormancy causes the up- and down regulation of proteins with 
distinct codon usage signatures.  
Volcano plots comparison of proteins up- or down-regulation between (A) H4 and Log, (D) H6 and Log, (G) H9 and Log, (J) H14 and Log, (M) 
H18 and Log, (P) R3 and Log, and (C) R6 and Log. The x axis indicates the differential protein expression profiles, plotting the fold-induction 
ratios in a log2 scale. The y axis indicates the statistical significance of the difference in expression (p-value from a t-test) in a log10 scale. 
Proteins >2 fold up-regulated with p < 0.05 are shown in blue; proteins >2 fold down-regulated with p < 0.05 in orange. These proteins are 
further analyzed for codon usage by PLS.  
In R6 vs. Log (C), no proteins made the cut-off, hence, PLS regression analysis was not performed.  
(B) RMSE plot for ThrACG (Y-variable) against the strongest latent factor (Factor 1). The predicted ThrACG value (purple) from the PLS model is 
plotted against the measured ThrACG value (brown). The goodness of this prediction can be validated by the differences between the slopes, 
offset, RMSE and R2 between the prediction and calibration reference. UP and DOWN refer to up- and down-regulated proteins at H4 relative 
to Log (Fig. 3C and S6A).  
PLS regression analysis of the most significantly up- (●) or down- (■) regulated proteins and their codon usages (●) visualized by scores (E – at 
H6; H – at H9; K – at H14; N – at H18; Q – at R3) and loadings plots (F – at H6; I – at H9; L – at H14; O – at H18; R – at R3). Eclipse in scores 
plots represents Hoteling T2 limit at p-value of 0.05 (F-test) while those in loadings plots indicate the explained variance. Outer and inner 
ellipses indicate 100% and 50% explained variance respectively. Codons contributing significantly to the regression (cross validation, by 
applying Marten’s Uncertainty Test) are circled in black. Percentages of observed variances explained by the Factor 1 and 2 are indicated in 
parentheses along their respective axes.
Page | 260  
 
(Legends -  next page) 
Page | 261  
 
Supplementary Figure 6.7. dosR mutants, reengineered with altered 
threonine codon usage, possess varied fitness and mistimed DosR 
activity.  
(A) Construction of mutant BCG strains containing dosR with altered 
threonine codon usage. dosSR were first deleted. Subsequent 
complementation re-introduced reengineered dosSR contructs with its native 
promoter generating strains with genotypes described in table S2. See 
Materials and Methods for full description of the process.  
(B) Turbidity (optical density at 600 nm, OD600) of cultures of recombinant 
BCG at H6, H18 and R6. Dashed line denotes the mean OD600 for wild type 
cultures.  
(C) Fold change in hspX expression of mutant strains relative to WT at H6, 
H18 and R6.  
For (B) and (C) n ≥ 5; mean ± SEM; p < 0.05, p < 0.01 and p < 0.001 are 
denoted as *, ** and *** respectively determined by two-way ANOVA with 
Bonferroni post-tests (vs. Log) considering interactions between mutations 
and hypoxia. Together with changes in CFU (Fig. 4D) and dosR expression 
(Fig S4E),  choice of threonine codon contributes 29.9-42.7% to the total 
variance (p < 0.0001); hypoxic exposures 20.3-38.4% (p < 0.0001)and 
interactions between the two 21.6-22.7% (p < 0.0001).
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Supplementary Figure 6.8. Proposed biosynthetic pathways for the synthesis of cmo5U and mcmo5U. 
(A) Biosynthetic pathway proposed by Nasvall et al [55] based on the phenotypes of cmoA and cmoB null mutants. cmo5U34 is thought to be 
formed in 2 steps. First, ho5U34 is methylated to mo5U34 by CmoB. And subsequently, mo5U34 is carboxylated to cmo5U34 by CmoA. Both 
enzymes require SAM and chorismate or one of its derivatives as cofactors (dashed arrow). The identity of uridine hydrolase is currently 
unknown. 
(B) Alternate biosynthetic pathway integrating the observations of Kim et al. [57], Byrne et al. [56]; Schneider et al. [73]; Nasvall et al. [44, 55]; 
Hagervall et al. [54]; Murao et al. [50] and Chionh et al. (this study). Chorismate is converted to prephenate by chroismate mutases 
(BCG_1002c – Mtb Rv0948c homolog and BCG_1922c – Rv1885c homolog). Prephenate is used as a cofactor by CmoA to generate Cx-SAM 
from SAM, releasing 2-oxo-phenylpropanoate as a by-product. Cx-SAM is a co-factor used by CmoB to directly acetylate ho5U34 to cmo5U34 
without generating mo5U34 intermediates. (?) mo5U34 is made from ho5U34 by a competing reaction catalyzed by either CmoB in the absence 
of CmoA induction or by another unidentified methyltransferase.  
ho5U34: wobble 5-hydroxyuridine; mo5U34: wobble 5-methoxyuridine; cmo5U: wobble uridine-5-oxyacetic acid; SAM: S-adenosyl-methionine; 
Cx-SAM: carboxy-S-adenosyl-L-methionine (reactive ylide form)
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6.6.2. Supplementary tables 
Supplementary Table 6.1. Primer, oligoribonucleotide, peptide 
sequences and strains used in this study. 
(A) Primers for cloning of 5’ and 3’ homologous regions 
















(B) Primers for cloning dosSR promoter and TF binding region 












(C) Primers for screening of mutants 
























(D) Primers for qPCR  
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(E) Oligonucleotides for the quantitation of tRNA species 





Quan: 916.1  346.1 
(w1) 
Qual: 916.1  572.1  
(y2) 
IStd CTCGUA 
Quan: 882.2  330.1 
(w1) 




Quan: 929.1  346.1 
(w1) 
Qual: 929.1  344.0  
(c1) 
IStd CTCGCCTTGTA 
Quan: 895.2  330.1 
(w1) 




Quan: 849.4  304.0 
(c1) 
Qual: 849.4  917.2 (y3) 
IStd GCGTTTCCA 
Quan: 819.4  303.0 
(c1) 
Qual: 819.4  634.1  
(w2) 
 
(F) Peptides for the targeted quantification of proteins 
Protein Role
~





679.8  818.4  
(y7) 
Qual TLLGLLSEGLTNK 




498.8  782.5  
(y8) 
Qual DESFGTLYLTDK 




686.15  548.4  
(y2) 
Qual KDAELTASADSVR 

















Wild type (WT) 
ΔdosSR As 1173P2 plus Δ(dosS-dosR)::hyR  
ΔdosSR::dosSR(WT) 
As ΔdosSR plus attB::[pMV306::dosS-dosR]::kan 
 
ΔdosSR::dosSR(ACA) 
As ΔdosSR plus attB::[pMV306::dosS-dosR(40C>T + 
61C>T + 115C>T +157G>T + 187C>T + 202G>T + 
400G>T + 409C>T]::kan 
 
ΔdosSR::dosSR(ACC) 
As ΔdosSR plus attB::[pMV306::dosS-dosR(40C>G + 
61C>G + 115C>G + 187C>G + 409C>G]::kan 
 
ΔdosSR::dosSR(ACG) 




As ΔdosSR plus attB::[pMV306::dosS-dosR(40C>A + 
61C>A+ 115C>A +157G>A + 187C>A + 202G>A + 
400G>A + 409C>A]::kan 
 
 
# Restriction endonuclease sites underlined. 
* Positive controls. Sequences obtained from [29]. 
^Sequences Obtained from [74]. 
`Cal: External calibration standards. IStd: Spiked internal standards used for 
relative quantitation. 
# Quan: Quantifier ion. Qual: Qualifier ion. Fragment identity indicated in 
parentheses. 
~ Quan: Quantifier peptide. Qual: Qualifier peptide. Unique peptide 
sequences from tryptic digests of target proteins.  
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7.  Targeting mycobacterial stress responses for 
biomarker and drug discovery: A perspective 
7.1. Summary 
The purpose of my research, as presented in this thesis, is to advance our 
understanding of how pathogens of the Mycobacterium tuberculosis (Mtb) 
complex regulate their gene expression in response to physiological stresses. 
Specifically, much of the work was focused on studying the effects of nutrient 
deprivation and hypoxia – stresses associated with the non-replicating, 
persistent and drug tolerant state of mycobacteria within pulmonary 
granulomas. To achieve this, I developed an analytical platform for the 
isolation, purification, characterization and quantification of intracellular RNA 
and its secondary modifications (Chapters 2-4). When combined with whole 
cell phenotype and metabolic screens, global analysis of mRNA levels 
revealed a metabolic shift towards ketogenesis in nutrient deprived 
mycobacterial persisters (Chapter 5). Separately, the dynamic reprogramming 
of tRNA by enzymatic modifications was quantified during hypoxia and, when 
this was matched with simultaneous changes in the proteome, we discovered 
that selective translation of codon-biased transcripts regulate the hypoxia-
induced dormancy response (Chapter 6). Yet, as more and more information 
on the stress response of mycobacteria becomes available, it is increasingly 
difficult not to be amazed – and worried – about the sophisticated strategies 
evolved by these pathogens to circumvent their host’s defenses and survive 
in seemingly hostile environments. Thus, in this closing chapter, I identify 
shortcomings in our current approaches to studying myobacteria, build new 
models that link our findings to clinical observations, and propose ways in 
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which our newfound knowledge could be employed to develop biomarkers of 
disease state and strategies for drug discovery. 
 
7.2. Clinical significance: Persister reactivation as a consequence of 
diabetic ketoacidosis 
The growing “co-epidemic” of TB and diabetes mellitus (DM) is a global public 
health concern [1, 2]. At present, 15% of TB cases worldwide are attributable 
to DM. Furthermore, having diabetes triples the risk of acquiring active TB 
and patients with inherent DM and latent TB are 4-times more likely to relapse 
[3-6]. More worrying is the 2- to 9-fold increased risk of MDR TB among 
diabetics [7-12]. Data from one longitudinal study even suggests that diabetic 
patients frequently relapsed with resistant strains [64]. Although the definite 
pathophysiological mechanism of the effect of DM as a predisposing risk 
factor for TB is unknown, several hypotheses had been suggested. They 
include depressed cellular immunity, dysfunction of alveolar macrophages, 
altered levels of pro-inflammatory cytokines including IFN-γ, IL-8 and TNF-α, 
pulmonary microangiopathy, and micronutrient deficiency [2, 13-18]. 
However, there is no explanation for the impact of DM on Mtb drug resistance 
[2, 13]. Our findings related to ketone body metabolism in starvation-induced 
mycobacterial persisters (detailed in Chapter 5) may shed light on this 
phenomenon. 
We propose a model wherein diabetic ketoacidosis induces the reactivation of 
antibiotic tolerant persisters. Diabetic ketoacidosis occurs in patients with both 
type 1 and type 2 DM [19, 20]. In both cases, the lack of proper dietary control 
coupled with exogeneous stress and insulin deficiency or resistance leads to 
the release of free fatty acids from adipose tissue (lipolysis), which are 
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converted, again in the liver, first into acetyl-coA then to the ketone bodies, 
acetoacetate (AA) and β-hydroxybutyrate (βHB) [21]. Part of the acetyl-coA is 
also shunted through the TCA cycle into glucose by gluconeogenesis (Figure 
7.1) [22]. The release of large amounts (>50-times normal blood 
concentrations) of AA, βHB and glucose into the bloodstream cause 
metabolic acidosis and hyperglycermia [21]. Our data suggest that in 
diabetics with latent TB, non-replicating persisters could be reactivated by the 
ketoacidotic conditions. Due to their nutrient deprivation-induced ketogenic 
state within lung granulomas, mycobacterial persisters would readily take up 
and utilize host AA, βHB and glucose (Figures 5.3C, 5.3E, 5.7G and 7.1). 
Glucose removes the block on replication, while the continued presence of 
ketone bodies maintains the induction of cytochrome P450s. Both glucose 
and ketone bodies are used as carbon sources for persister reactivation. The 
latter, in particular, induces an altered pharmacodynamic state through the 
facilitates antibiotic tolerance and the development of genetic drug resistance 
 
 
Figure 7.1. Proposed host-pathogen metabolic interactions leading 
to Mtb persister reactivation in diabetics experiencing ketoacidosis. 
During diabetic ketoacidosis, the metabolism of fatty acids occurs at high 
rates in the liver producing ketone bodies (AA and βHB) that enter the 
bloodstream and reduce its pH. These ketone bodies are transported to 
other organs, including the lung where nonreplicating Mtb resides. This 
provides a carbon source for persister reactivation. Concurrent 
gluconeogenesis in the liver releases glucose that helps to remove 
stringency signals blocking regrowth.  
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induction of bacterial cytochrome P450s in these reactivated persisters, which 
(Chapter 5; Figure 7.1).  
We could directly test this hypothesis in two steps. First, starvation-induced 
BCG and Mtb persisters could be exposed to AA, βHB and glucose in batch 
cultures and their drug susceptibility tested. Our phenotypic screens indicate 
that these persisters readily utilize these metabolites as carbon sources, and 
if our hypothesis is true, we would expect persisters to be reactivated by 
ketone bodies, in both the presence and absence of glucose, to possess 
higher antibiotic tolerances than those resuscitated by nutrient replete 7H9 
media (Figure 5.2A-D). The levels of bacterial cytochrome p450s and their 
activities would be determined using qPCR and chemical probes respectively 
[23, 24]; thereby establishing an experimental link between carbon utilization 
and antibiotic tolerance. Second, further testing of this host-pathogen 
metabolic interaction could be performed in animal models [15]. For instance, 
a Wistar rat model for Mtb could be used [25, 26]. In this model, the treatment 
of Mtb-infected rats with dexamethasone induced the reactivation of bacilli 
otherwise suppressed by the host immunity [25]. Glucagon, a key hormone 
required for the initiation of diabetic ketoacidosis [20], is known to be induced 
by corticosteorids such as dexamethasone [27]. Hence, we could treat Mtb 
infected rats with glucagon to determine if this hormone acts downstream of 
dexamethasone to reactivate Mtb growth. Furthermore, ketosis or insulin 
insensitivity could be induced in these animals by switching them over to 
ketogenic or high-fat hypercaloric diets respectively [28, 29]. If our hypothesis 
is true, we would expect to observe an increase in bacterial burden in these 
rats that is closely associated with the levels of ketone bodies in the blood. 
Levels of bacterial cytochrome P450s could be measured by qPCR, and  
ideally, tRNA modification-based biomarkers could be used to ascertain drug 
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tolerance (see following section). Together, these studies could help aid 
clinical assessment of MDR-TB risks in ketosis-prone type 1 and type 2 
diabetes patients. 
7.3. Disease diagnosis: tRNA modifications as biomarkers of TB 
pathogenesis, stress exposure and antibiotic susceptibility 
Despite my identification of 40 tRNA modifications in BCG – the most in any 
microorganism to date (E.coli: 27 modifications; S. cerevisiae: 24 
modifications. Table 1.4) – and the fact that each stage of hypoxia- induced 
dormancy possessed distinctive tRNA modification patterns (Figure 6.2) - 
some of which (e.g., cmo5U) are highly correlated with the hypoxic stress 
response (Supplementary Figure 6.5H) - several immediate questions 
remain unanswered. Has the full spectrum of tRNA modifications truly been 
determined? Are the same modifications found in Mtb? Most importantly, how 
relevant are the changes that we detect to the actual survival of mycobacterial 
pathogens in their hosts? 
Ongoing research in our laboratory has partially addressed the first two 
questions. 2’-O-Methyladenosine (Am) and queuosine (Q, and its precursors 
or its hypermodified derivatives) are two prominent modifications thought to 
be conserved in prokaryotes that we did not found in our analysis of BCG 
tRNA modifications. We have since acquired chemically synthesized Am 
standards (Berry & Associates, Inc.), which led to identification and 
quantification of Am in the tRNA from M. smegmatis and Pseudomonas 
aeruginosa, 16S and 23S rRNA from BCG (unpublished), and vRNA from 
Dengue virus serotype 2 [30]. Preliminary analysis of tRNA from Mtb strain 
H37Rv by Molecular Feature Extraction of high accuracy LC-QToF mass 
spectra [31], conversely, failed to find Am (Lim et al., unpublished). These 
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results suggest that members of the Mtb complex might not possess Am in 
their tRNA. The failure to detect Q in BCG tRNA, similarly, might be reflective 
of its biology. The absence from BCG of tgt (clusters of orthologous groups 
(COG)-0343) and queA (COG0809) homologs required for the biosynthesis of 
Q suggests that this modified base is not naturally found in mycobacteria [32, 
33]. Nonetheless, rare, uncharacterized modifications, such as the recently 
discovered wobble 2-geranylthiouridine and its derivatives, which are found in 
a small fraction (~ 2.8-6.7%) of E. coli tRNALysUUU and tRNAGlnUUG [34], 
could be missed due to insufficient analytical sensitivity. In addition, our 
current electron spray ionization (ESI) and ion transmission (fragmentor 
voltage) or collision induced dissociation (CID) settings might be too harsh to 
preserve N- and O-linked RNA glycosylations [35]. Repeating our analyses in 
negative ion mode might also yield 2’-O-phosphoribosyl modifications (2'-O-
ribosyladenosine phosphate (Ar(p)) and 2'-O-ribosylguanosine phosphate 
(Gr(p)) that had been described previously in S. cerevisiae [36, 37], as well as 
phosphate modifications such as phosphorothioations [38, 39]. Finally, Mtb 
might contain unique tRNA modifications not found in BCG. For instance, 
lipidomic comparisons between Mtb and BCG recently identified 1-
tuberculosinyladenosine (1-TbAd) as a unique terpene-adducted member of 
the Mtb metabolite pool [40]. It is quite possible that similar modifications 
could be found in Mtb tRNA. 
The longstanding knowledge that modified ribonucleosides are excreted 
rather than recycled by nucleoside salvage pathways [41-43], and 
observations that Mtb secretes unique nucleosides like 1-TbAd [40, 44] raises 
the possibility that these molecules could be used as biomarkers of infection. 
More importantly, each stage of hypoxia survival induced signature changes 
in the abundance of tRNA modifications (Chapter 6). The potential of tRNA 
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modifications as biochemical indicators of stress (including antibiotic) 
exposure and disease state is highlighted by these signature changes, as well 
as our previous results from S. cerevisiae, which indicate that exposures to 
different cytotoxic agents, specifically, methylmethanesulfonate (MMS), 
hydrogen peroxide (H2O2), sodium arsenite (NaAsO2) and sodium 
hypochlorite (NaOCl), give unique patterns of modifications closely 
associated with the mechanism of toxicity [45]. Similarly, the bactericidal 
effects of antibiotics can be thought of as a form of cytotoxic stress. Hence, I 
hypothesize that not only would classes of antibiotics induce changes in tRNA 
modification signatures based on their killing mechanisms, but this signature 
would differ significantly in antibiotic susceptible and resistant (both 
phenotypic or genetic) mycobacteria. This is an easily testable hypothesis, 
which, if true, could be a potentially exploitable property of mycobacterial 
stress responses for the development of biomarkers of cell state and drug 
susceptibility.  
Worldwide, effective management of TB is hamstrung, in part, by the failure to 
obtain timely and accurate diagnosis of the disease [46]. Commonly used 
diagnostic techniques, such as the Tuberculin skin test (Mantoux test) that 
screens for the presence of antibodies against mycobacterial proteins, will 
return false positive results in persons who have had the BCG vaccine [47, 
48], making it unsuitable in many parts of the world – including Singapore. 
Traditional sputum smear microscopy can only detect active infections in 
patients with a relatively high disease burden and is unable to distinguish Mtb 
from other non-tuberculous mycobacterial pathogens (NTMs). In addition, it is 
also difficult to rapidly diagnose MDR-TB. Definitive diagnosis requires 
culturing that could take more than a month, which introduces significant 
delays to appropriate treatment [49]. New molecular diagnostic methods in 
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particular the Xpert® MTB/RIF tests show promise [50, 51], but, being a PCR-
based assay, is not always practical for field work in developing countries with 
high disease burdens [52]. Thus, there is an unmet need in the development 
for rapid, noninvasive diagnostics for disease state and antibiotic 
susceptibility in both the clinical and laboratory setting.  
Given their metabolic stability, distinctiveness and biological roles in stress 
responses, tRNA modifications would make attractive candidates for 
biomarker development. Thus, I propose to examine the utility of these 
ubiquitous natural products as biochemical indicators of mycobacterial 
dormancy and antibiotic susceptibility in a series of steps:  
(1) Compare the spectrum of modified ribonucleosides in BCG with that of 
Mtb. The latter might contain unique RNA modifications that are 
uncharacterized and could thus be useful in distinguishing Mtb infections from 
those caused by other mycobacteria. 
(2) Perform systems-level analysis on changes in tRNA modifications under 
cytotoxic (with antibiotic, nitrosative and oxidative agents, et cetera.) and 
physiological stresses (nutrient deprivation, acid pH, etc.) for both Mtb and 
BCG. The stress-induced changes in tRNA modifications from persisters and 
drug resistant mutant strains would be analyzed, laying the groundwork for 
further studies to identify critical tRNA modification signatures that define 
each stress response. 
(3) Compare these modification profiles using multivariate statistics and 
machine learning algorithms to determine sets of modifications that 
discriminates each group. These would serve as potential biomarker 
candidates of stress exposure and antibiotic resistance. 
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(4) Examine the “secretome” of Mtb in ex vivo macrophage infection models 
[44, 53-55] and in the urine, serum and lung of infected animals [49, 56] for 
the presence of these modified ribonucleosides biomarkers.  
Several possible scenarios could emerge from the proposed studies. The 
ideal one is the discovery of a group of ribonucleosides that is always present 
in the infected animals with active disease, another for latent disease and 
neither are present in the uninfected animals. However, it is likely that no 
single group of ribonucleosides can distinguish infection status. Nonetheless, 
groups of ribonucleosides among infected animals might be sufficiently 
unique and reproducible that they could serve as fingerprints of disease state 
and progression. Just as modification signatures serve as fingerprints of 
stress exposure in vitro, panels of ribonucleoside markers might be predictive 
of increased lethality or antibiotic resistance in vivo. Failing that, the complex 
host immunity-induced stress response signatures represented by the tRNA 
modification profiles of mycobacteria recovered from these infection models 
could be parsed using multivariate breakdown and discriminant function 
analysis into its essential components. These components would then be 
compared to the tRNA signatures of stress exposures previously acquired in 
step 2 to associate infection outcomes and antibiotic susceptibility status with 
their corresponding stress responses. 
Preliminary studies in M. smegmatis show that cytotoxic exposure to 
antibiotics and H2O2 induces dose-dependent changes in the tRNA 
modifications. Some of these profiles possess components that closely 
resemble those of antibiotic tolerant persisters produced by nutrient starvation 
(Cai et al., unpublished). Furthermore, members of our laboratory had also 
managed to recover modified ribonucleosides from the urine of BCG infected 
Wistar rats [57]. These early results will hopefully lead into proof-of-concept 
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studies in Mtb infection models, which if successful, could be extended into 
the analysis of the urine from TB patients. Identification and validation of 
urinary biomarkers could lead to the development of a rapid, non-invasive test 
for the disease state and drug susceptibility of Mtb infections, which would be 
a major boon to global health. 
 
7.4. Drug discovery: targeting tRNA modifications to disrupt 
mycobacterial dormancy and antibiotic tolerance  
Our studies of tRNA modifications in mycobacteria do more than just inform 
us of their potential as functional biomarkers, they also lead us to evaluate the 
mechanism of selective translation wherein reprogrammed tRNA regulate the 
translation priority and abundance of codon biased genes as a target for TB 
drug discovery. Though it is now generally acknowledged that the choice 
between synonymous codons can significantly influence protein abundance 
by changes in translation efficiency [58-62], there is a disparity in our 
understanding of the biophysical mechanisms of translational selection and it 
biological function and significance. Current models of translational section is 
based on a yeast–E.coli paradigm, stating that highly expressed genes use a 
subset of “optimal” codons in accordance with their respective major 
isoacceptor tRNA levels [63-66]. Recent computational and experimental 
models share three common themes: (1) codon bias affects translational rate 
at the elongation step [8, 60-62, 65, 67-70]; (2) associations between local 
mRNA secondary structures to translational rates and protein expression and 
folding [58, 71-74]; (3) availability of tRNAs influence overall translational 
efficiency and ribosomal usage [63, 65, 69, 72, 75-77]. The models also share 
three limitations: (1) maximal growth rate is considered the ideal outcome, 
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even for cells under stress [62, 67, 70, 75, 76, 78-80]; (2) arbitrary 
designation of mRNA secondary structures as beneficial or detrimental to 
translational elongation, cell survival and growth, leading to contradictory 
findings and conclusions [58, 68, 71-73]; and (3) usage of the number of 
tRNA isoacceptor and isodecoder genes as proxy estimations of tRNA copy 
numbers which fails to appreciate changes in tRNA abundance and 
modification status in the tRNA pool [62, 63, 68, 69, 72, 75-77]. Nonetheless, 
these studies all support the premise that codons choice contains more 
information than merely amino acids identity [64, 74, 81]. The biological 
nature of this secondary message, however, remains elusive. 
Together with recent progress with ribosome profiling [65, 82, 83], our recent 
advances in deep tRNA sequencing (tRNA-seq) [84] and quantification of 
tRNA by targeted mass spectrometric (Chapter 6) directly resolved several 
technical issues associated with the aforementioned models. However, the 
current narrow focus on elongation rates and secondary structures as 
determinants of translational control makes our current understanding 
relatively “static”, in that, while these features are undoubtedly necessary for 
proper cellular functioning, they neither account for adaptive changes in 
cellular composition nor participate in dynamic processes [59, 62, 65, 70, 78, 
80]. For instance, our codon re-engineered dosR mutants all possess 
identical 3’ and 5’ structures (no changes were made in the flanking dosS and 
BCG_3157c sequences, Supplementary Figure 6.7) and modest changes to 
local dosR secondary structures (ΔG0 were stable at 28-32 kCal/mol for the 
top 5 structures for all dosR sequences – wild type and mutants – as 
predicted by mfold: http://mfold.rna.albany.edu). Yet, codon re-reengineered 
dosR mutants that showed no differences in growth phenotype at maximal 
growth rates in aerobic conditions, showed altered fitness under hypoxic 
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stress (Figure 6.5). As alluded to in Chapter 6, one possible explanation for 
this phenomenon, from the standpoint of network biology, is that codon usage 
and tRNA modifications work together to ensure an orderly scheduling of 
transcripts for translation. 
At any point in time, cells need to integrate and run multiple genetic programs 
comprised of gene transcripts. However, these programs use the same 
system resources. Two such resources are amino acids and ribosomes. 
Naturally, given sufficient time and resources all transcripts can be translated 
into proteins. The amount of resources each genetic program requires would 
be largely determined by the abundance of their representative transcripts. 
However, during stress when specific stress response programs would need 
to be prioritized ahead of others, a mechanism would be required to allocate 
system resources accordingly. A system monitor, a programming construct 
from computer science, which controls access, by multiple processes, to a 
common resource in a parallel programming environment, could be used to 
allocate priority to specific genetic programs [85-87]. tRNA could play this 
resource monitoring and allocating role. To do so, the “value” of the tRNA is 
re-written by enzymatic modification to designate its decoding partner, 
unlocking translation for specific codon using transcripts but excluding others. 
To illustrate, we consider three tasks that are to be performed under stress, 
one of high priority – essential stress response genes such as dosR, a 
second of medium priority – housekeeping genes, and a third of low priority – 
genes whose expression is detrimental to survival under stress, such as 
those for the rapid synthesis of cellular material in preparation for division. 
Normally, high priority tasks would be allocated resources first, followed by 
medium priority ones, and finally low priority tasks (Figure 7.2A). At the 
hypoxic transition (Supplementary Figure 6.1), we observed that 
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tRNAThr(mo5UGU) is re-written to tRNAThr(cmo5UGU) which shifts the priority of 
translation to ACG (and ACA) biased transcripts from ACC biased ones. 
Decreases in tRNAThr(CUG) levels and steady levels of tRNAThr(GUG) ensures the 
primacy of stress response gene transcripts over housekeeping ones while 
excluding the processing of those using rare ACT codons (Figure 7.2B). By 
swapping synonymous codons, we inverted the priority of transcripts for 
translation. In ΔdosSR::dosSR(ACC) mutants for example (Figure 6.5), initial 
exposure to hypoxia failed to halt bacterial growth, eventually to the loss of 
viability and resuscitability. When dosR lost its ACG bias for the “optimal” 
ACC codon shared by other housekeeping genes (such as sigA), its priority in 
the translational queue was lost. tRNAThr(cmo5U) normally used to grant access 
to threonines fails to recognize the re-engineered dosR transcripts, forcing it 
to compete with other ACC-rich housekeeping genes for threonine (Figure 
7.2D). We note while dosR is best known for the inducing the transcription of 
dos regulon genes, it also binds to and suppress the expression of dozens of 
other genes [88, 89], and its complete loss in dosSR knockouts is deleterious 
to survival under hypoxia (Figure 6.5D). Thus, priority inversion occurs when 
one synonymous threonine codon is swapped for another, limiting the 
capacity of the system to execute high priority tasks (Figure 7.2C and D). 
Obviously, this priority assignment model of selective translation is highly 
speculative. The validity of this model, however, could be tested by 
performing quantitative proteomics and transcriptomics analysis on the dosR 
re-engineered mutants. Rigourous mathemtical descriptions would be 
required to define its parameters and generate predictions of system 
behavior. Its general applicability would also need to be ascertained using 
synthetic biology approaches to engineer gene circuits in other organisms. 
Nonetheless, based on our understanding of tRNA modification mediated 
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Figure 7.2. tRNAs act as system monitors to schedule mRNA for 
translation. (A) Correct scheduling of translational tasks from high to 
medium to low priority. Access to the amino acid threonine is used as an 
example of a common system resource. (B) To initiate the dormancy 
response, levels of tRNAThrcmo5UGU increase allocating Thr to transcripts 
with ACG or ACA first. Though tRNAThrCGU decrease, it too favours 
transcripts using ThrACG. Levels of tRNAThrGGU which favors ThrACC over 
ThrACT codons remains relatively unchanged, thus, giving rise to the 
priority inheritance order of ThrACG≥ThrACA>ThrACC>ThrACT. ThrACA is a rare 
codon and used to a limited extent in a small number of transcripts. (C) A 
problematic scenario in scheduling occurs when a high priority task is 
indirectly preempted by a medium priority task effectively "inverting" the 
relative priorities of the two tasks. (D) This occurred for dosR transcripts 
when we swapped its ThrACG codons for ThrACC. While the remodeling 
events in the tRNAThr pool remains unchanged, dosR transcripts lost their 
priority. Instead, it now competes with other ThrACC-using transcripts for 
threonines. ThrACC is the most common Thr codon used in Mtb and BCG, 
hence, the translation of dosR becomes a purely stochastic event. While 
low levels of DosR aid cell survival, the dormancy response (represented 
by the dos regulon) fails to trigger, cells continue to replicate under 
hypoxia. This effect is exacerbated by the limited ability of tRNAThrcmo5UGU 
to read transcripts using ThrACT, further pushing mutant dosR transcripts 
down the translation queue. 
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selective translation, I propose that it is feasible to design a hybrid whole-cell 
target-based drug screen for theraputics which would block the dormancy 
response of mycobacteria. 
Contemporary drug discovery efforts are based on two broad types of 
screens: phenotypic or whole-cell screens and target-based screens. The 
former looks at the effects, or phenotypes, that compounds induce in cells, 
tissues or whole organisms, whereas the latter measures the effect of 
compounds on a purified target protein via in vitro assays [90-92]. Each 
approach has its own drawbacks. While phenotypic screening can potentially 
lead to the identification of a molecule that modifies cellular phenotypes by 
acting on a previously undescribed target or by acting simultaneously acting 
on multiple targets, much effort and chemoproteomic resources are required 
to elucidate the target or targets affected by the lead compound [91, 93]. 
Target-based screening, on the other hand, uses our understanding of 
genetics, structural biology and biochemistry to provide specific and high 
throughput testing of large compound libraries for molecules that interact with 
a validated drug target. However, this reductionist approach fails to capture 
the pharmacology of small molecules in complex biological systems and as a 
result many candidate drug compounds fail to illicit their anticipated 
responses in vivo [94, 95]. Hence, several efforts had been made to develop 
hybrid screens which incorporate the strengths of both classical phenotypic 
screens and target-based screens without their associated limitations [95, 96].  
Most antibiotics, including first line TB drugs, are more effective against 
replicating than non-replicating bacteria [97-99]. However, a major need in 
global health is to eradicate persistent or non-replicating subpopulations of 
Mtb [100, 101]. Mycobacterial persisters, however, they take days or weeks to 
generate and are difficult to maintain. Furthermore, it is difficult to assess cell 
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killing activities of compounds in persister cultures rapidly. Hence, it is difficult 
to develop phenotypic screens based on mycobacterial persister. 
Development of target-based screens is also complicated as mycobacterial 
persisters likely possess altered pharmacokinetic and pharmacodynamic 
properties which could invalidate in vitro findings (Chapter 5).  
One solution is to prevent Mtb from entering dormancy altogether and thus, 
sensitize the pathogen to antibiotics that kill replicating bacteria. Instead of 
targeting just a single target such as dosR [102-104], the translation of 
multiple stress response proteins, including dosR, could be inhibited by 
targeting cmo5U biosynthesis. This biosynthetic pathway, however, is not 
annotated in mycobacteria. Nonetheless, comparative genomic tools such as 
Integrated Microbial Genomes system (http://img.jgi.doe.gov/cgi-
bin/w/main.cgi/), Clusters of Orthologous Groups 
(http://www.ncbi.nlm.nih.gov/COG/) and BioCys (http://biocyc.org/) could be 
used to identify the enzymes, CmoA and CmoB, responsible for cmo5U 
biosynthesis. Already, we had identified several candidate genes including 
BCG_0612 and BCG_2975c with a relatively high protein sequence homology 
to E.coli cmoA and cmoB respectively (see Chapter 6). Furthermore, we can 
evaluate the molecular phenotypes of transposon mutants from the TraSH 
library for the absence of cmo5U [105, 106]. The identification of cmoA and 
cmoB allows us to construct a strain over-expressing these two enzymes. 
cmoAB over-expression would drive mycobacteria into a dormant-like state by 
increasing the tRNAcmo5UGU levels and driving selective translation of ThrACG 
biased proteins without the need for extensive and sustained stress 
exposures (Figure 7.2). 
To attain a measurable signal for on-target therapeutic activates for high 
throughput screening, we would then introduce a dual fluorescence 
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Figure 7.3. Proposed hybrid target-based phenotypic screen for small molecules that inhibit mycobacterial dormancy. 1. Over-
expression of cmoAB leads to a “pseudo-dormant’ phenotype presenting a target for drug inhibition without the need for extended hypoxic 
exposures. 2. A dual fluorescent reporter is introduced. When small molecules successfully enter and turn “off” enhanced translation, cells 
would appear more green than red. 3. High throughput screens against chemical libraries would reveal lead compound with the ability to 
disrupt multiple codon-anticodon interactions. Adapted from Protein Databank structure 2UU9 and Cai et al. (unpublished) 
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translation activity reporter into the genome of the cmoAB overexpression 
strain. This reporter codes for a fusion protein consisting of an internal control 
fluorescent domain (represented by green fluorescent protein (GFP) in Figure 
7.2), a codon-biased linker made solely out of ThrACG codons, and a selective 
translation signaling fluorescent domain (represented by red fluorescent 
protein (RFP) in Figure 7.2). Baseline translational activities of cells exposed 
to different compounds could be tracked using GFP fluorescence while high 
levels of RFP fluorescence would only be detected when selective translation 
by tRNAcmo5UGU took place. Increased tRNAcmo5UGU levels would lead to the 
efficient read-through of the ThrACG biased linker allowing the RFP domain to 
be translated readily. Hence, we now have an indicator for successful on-
target activity. This comprises of an “on” signal made out of both red and 
green fluorescence and an “off” signal made mainly of green fluorescence. 
The former indicates the failure of the compound to inhibit the enhanced 
translation of the ThrACG biased linker while the latter indicates successful on-
target inhibition leading to reduced translation of the RFP domain (Figure 
7.2). Cultures of these cells could be grown and dispensed into 384 well or 96 
well pates for screens against drug compound libraries based on GFP and 
RFP fluorescence. Unlike traditional targeted-based screens against CmoA or 
CmoB, this approach also possess the added advantage of the whole cell, 
including the mycobacterial cell wall – a considerable pharmacological barrier 
[107] – remaining intact. Thus, hits are more likely to work in vivo. Secondary 
screens for target specificity could be performed by targeted mass 
spectrometry measurements of cmo5U levels from drug candidate treated 
cells. An inhibitor of cmo5U biosynthesis would be extremely potent as it 
would directly affect the decoding of 21 codons in 6 of the 8 four-codon boxes 
(Figure 7.2 and Supplementary Figure 6.2); and could become an 
efficacious first-in-class drug against dormant Mtb. 
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7.5. Conclusion 
The success of mycobacteria pathogens can be attributed to its extraordinary 
stealth and capacity to adapt to environmental changes throughout the course 
of infection. These changes include nutrient starvation and hypoxia, various 
exogenous stress conditions and the intra-phagosomal environment. In this 
thesis, the stress responses induced by nutrient starvation and hypoxia were 
studied in detail. To facilitate these studies we developed of an analytical 
platform for the isolation, purification and quantification of RNA and its 
modifications. This platform is generally applicable to other biological systems 
and will be useful to RNA scientists.  
More importantly, my work furthers our understanding of mycobacterial stress 
responses and how it contributes to phenotypic drug resistance. The study of 
nutrient starvation led us to understand how a shift towards ketogenic 
metabolism and radical formation offer mechanistic insights into starvation-
induced antibiotic tolerance and persistence. Key findings include: 
1. Nutrient deprivation generates viable but reversible persisters.  
2. Starvation survival is modulated in a biphasic manner – an early 
adaptive phase and an extended persistent phase. 
3. Lipolysis and ketogenesis are metabolic signatures of the adaptive 
and persistent phases respectively. 
4. Ketoacidosis is prevented by cytochrome P450s which oxidizes 
ketone bodies generating reactive oxygen species. 
5. The cytochrome P450 reactome bridges carbon cycling and 
xenobiotic detoxification contributing to antibiotic tolerance. 
6. Targeted killing of persisters achieved through disruption of the 
P450 reactome with Fenton chemistry. 
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Though mycobacterial stress responses have been an active field of research 
in the past two decades, knowledge has been mostly limited to adaptations at 
the level of transcription. Knowledge of the translational adaptions to 
physiological stresses had been hitherto limited due to the lack of a platform 
to quantify tRNA, its modifications and their dynamics. Just as previous work 
performed in the Dedon laboratory on the cytotoxic stress response of S. 
cerevisiae indicates strongly wobble modifications on tRNAs control gene 
expression through selective translation [108], I have provided evidence to 
suggest that the survival of pathogenic mycobacteria under hypoxic 
conditions is governed by a similar process. This process mechanistically 
involves key chemical modifications at the wobble base of tRNA to select for 
specific codons that are innately biased in all protein coding mRNA transcripts 
which, in turn, are essential to mount an appropriate response to external 
stresses. Key findings include: 
1. tRNA modifications are dynamic and change as a function of 
exposure to hypoxic stress. 
2. The wobble occupancy of cmo5U and mo5U on tRNAThrUGU are 
hallmarks of the dormant and replicating states. 
3. Signatures of tRNA reprogramming are prevalent in the hypoxic 
proteome. 
4. Up- and down-regulated proteins possess codon enrichments 
which define their expression during translation. 
5. Disruption of this “Code of Codons” adversely affects survival 
under hypoxia. 
These studies show that metabolic shifts and tRNA reprogramming play 
essential roles in mycobacterial pathogenesis; and that their modulation could 
become promising targets for the development of new clinical and laboratory 
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tools that can aid TB management, improve diagnosis, and reverse antibiotic 
tolerance. 
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Appendix I: Modified ribonucleosides in Mycobacterium bovis BCG tRNA 
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Notes: 
a: Method of S. Kellner et al., Chem Commun (Camb) 50, 3516 (Apr 4, 2014). 
b: Previously reported by E. Dudley et al., Rapid Commun Mass Spectrom 19, 3075 (2005). 
c: MS2 fragmention at collision energies of 8eV, 15eV and 30eV matched with previously reported CID spectra (K. Miyauchi, S. Kimura, T. 
Suzuki, Nat Chem Biol 9, 105 (Feb, 2013).). 
d: Isolation and purified by I. Moukadiri, M. J. Garzon, G. R. Bjork, M. E. Armengod, Nucleic Acids Res 42, 2602 (Feb, 2014). 




U standard  at collision energies of 8eV, 15eV and 30eV. 
f: Previously identified by Y. H. Chionh et al., Nucleic Acids Res 41, e168 (Sep, 2013). and C. T. Chan et al., Molecules 16, 5168 (2011). 




G standards  at collision energies of 8eV, 20eV and 45eV. 
h: MS2 and MS3 fragments match with previous reported CID spectra (A. M. Giessing et al., RNA 15, 327 (Feb, 2009). 
i: Further confirmed by MS2 fragmentation of s
2
U standard at collision energies of 8eV, 25eV and 45eV. 
j: Further confirmed by MS2 fragmentation of cmo
5
U standard  at collision energies of 8eV, 15eV and 30eV. 
k: Further confirmed by MS2 fragmentation of cmnm
5
U standard  at collision energies of 8eV, 15eV and 30eV. 






A standards  at collision energies of 8eV, 15eV, 25eV and 45eV. 
m: Further confirmed by MS2 of t
6
A at collision energies of 8eV, 15eV and 30 eV. 
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1
 Confirmed by Sanger sequencing (performed by GeneScript USA Inc.). 
2
 BCG_3157c (blue); dosR (yellow); dosS (green). Start codons underlined. 
3
AAGCCT: HindIII site in non-coding region used for cloning. 
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tttgcagggtgctgtcccgcacgaacgtaatcctgaagtgcagcaacgactctcggacgtggtagacgatctgc
aagacgttatacaggaaatccggaccaccatttatgacctgcacggagcatcgcagggtatcactcggctccg
gcagcgaatcgatgcggccgtagcccaatttgccgactcggggttgcgcaccagcgttcaattcgtgggtccatt
gtcggtggtcgacagcgcgctcgccgatcaggccgaggcggtggttcgggaagcggtcagcaacgcggttcg
ccatgcgaaggccagcacgttgaccgtccgggtcaaagtcgacgacgacttgtgcatcgaggtgaccgacaa
cggccgcgggctgcccgacgagttcaccggaagcggcttaacgaacctgcggcagcgggcagagcaggcc
ggcggcgaattcaccctcgcgagcgtaccgggcgcgagcggaacagtgctgcgatggtcagcaccgttgtcg
cagtagGTCGAC 
 
